CINXE.COM

Atypical antipsychotic - Wikipedia

<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Atypical antipsychotic - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"f80ee14b-f40b-4aeb-a4b1-a331af7607f0","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Atypical_antipsychotic","wgTitle":"Atypical antipsychotic","wgCurRevisionId":1282674019,"wgRevisionId":1282674019,"wgArticleId":185272,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: numeric names: authors list","All articles with incomplete citations","Articles with incomplete citations from August 2013","Articles with incomplete citations from August 2015","Articles with short description","Short description matches Wikidata","Use mdy dates from January 2012","All pages needing factual verification","Wikipedia articles needing factual verification from February 2018","All articles with unsourced statements","Articles with unsourced statements from March 2023","Articles containing potentially dated statements from July 2013","All articles containing potentially dated statements","Commons category link from Wikidata","Atypical antipsychotics","Hallucinogen antidotes","Psychopharmacology","Treatment of psychosis"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Atypical_antipsychotic","wgRelevantArticleId":185272,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":100000,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q758295","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGELevelingUpEnabledForUser":false}; RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.tablesorter.styles":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.tablesorter","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cjquery.tablesorter.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022"> <script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.22"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/1200px-Clozapine.svg.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="1132"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/800px-Clozapine.svg.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="755"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/640px-Clozapine.svg.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="604"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="Atypical antipsychotic - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Atypical_antipsychotic"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Atypical_antipsychotic"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Atypical_antipsychotic rootpage-Atypical_antipsychotic skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" title="Main menu" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span> <span class="vector-dropdown-label-text">Main menu</span> </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li><li id="n-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages"><span>Special pages</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <span class="mw-logo-container skin-invert"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </span> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page&#039;s font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span> <span class="vector-dropdown-label-text">Appearance</span> </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/?wmf_source=donate&amp;wmf_medium=sidebar&amp;wmf_campaign=en.wikipedia.org&amp;uselang=en" class=""><span>Donate</span></a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&amp;returnto=Atypical+antipsychotic" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&amp;returnto=Atypical+antipsychotic" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span> <span class="vector-dropdown-label-text">Personal tools</span> </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/?wmf_source=donate&amp;wmf_medium=sidebar&amp;wmf_campaign=en.wikipedia.org&amp;uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Atypical+antipsychotic" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atypical+antipsychotic" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"><!-- CentralNotice --></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-Medical_uses" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Medical_uses"> <div class="vector-toc-text"> <span class="vector-toc-numb">1</span> <span>Medical uses</span> </div> </a> <button aria-controls="toc-Medical_uses-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Medical uses subsection</span> </button> <ul id="toc-Medical_uses-sublist" class="vector-toc-list"> <li id="toc-Schizophrenia" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Schizophrenia"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.1</span> <span>Schizophrenia</span> </div> </a> <ul id="toc-Schizophrenia-sublist" class="vector-toc-list"> <li id="toc-Efficacy_in_the_treatment_of_schizophrenia" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Efficacy_in_the_treatment_of_schizophrenia"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.1.1</span> <span>Efficacy in the treatment of schizophrenia</span> </div> </a> <ul id="toc-Efficacy_in_the_treatment_of_schizophrenia-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Bipolar_disorder" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Bipolar_disorder"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.2</span> <span>Bipolar disorder</span> </div> </a> <ul id="toc-Bipolar_disorder-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Major_depressive_disorder" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Major_depressive_disorder"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.3</span> <span>Major depressive disorder</span> </div> </a> <ul id="toc-Major_depressive_disorder-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Autism" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Autism"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.4</span> <span>Autism</span> </div> </a> <ul id="toc-Autism-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Dementia_and_Alzheimer&#039;s_disease" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Dementia_and_Alzheimer&#039;s_disease"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.5</span> <span>Dementia and Alzheimer's disease</span> </div> </a> <ul id="toc-Dementia_and_Alzheimer&#039;s_disease-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Comparison_table_of_efficacy" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Comparison_table_of_efficacy"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.6</span> <span>Comparison table of efficacy</span> </div> </a> <ul id="toc-Comparison_table_of_efficacy-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Adverse_effects" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Adverse_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">2</span> <span>Adverse effects</span> </div> </a> <button aria-controls="toc-Adverse_effects-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Adverse effects subsection</span> </button> <ul id="toc-Adverse_effects-sublist" class="vector-toc-list"> <li id="toc-Tardive_dyskinesia" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Tardive_dyskinesia"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.1</span> <span>Tardive dyskinesia</span> </div> </a> <ul id="toc-Tardive_dyskinesia-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Cardiovascular_disease" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Cardiovascular_disease"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.2</span> <span>Cardiovascular disease</span> </div> </a> <ul id="toc-Cardiovascular_disease-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Sexual_side_effects" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Sexual_side_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.3</span> <span>Sexual side effects</span> </div> </a> <ul id="toc-Sexual_side_effects-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Dementia" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Dementia"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.4</span> <span>Dementia</span> </div> </a> <ul id="toc-Dementia-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Drug-induced_OCD" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Drug-induced_OCD"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.5</span> <span>Drug-induced OCD</span> </div> </a> <ul id="toc-Drug-induced_OCD-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Metabolism" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Metabolism"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.6</span> <span>Metabolism</span> </div> </a> <ul id="toc-Metabolism-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Comparison_table_of_adverse_effects" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Comparison_table_of_adverse_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.7</span> <span>Comparison table of adverse effects</span> </div> </a> <ul id="toc-Comparison_table_of_adverse_effects-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Discontinuation" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Discontinuation"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.8</span> <span>Discontinuation</span> </div> </a> <ul id="toc-Discontinuation-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Pharmacology" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Pharmacology"> <div class="vector-toc-text"> <span class="vector-toc-numb">3</span> <span>Pharmacology</span> </div> </a> <button aria-controls="toc-Pharmacology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Pharmacology subsection</span> </button> <ul id="toc-Pharmacology-sublist" class="vector-toc-list"> <li id="toc-Pharmacodynamics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pharmacodynamics"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.1</span> <span>Pharmacodynamics</span> </div> </a> <ul id="toc-Pharmacodynamics-sublist" class="vector-toc-list"> <li id="toc-Terms" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Terms"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.1.1</span> <span>Terms</span> </div> </a> <ul id="toc-Terms-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Binding_profile" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Binding_profile"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.2</span> <span>Binding profile</span> </div> </a> <ul id="toc-Binding_profile-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pharmacokinetics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pharmacokinetics"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.3</span> <span>Pharmacokinetics</span> </div> </a> <ul id="toc-Pharmacokinetics-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-History" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#History"> <div class="vector-toc-text"> <span class="vector-toc-numb">4</span> <span>History</span> </div> </a> <ul id="toc-History-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Society_and_culture" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Society_and_culture"> <div class="vector-toc-text"> <span class="vector-toc-numb">5</span> <span>Society and culture</span> </div> </a> <button aria-controls="toc-Society_and_culture-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Society and culture subsection</span> </button> <ul id="toc-Society_and_culture-sublist" class="vector-toc-list"> <li id="toc-Regulatory_status" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Regulatory_status"> <div class="vector-toc-text"> <span class="vector-toc-numb">5.1</span> <span>Regulatory status</span> </div> </a> <ul id="toc-Regulatory_status-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Notes" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Notes"> <div class="vector-toc-text"> <span class="vector-toc-numb">6</span> <span>Notes</span> </div> </a> <ul id="toc-Notes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-See_also" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#See_also"> <div class="vector-toc-text"> <span class="vector-toc-numb">7</span> <span>See also</span> </div> </a> <ul id="toc-See_also-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> <span class="vector-toc-numb">8</span> <span>References</span> </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Further_reading" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Further_reading"> <div class="vector-toc-text"> <span class="vector-toc-numb">9</span> <span>Further reading</span> </div> </a> <ul id="toc-Further_reading-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-External_links" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#External_links"> <div class="vector-toc-text"> <span class="vector-toc-numb">10</span> <span>External links</span> </div> </a> <ul id="toc-External_links-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" title="Table of Contents" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span> <span class="vector-dropdown-label-text">Toggle the table of contents</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Atypical antipsychotic</span></h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 22 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-22" aria-hidden="true" ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span> <span class="vector-dropdown-label-text">22 languages</span> </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D9%85%D8%B6%D8%A7%D8%AF_%D8%BA%D9%8A%D8%B1_%D9%86%D9%85%D8%B7%D9%8A_%D9%84%D9%84%D8%B0%D9%87%D8%A7%D9%86" title="مضاد غير نمطي للذهان – Arabic" lang="ar" hreflang="ar" data-title="مضاد غير نمطي للذهان" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Antipsic%C3%B2tic_at%C3%ADpic" title="Antipsicòtic atípic – Catalan" lang="ca" hreflang="ca" data-title="Antipsicòtic atípic" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Atypisches_Neuroleptikum" title="Atypisches Neuroleptikum – German" lang="de" hreflang="de" data-title="Atypisches Neuroleptikum" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Antipsic%C3%B3tico_at%C3%ADpico" title="Antipsicótico atípico – Spanish" lang="es" hreflang="es" data-title="Antipsicótico atípico" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A2%D9%86%D8%AA%DB%8C%E2%80%8C%D8%B3%D8%A7%DB%8C%DA%A9%D9%88%D8%AA%DB%8C%DA%A9_%D8%A2%D8%AA%DB%8C%D9%BE%DB%8C%DA%A9%D8%A7%D9%84" title="آنتی‌سایکوتیک آتیپیکال – Persian" lang="fa" hreflang="fa" data-title="آنتی‌سایکوتیک آتیپیکال" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Antipsychotique_atypique" title="Antipsychotique atypique – French" lang="fr" hreflang="fr" data-title="Antipsychotique atypique" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EB%B9%84%EC%A0%95%ED%98%95%EC%A0%81_%ED%95%AD%EC%A0%95%EC%8B%A0%EB%B3%91%EC%A0%9C%EC%A0%9C" title="비정형적 항정신병제제 – Korean" lang="ko" hreflang="ko" data-title="비정형적 항정신병제제" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Antipsicotico_atipico" title="Antipsicotico atipico – Italian" lang="it" hreflang="it" data-title="Antipsicotico atipico" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%AA%D7%A8%D7%95%D7%A4%D7%95%D7%AA_%D7%90%D7%A0%D7%98%D7%99-%D7%A4%D7%A1%D7%99%D7%9B%D7%95%D7%98%D7%99%D7%95%D7%AA_%D7%9C%D7%90_%D7%98%D7%99%D7%A4%D7%95%D7%A1%D7%99%D7%95%D7%AA" title="תרופות אנטי-פסיכוטיות לא טיפוסיות – Hebrew" lang="he" hreflang="he" data-title="תרופות אנטי-פסיכוטיות לא טיפוסיות" data-language-autonym="עברית" data-language-local-name="Hebrew" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Atypische_antipsychotica" title="Atypische antipsychotica – Dutch" lang="nl" hreflang="nl" data-title="Atypische antipsychotica" data-language-autonym="Nederlands" data-language-local-name="Dutch" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E9%9D%9E%E5%AE%9A%E5%9E%8B%E6%8A%97%E7%B2%BE%E7%A5%9E%E7%97%85%E8%96%AC" title="非定型抗精神病薬 – Japanese" lang="ja" hreflang="ja" data-title="非定型抗精神病薬" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%8F%E0%AC%9F%E0%AC%BF%E0%AC%AA%E0%AC%BF%E0%AC%95%E0%AC%BE%E0%AC%B2%E0%AD%8D_%E0%AC%86%E0%AC%A3%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%B8%E0%AC%BE%E0%AC%87%E0%AC%95%E0%AD%8B%E0%AC%9F%E0%AC%BF%E0%AC%95" title="ଏଟିପିକାଲ୍ ଆଣ୍ଟିସାଇକୋଟିକ – Odia" lang="or" hreflang="or" data-title="ଏଟିପିକାଲ୍ ଆଣ୍ଟିସାଇକୋଟିକ" data-language-autonym="ଓଡ଼ିଆ" data-language-local-name="Odia" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Antipsic%C3%B3tico_at%C3%ADpico" title="Antipsicótico atípico – Portuguese" lang="pt" hreflang="pt" data-title="Antipsicótico atípico" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Antipsihotic_atipic" title="Antipsihotic atipic – Romanian" lang="ro" hreflang="ro" data-title="Antipsihotic atipic" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%90%D1%82%D0%B8%D0%BF%D0%B8%D1%87%D0%BD%D1%8B%D0%B5_%D0%B0%D0%BD%D1%82%D0%B8%D0%BF%D1%81%D0%B8%D1%85%D0%BE%D1%82%D0%B8%D0%BA%D0%B8" title="Атипичные антипсихотики – Russian" lang="ru" hreflang="ru" data-title="Атипичные антипсихотики" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Atypical_antipsychotic" title="Atypical antipsychotic – Simple English" lang="en-simple" hreflang="en-simple" data-title="Atypical antipsychotic" data-language-autonym="Simple English" data-language-local-name="Simple English" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Atipi%C4%8Dni_antipsihotik" title="Atipični antipsihotik – Serbian" lang="sr" hreflang="sr" data-title="Atipični antipsihotik" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Atipi%C4%8Dni_antipsihotik" title="Atipični antipsihotik – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Atipični antipsihotik" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Atypiska_antipsykotika" title="Atypiska antipsykotika – Swedish" lang="sv" hreflang="sv" data-title="Atypiska antipsykotika" data-language-autonym="Svenska" data-language-local-name="Swedish" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Atipik_antipsikotik" title="Atipik antipsikotik – Turkish" lang="tr" hreflang="tr" data-title="Atipik antipsikotik" data-language-autonym="Türkçe" data-language-local-name="Turkish" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/Thu%E1%BB%91c_ch%E1%BB%91ng_lo%E1%BA%A1n_th%E1%BA%A7n_kh%C3%B4ng_%C4%91i%E1%BB%83n_h%C3%ACnh" title="Thuốc chống loạn thần không điển hình – Vietnamese" lang="vi" hreflang="vi" data-title="Thuốc chống loạn thần không điển hình" data-language-autonym="Tiếng Việt" data-language-local-name="Vietnamese" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E9%9D%9E%E5%85%B8%E5%9E%8B%E6%8A%97%E7%B2%BE%E7%A5%9E%E7%97%85%E8%97%A5%E7%89%A9" title="非典型抗精神病藥物 – Chinese" lang="zh" hreflang="zh" data-title="非典型抗精神病藥物" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target"><span>中文</span></a></li> </ul> <div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q758295#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Atypical_antipsychotic" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Atypical_antipsychotic" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">English</span> </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Atypical_antipsychotic"><span>Read</span></a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">Tools</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Atypical_antipsychotic"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=history"><span>View history</span></a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Atypical_antipsychotic" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Atypical_antipsychotic" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;oldid=1282674019" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Atypical_antipsychotic&amp;id=1282674019&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FAtypical_antipsychotic"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FAtypical_antipsychotic"><span>Download QR code</span></a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Atypical_antipsychotic&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Atypical_antipsychotic&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Atypical_antipsychotics" hreflang="en"><span>Wikimedia Commons</span></a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q758295" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Class of pharmaceutical drugs</div> <p class="mw-empty-elt"> </p> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background-color: #ddbbee">Atypical antipsychotic</th></tr><tr><td colspan="2" class="infobox-subheader"><i><a href="/wiki/Drug_class" title="Drug class">Drug class</a></i></td></tr><tr><td colspan="2" class="infobox-image"><span class="mw-default-size skin-invert-image" typeof="mw:File/Frameless"><a href="/wiki/File:Clozapine.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/330px-Clozapine.svg.png" decoding="async" width="280" height="264" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/500px-Clozapine.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clozapine.svg/560px-Clozapine.svg.png 2x" data-file-width="512" data-file-height="483" /></a></span><div class="infobox-caption"><a href="/wiki/Skeletal_formula" title="Skeletal formula">Skeletal formula</a> of <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, the first atypical antipsychotic (1972)</div></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Synonym" title="Synonym">Synonyms</a></th><td class="infobox-data">Second generation antipsychotic, serotonin–dopamine antagonist</td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">Legal status</th></tr><tr><td colspan="2" class="infobox-below" style="background: #e8e8e8; text-align: center"><a href="https://www.wikidata.org/wiki/Q758295" class="extiw" title="d:Q758295">In Wikidata</a></td></tr></tbody></table> <p>The <b>atypical antipsychotics</b> (<b>AAP</b>), also known as <b>second generation antipsychotics</b> (<b>SGAs</b>) and <b><a href="/wiki/Serotonin" title="Serotonin">serotonin</a>–dopamine antagonists</b> (<b>SDAs</b>),<sup id="cite_ref-Miyake_1-0" class="reference"><a href="#cite_note-Miyake-1"><span class="cite-bracket">&#91;</span>1<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span class="cite-bracket">&#91;</span>2<span class="cite-bracket">&#93;</span></a></sup> are a group of <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> drugs (antipsychotic drugs in general are also known as <a href="/wiki/Tranquilizer" class="mw-redirect" title="Tranquilizer">tranquilizers</a> and <a href="/wiki/Neuroleptic" class="mw-redirect" title="Neuroleptic">neuroleptics</a>, although the latter is usually reserved for the <i><a href="/wiki/Typical_antipsychotics" class="mw-redirect" title="Typical antipsychotics">typical antipsychotics</a></i>) largely introduced after the 1970s and used to treat psychiatric conditions. Some atypical antipsychotics have received regulatory approval (e.g. by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> of the <a href="/wiki/United_States_of_America" class="mw-redirect" title="United States of America">US</a>, the <a href="/wiki/Therapeutic_Goods_Administration" title="Therapeutic Goods Administration">TGA</a> of <a href="/wiki/Australia" title="Australia">Australia</a>, the <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> of the <a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>) for <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, irritability in <a href="/wiki/Autism" title="Autism">autism</a>, and as an <a href="/wiki/Adjuvant_therapy" title="Adjuvant therapy">adjunct</a> in <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a>. </p><p>Both generations of medication tend to block receptors in the brain's <a href="/wiki/Dopamine_pathways" class="mw-redirect" title="Dopamine pathways">dopamine pathways</a>. Atypicals are less likely than <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>&#8212;the most widely used <a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">typical antipsychotic</a>&#8212;to cause <a href="/wiki/Extrapyramidal_symptom" class="mw-redirect" title="Extrapyramidal symptom">extrapyramidal</a> <a href="/wiki/Motor_control" title="Motor control">motor control</a> <a href="/wiki/Disabilities" class="mw-redirect" title="Disabilities">disabilities</a> in patients such as unsteady <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>–type movements, body <a href="/wiki/Rigidity_(neurology)" class="mw-redirect" title="Rigidity (neurology)">rigidity</a>, and involuntary <a href="/wiki/Tremor" title="Tremor">tremors</a>. However, only a few of the atypicals have been demonstrated to be superior to lesser-used, low-<a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">potency</a> first-generation antipsychotics in this regard.<sup id="cite_ref-leucht_3-0" class="reference"><a href="#cite_note-leucht-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Leucht_2013_4-0" class="reference"><a href="#cite_note-Leucht_2013-4"><span class="cite-bracket">&#91;</span>4<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span class="cite-bracket">&#91;</span>5<span class="cite-bracket">&#93;</span></a></sup> </p><p>As experience with these agents has grown, several studies have questioned the utility of broadly characterizing antipsychotic drugs as "atypical/second generation" as opposed to "first generation", noting that each agent has its own efficacy and side-effect profile. It has been argued that a more nuanced view in which the needs of individual patients are matched to the properties of individual drugs is more appropriate.<sup id="cite_ref-Leucht_2013_4-1" class="reference"><a href="#cite_note-Leucht_2013-4"><span class="cite-bracket">&#91;</span>4<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-leucht_3-1" class="reference"><a href="#cite_note-leucht-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup> Although atypical antipsychotics are thought to be safer than typical antipsychotics, they still have severe side effects, including <a href="/wiki/Tardive_dyskinesia" title="Tardive dyskinesia">tardive dyskinesia</a> (a serious movement disorder), <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a>, and increased risk of <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Sudden_Cardiac_Death" class="mw-redirect" title="Sudden Cardiac Death">sudden cardiac death</a>, <a href="/wiki/Thrombus" title="Thrombus">blood clots</a>, and <a href="/wiki/Diabetes" title="Diabetes">diabetes</a>. <a href="/wiki/Obesity" title="Obesity">Significant weight gain</a> may occur. Critics have argued that "the time has come to abandon the terms first-generation and second-generation antipsychotics, as they do not merit this distinction."<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span class="cite-bracket">&#91;</span>6<span class="cite-bracket">&#93;</span></a></sup> </p> <meta property="mw:PageProp/toc" /> <div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=1" title="Edit section: Medical uses"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Atypical antipsychotics are typically used to treat <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> or <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>.<sup id="cite_ref-AHFS_7-0" class="reference"><a href="#cite_note-AHFS-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup> They are also frequently used to treat <a href="/wiki/Psychomotor_agitation" title="Psychomotor agitation">agitation</a> associated with <a href="/wiki/Dementia" title="Dementia">dementia</a>, <a href="/wiki/Anxiety_disorder" title="Anxiety disorder">anxiety disorder</a>, <a href="/wiki/Autism_spectrum_disorder" class="mw-redirect" title="Autism spectrum disorder">autism spectrum disorder</a>, <a href="/wiki/Persecutory_delusion" title="Persecutory delusion">persecutory delusion</a> and <a href="/wiki/Obsessive-compulsive_disorder" class="mw-redirect" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a> (an <a href="/wiki/Off-label_use" title="Off-label use">off-label use</a>).<sup id="cite_ref-Off11_8-0" class="reference"><a href="#cite_note-Off11-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup> In dementia, they should only be considered after other treatments have failed and if the patient is a risk to themselves and/or others.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Schizophrenia">Schizophrenia</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=2" title="Edit section: Schizophrenia"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The first-line psychiatric treatment for schizophrenia is antipsychotic medication,<sup id="cite_ref-fn_72_11-0" class="reference"><a href="#cite_note-fn_72-11"><span class="cite-bracket">&#91;</span>11<span class="cite-bracket">&#93;</span></a></sup> which can reduce the positive symptoms of schizophrenia in about 8–15 days. Antipsychotics only appear to improve secondary <a href="/wiki/Negative_symptoms" class="mw-redirect" title="Negative symptoms">negative symptoms</a> of schizophrenia in the short term and may worsen negative symptoms overall.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span class="cite-bracket">&#91;</span>12<span class="cite-bracket">&#93;</span></a></sup> Overall there is no good evidence that atypical antipsychotics have any therapeutic benefit for treating the negative symptoms of schizophrenia.<sup id="cite_ref-pmc4466178_13-0" class="reference"><a href="#cite_note-pmc4466178-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p><p>There is very little evidence on which to base a risk and benefit assessment of using antipsychotics for long-term treatment.<sup id="cite_ref-pmid27802977_14-0" class="reference"><a href="#cite_note-pmid27802977-14"><span class="cite-bracket">&#91;</span>14<span class="cite-bracket">&#93;</span></a></sup> </p><p>The choice of which antipsychotic to use for a specific patient is based on benefits, risks, and costs.<sup id="cite_ref-Lancet09_15-0" class="reference"><a href="#cite_note-Lancet09-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup> It is debatable whether, as a class, <a href="/wiki/Typical_antipsychotics" class="mw-redirect" title="Typical antipsychotics">typical</a> or atypical antipsychotics are better.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup> Both have equal drop-out and symptom relapse rates when typicals are used at low to moderate dosages.<sup id="cite_ref-AFP07_17-0" class="reference"><a href="#cite_note-AFP07-17"><span class="cite-bracket">&#91;</span>17<span class="cite-bracket">&#93;</span></a></sup> There is a good response in 40–50% of patients, a partial response in 30–40%, and treatment resistance (failure of symptoms to respond satisfactorily after six weeks to two of three different antipsychotics) in the remaining 20%.<sup id="cite_ref-AFP10_18-0" class="reference"><a href="#cite_note-AFP10-18"><span class="cite-bracket">&#91;</span>18<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Clozapine" title="Clozapine">Clozapine</a> is considered a first choice treatment for <a href="/wiki/Treatment_resistant_schizophrenia" class="mw-redirect" title="Treatment resistant schizophrenia">treatment resistant schizophrenia</a>, especially in the short term; in the longer-terms the risks of adverse effects complicate the choice.<sup id="cite_ref-refac_19-0" class="reference"><a href="#cite_note-refac-19"><span class="cite-bracket">&#91;</span>19<span class="cite-bracket">&#93;</span></a></sup> In turn, risperidone, olanzapine, and <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> have been recommended for the treatment of first-episode psychosis.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span class="cite-bracket">&#91;</span>21<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Efficacy_in_the_treatment_of_schizophrenia">Efficacy in the treatment of schizophrenia</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=3" title="Edit section: Efficacy in the treatment of schizophrenia"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The utility of broadly grouping the antipsychotics into first generation and atypical categories has been challenged. It has been argued that a more nuanced view, matching the properties of individual drugs to the needs of specific patients is preferable.<sup id="cite_ref-leucht_3-2" class="reference"><a href="#cite_note-leucht-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup> While the atypical (second-generation) antipsychotics were marketed as offering greater efficacy in reducing psychotic symptoms while reducing side effects (and <a href="/wiki/Extrapyramidal_symptoms" title="Extrapyramidal symptoms">extrapyramidal symptoms</a> in particular) than typical medications, the results showing these effects often lacked robustness, and the assumption was increasingly challenged even as atypical prescriptions were soaring.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span class="cite-bracket">&#91;</span>22<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span class="cite-bracket">&#91;</span>23<span class="cite-bracket">&#93;</span></a></sup> In 2005 the US government body <a href="/wiki/National_Institute_of_Mental_Health" title="National Institute of Mental Health">NIMH</a> published the results of a major independent (not funded by the pharmaceutical companies) multi-site, double-blind study (the CATIE project).<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span class="cite-bracket">&#91;</span>24<span class="cite-bracket">&#93;</span></a></sup> This study compared several atypical antipsychotics to an older, mid-potency typical antipsychotic, <a href="/wiki/Perphenazine" title="Perphenazine">perphenazine</a>, among 1,493 persons with schizophrenia. The study found that only <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a> outperformed perphenazine in discontinuation rate (the rate at which people stopped taking it due to its effects). The authors noted an apparent superior efficacy of olanzapine to the other drugs in terms of reduction in psychopathology and rate of hospitalizations, but olanzapine was associated with relatively severe <a href="/wiki/Metabolism" title="Metabolism">metabolic</a> effects such as a major weight gain problem (averaging 9.4&#160;lbs over 18 months) and increases in <a href="/wiki/Blood_glucose" class="mw-redirect" title="Blood glucose">glucose</a>, <a href="/wiki/Blood_cholesterol_level" class="mw-redirect" title="Blood cholesterol level">cholesterol</a>, and <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>. No other atypical studied (<a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>, and <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>) did better than the typical perphenazine on the measures used, nor did they produce fewer adverse effects than the typical antipsychotic perphenazine (a result supported by a meta-analysis<sup id="cite_ref-leucht_3-3" class="reference"><a href="#cite_note-leucht-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup> by Leucht <i>et al.</i> published in <i><a href="/wiki/The_Lancet" title="The Lancet">The Lancet</a></i>), although more patients discontinued perphenazine owing to extrapyramidal effects compared to the atypical agents (8% vs. 2% to 4%, P=0.002). A phase 2 part of this CATIE study roughly replicated these findings.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span class="cite-bracket">&#91;</span>25<span class="cite-bracket">&#93;</span></a></sup> Compliance has not been shown to be different between the two types.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span class="cite-bracket">&#91;</span>26<span class="cite-bracket">&#93;</span></a></sup> Overall evaluations of the CATIE and other studies have led many researchers to question the first-line prescribing of atypicals over typicals, or even to question the distinction between the two classes.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span class="cite-bracket">&#91;</span>27<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span class="cite-bracket">&#91;</span>28<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span class="cite-bracket">&#91;</span>29<span class="cite-bracket">&#93;</span></a></sup> </p><p>It has been suggested that there is no validity to the term "second-generation antipsychotic drugs" and that the drugs that currently occupy this category are not identical to each other in mechanism, efficacy, and side-effect profiles.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span class="cite-bracket">&#91;</span>30<span class="cite-bracket">&#93;</span></a></sup> </p><p> Each drug has its own mechanism, as Dr. Rif S. El-Mallakh, explained regarding the binding site and occupancy with a focus on the dopamine D2 receptor:</p><blockquote><p>In general, when an antagonist of a neurotransmitter receptor is used, it must occupy a minimum of 65% to 70% of the target receptor to be effective. This is clearly the case when the target is a postsynaptic receptor, such as the dopamine D2 receptor. Similarly, despite significant variability in antidepressant response, blockade of 65% to 80% of presynaptic transport proteins—such as the serotonin reuptake pumps when considering serotoninergic antidepressants, or the norepinephrine reuptake pumps when considering noradrenergic agents such as nortriptyline—is necessary for these medications to be effective.... Depending on the level of intrinsic activity of a partial agonist and clinical goal, the clinician may aim for a different level of receptor occupancy. For example, <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> will act as a dopamine agonist at lower concentrations, but blocks the receptor at higher concentrations. Unlike antagonist antipsychotics, which require only 65% to 70% D2 <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor occupancy</a> to be effective, aripiprazole receptor binding at effective antipsychotic doses is 90% to 95%. Since aripiprazole has an intrinsic activity of approximately 30% (i.e., when it binds, it stimulates the D2 receptor to about 30% of the effect of dopamine binding to the receptor), binding to 90% of the receptors, and displacing endogenous dopamine, allows aripiprazole to replace the background or tonic tone of dopamine, which has been measured at 19% in people with schizophrenia and 9% in controls. Clinically, this still appears as the minimal effective dose achieving maximal response without significant parkinsonism despite &gt;90% receptor occupancy.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span class="cite-bracket">&#91;</span>31<span class="cite-bracket">&#93;</span></a></sup></p></blockquote> <div class="mw-heading mw-heading3"><h3 id="Bipolar_disorder">Bipolar disorder</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=4" title="Edit section: Bipolar disorder"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In bipolar disorder, SGAs are most commonly used to rapidly control <a href="/wiki/Mania" title="Mania">acute mania</a> and <a href="/wiki/Mixed_episodes" class="mw-redirect" title="Mixed episodes">mixed episodes</a>, often in conjunction with mood stabilizers (which tend to have a delayed onset of action in such cases) such as <a href="/wiki/Lithium_(medication)" title="Lithium (medication)">lithium</a> and <a href="/wiki/Sodium_valproate" class="mw-redirect" title="Sodium valproate">valproate</a>. In milder cases of mania or mixed episodes, mood stabilizer monotherapy may be attempted first.<sup id="cite_ref-Maudsley_32-0" class="reference"><a href="#cite_note-Maudsley-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> SGAs are also used to treat other aspects of the disorder (such as acute bipolar depression or as a prophylactic treatment) as adjuncts or as a monotherapy, depending on the drug. Both <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a> and <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a> have demonstrated significant efficacy in all three treatment phases of bipolar disorder. <a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a> (trade name Latuda) has demonstrated some efficacy in the acute depressive phase of bipolar disorder.<sup id="cite_ref-Maudsley_32-1" class="reference"><a href="#cite_note-Maudsley-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-UpToDateBPMT_34-0" class="reference"><a href="#cite_note-UpToDateBPMT-34"><span class="cite-bracket">&#91;</span>34<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Major_depressive_disorder">Major depressive disorder</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=5" title="Edit section: Major depressive disorder"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In <i>non-psychotic</i> <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a> (MDD), some SGAs have demonstrated significant efficacy as adjunctive agents; and, such agents include:<sup id="cite_ref-Coch_35-0" class="reference"><a href="#cite_note-Coch-35"><span class="cite-bracket">&#91;</span>35<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-pmid23554581_36-0" class="reference"><a href="#cite_note-pmid23554581-36"><span class="cite-bracket">&#91;</span>36<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-AmJPsych_37-0" class="reference"><a href="#cite_note-AmJPsych-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span class="cite-bracket">&#91;</span>38<span class="cite-bracket">&#93;</span></a></sup> </p> <ul><li><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></li> <li><a href="/wiki/Brexpiprazole" title="Brexpiprazole">Brexpiprazole</a></li> <li><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></li> <li><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></li> <li><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></li> <li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a><sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span class="cite-bracket">&#91;</span>39<span class="cite-bracket">&#93;</span></a></sup></li></ul> <p>whereas only quetiapine has demonstrated efficacy as a monotherapy in non-psychotic MDD.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span class="cite-bracket">&#91;</span>40<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Olanzapine/fluoxetine" title="Olanzapine/fluoxetine">Olanzapine/fluoxetine</a> is an efficacious treatment in both <i>psychotic</i> and <i>non-psychotic</i> MDD.<sup id="cite_ref-DD_41-0" class="reference"><a href="#cite_note-DD-41"><span class="cite-bracket">&#91;</span>41<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup> </p><p><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a>, <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>, <a href="/wiki/Cariprazine" title="Cariprazine">cariprazine</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, and <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a> have been approved as adjunct treatment for MDD by the FDA in the United States.<sup id="cite_ref-pmid25963405_43-0" class="reference"><a href="#cite_note-pmid25963405-43"><span class="cite-bracket">&#91;</span>43<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span class="cite-bracket">&#91;</span>44<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a>, <a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a>, <a href="/wiki/Lurasidone" title="Lurasidone">lurasidone</a>, and <a href="/wiki/Lumateperone" title="Lumateperone">lumateperone</a><sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span class="cite-bracket">&#91;</span>45<span class="cite-bracket">&#93;</span></a></sup> have been approved, as monotherapies, for <a href="/wiki/Bipolar_depression" class="mw-redirect" title="Bipolar depression">bipolar depression</a>, but as of present, lurasidone has not been approved for MDD.<sup id="cite_ref-pmid25963405_43-1" class="reference"><a href="#cite_note-pmid25963405-43"><span class="cite-bracket">&#91;</span>43<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Autism">Autism</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=6" title="Edit section: Autism"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Both <a href="/wiki/Risperidone" title="Risperidone">risperidone</a> and <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> have received FDA approval for irritability in autism.<sup id="cite_ref-DD_41-1" class="reference"><a href="#cite_note-DD-41"><span class="cite-bracket">&#91;</span>41<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Dementia_and_Alzheimer's_disease"><span id="Dementia_and_Alzheimer.27s_disease"></span>Dementia and Alzheimer's disease</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=7" title="Edit section: Dementia and Alzheimer&#39;s disease"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Between May 2007 and April 2008, Dementia and Alzheimer's together accounted for 28% of atypical antipsychotic use in patients aged 65 or older.<sup id="cite_ref-pmid19727265_46-0" class="reference"><a href="#cite_note-pmid19727265-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup> The U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> requires that all atypical antipsychotics carry a <a href="/wiki/Boxed_warning" title="Boxed warning">black box warning</a> that the medication has been associated with an increased risk of mortality in elderly patients.<sup id="cite_ref-pmid19727265_46-1" class="reference"><a href="#cite_note-pmid19727265-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup> In 2005, the FDA issued an advisory warning of an increased risk of death when atypical antipsychotics are used in dementia.<sup id="cite_ref-pmid21191528_47-0" class="reference"><a href="#cite_note-pmid21191528-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> In the subsequent 5 years, the use of atypical antipsychotics to treat dementia decreased by nearly 50%.<sup id="cite_ref-pmid21191528_47-1" class="reference"><a href="#cite_note-pmid21191528-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> As of now, the only FDA-approved atypical antipsychotic for alzheimer-related dementia is <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>. </p> <div class="mw-heading mw-heading3"><h3 id="Comparison_table_of_efficacy">Comparison table of efficacy</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=8" title="Edit section: Comparison table of efficacy"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <table class="wikitable collapsible collapsed" style="width:100%;"> <tbody><tr> <th colspan="6"><span style="font-size:115%;">Relative efficacy of SGAs</span> </th></tr> <tr> <th>Generic Drug Name<sup id="cite_ref-Coch_35-1" class="reference"><a href="#cite_note-Coch-35"><span class="cite-bracket">&#91;</span>35<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-pmid23554581_36-1" class="reference"><a href="#cite_note-pmid23554581-36"><span class="cite-bracket">&#91;</span>36<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span class="cite-bracket">&#91;</span>48<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Leucht_2013_4-2" class="reference"><a href="#cite_note-Leucht_2013-4"><span class="cite-bracket">&#91;</span>4<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-pmc2762364_49-0" class="reference"><a href="#cite_note-pmc2762364-49"><span class="cite-bracket">&#91;</span>49<span class="cite-bracket">&#93;</span></a></sup></th> <th>Schizophrenia</th> <th>Mania</th> <th>Bipolar Maintenance</th> <th>Bipolar Depression</th> <th>Adjunct in Major Depressive Disorder </th></tr> <tr> <td><a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></td> <td>+++</td> <td>?</td> <td>?</td> <td>?</td> <td>? (+++ as a dysthymia monotherapy, however) </td></tr> <tr> <td><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></td> <td>++</td> <td>++</td> <td>++/+</td> <td>-<sup id="cite_ref-BPD_50-0" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>+++ </td></tr> <tr> <td><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></td> <td>+++</td> <td>++</td> <td>++</td> <td>? (some evidence has suggested efficacy in treating depressive symptoms in mixed/manic episodes<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span class="cite-bracket">&#91;</span>51<span class="cite-bracket">&#93;</span></a></sup>)</td> <td>? </td></tr> <tr> <td><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></td> <td>++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></td> <td>+++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></td> <td>+++</td> <td>+++</td> <td>+++</td> <td>+++</td> <td>? </td></tr> <tr> <td><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></td> <td>+</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></td> <td>+</td> <td>?</td> <td>?</td> <td>+++<sup id="cite_ref-BPD_50-1" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>? </td></tr> <tr> <td><a href="/wiki/Melperone" title="Melperone">Melperone</a></td> <td>+++/++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></td> <td>+++</td> <td>+++</td> <td>++</td> <td>+++/++ (+++ when combined with fluoxetine)<sup id="cite_ref-BPD_50-2" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>++ </td></tr> <tr> <td><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></td> <td>++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a><sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span class="cite-bracket">&#91;</span>52<span class="cite-bracket">&#93;</span></a></sup></td> <td>+</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></td> <td>++</td> <td>++</td> <td>+++</td> <td>++<sup id="cite_ref-BPD_50-3" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>++ </td></tr> <tr> <td><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></td> <td>+++</td> <td>+++</td> <td>++</td> <td>-<sup id="cite_ref-BPD_50-4" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>+ </td></tr> <tr> <td><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></td> <td>++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></td> <td>++/+</td> <td>++/+</td> <td>?</td> <td>-<sup id="cite_ref-BPD_50-5" class="reference"><a href="#cite_note-BPD-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup></td> <td>? </td></tr> <tr> <td><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></td> <td>++</td> <td>?</td> <td>?</td> <td>?</td> <td>? </td></tr> <tr> <td colspan="6"> <p><b>Legend:</b> </p> <dl><dd>- Inefficacious</dd> <dd>+ Less effective than most treatments, but still with some efficacy.</dd> <dd>++ Standard, in terms of efficacy, treatment. No convincing evidence to say it is superior to other standard treatments.</dd> <dd>+++ Very efficacious agent. The efficacy of this treatment in the indication in question has been proven to be significantly greater than many other treatments.</dd></dl> </td></tr></tbody></table> <div class="mw-heading mw-heading2"><h2 id="Adverse_effects">Adverse effects</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=9" title="Edit section: Adverse effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The side effects reportedly associated with the various atypical antipsychotics vary and are medication-specific. </p> <div class="mw-heading mw-heading3"><h3 id="Tardive_dyskinesia">Tardive dyskinesia</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=10" title="Edit section: Tardive dyskinesia"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Both typical and atypical antipsychotics can cause tardive dyskinesia.<sup id="cite_ref-TD08_53-0" class="reference"><a href="#cite_note-TD08-53"><span class="cite-bracket">&#91;</span>53<span class="cite-bracket">&#93;</span></a></sup> According to one study, rates are lower with the atypicals at 3.9% per year as opposed to the typicals at 5.5% per year.<sup id="cite_ref-TD08_53-1" class="reference"><a href="#cite_note-TD08-53"><span class="cite-bracket">&#91;</span>53<span class="cite-bracket">&#93;</span></a></sup> However, tardive dyskinesia typically develops after long-term (possibly decades) use of antipsychotics. It is not clear if atypical antipsychotics, having been in use for a relatively short time, produce a lower incidence of tardive dyskinesia.<sup id="cite_ref-Maudsley_32-2" class="reference"><a href="#cite_note-Maudsley-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-UpToDateSchiz_54-0" class="reference"><a href="#cite_note-UpToDateSchiz-54"><span class="cite-bracket">&#91;</span>54<span class="cite-bracket">&#93;</span></a></sup> </p><p>One hypothesis as to why atypicals have a lower risk of tardive dyskinesia is because they are much less fat-soluble than the typical antipsychotics and because they are readily released from D2 receptor and brain tissue.<sup id="cite_ref-pmid11873706_55-0" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> The typical antipsychotics remain attached to the D2 receptors and accumulate in the brain tissue which may lead to TD.<sup id="cite_ref-pmid11873706_55-1" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Cardiovascular_disease">Cardiovascular disease</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=11" title="Edit section: Cardiovascular disease"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>It has been suggested that atypical antipsychotics increase the risk of cardiovascular disease.<sup id="cite_ref-pmid15156241_56-0" class="reference"><a href="#cite_note-pmid15156241-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span class="cite-bracket">&#91;</span>57<span class="cite-bracket">&#93;</span></a></sup> However, Kabinoff and colleagues (2003) suggest that the increase in cardiovascular disease is seen regardless of the treatment received, and that it is instead caused by many different factors such as lifestyle or diet.<sup id="cite_ref-pmid15156241_56-1" class="reference"><a href="#cite_note-pmid15156241-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup> </p><p>Despite increasing some <a href="/wiki/Cardiovascular_disease#Risk_factors" title="Cardiovascular disease">risk factors</a>, SGAs are not associated with excess cardiovascular mortality when used to treat serious psychiatric disorders.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span class="cite-bracket">&#91;</span>58<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Sexual_side_effects">Sexual side effects</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=12" title="Edit section: Sexual side effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Sexual side effects have also been reported when taking atypical antipsychotics.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span class="cite-bracket">&#91;</span>59<span class="cite-bracket">&#93;</span></a></sup> In males antipsychotics reduce sexual interest, impair sexual performance with the main difficulties being failure to ejaculate.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-0" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> In females there may be abnormal menstrual cycles and infertility.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-1" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> In both males and females the breasts may become enlarged and a fluid will sometimes ooze from the nipples.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-2" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> Sexual adverse effects caused by some antipsychotics are a result of an increase of <a href="/wiki/Prolactin" title="Prolactin">prolactin</a>. Sulpiride and Amisulpiride, as well as Risperdone and paliperidone (to a lesser extent), cause a high increase of prolactin. </p> <div class="mw-heading mw-heading3"><h3 id="Dementia">Dementia</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=13" title="Edit section: Dementia"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In April 2005, the US Food and Drug Administration (FDA) issued an advisory and subsequent black box warning regarding the risks of atypical antipsychotic use among elderly patients with dementia. The FDA advisory was associated with decreases in the use of atypical antipsychotics, especially among elderly patients with dementia.<sup id="cite_ref-dorsey_61-0" class="reference"><a href="#cite_note-dorsey-61"><span class="cite-bracket">&#91;</span>61<span class="cite-bracket">&#93;</span></a></sup> Subsequent research reports confirmed the mortality risks associated with the use of both conventional and atypical antipsychotics to treat patients with dementia. Consequently, in 2008 the FDA issued although a black box warning for classical neuroleptics. Data on treatment efficacies are strongest for atypical antipsychotics. Adverse effects in patients with <a href="/wiki/Dementia" title="Dementia">dementia</a> include an increased risk of mortality and cerebrovascular events, as well as metabolic effects, extrapyramidal symptoms, falls, cognitive worsening, cardiac arrhythmia, and pneumonia.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span class="cite-bracket">&#91;</span>62<span class="cite-bracket">&#93;</span></a></sup> Conventional antipsychotics may pose an even greater safety risk. No clear efficacy evidence exists to support the use of alternative psychotropic classes (e.g. antidepressants, anticonvulsants) in patients with dementia.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span class="cite-bracket">&#91;</span>63<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Drug-induced_OCD">Drug-induced OCD</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=14" title="Edit section: Drug-induced OCD"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Obsessive%E2%80%93compulsive_disorder#Drug-induced_OCD" title="Obsessive–compulsive disorder">Obsessive–compulsive disorder §&#160;Drug-induced OCD</a></div> <p>Many different types of medication can induce in patients that have never had symptoms before. A new chapter about OCD in the <a href="/wiki/DSM-5" title="DSM-5">DSM-5</a> (2013) now specifically includes drug-induced OCD. </p><p>There are reports that some atypical antipsychotics could cause drug-induced OCD in already schizophrenic patients.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span class="cite-bracket">&#91;</span>64<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span class="cite-bracket">&#91;</span>65<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span class="cite-bracket">&#91;</span>66<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span class="cite-bracket">&#91;</span>67<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Metabolism">Metabolism</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=15" title="Edit section: Metabolism"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Recently, metabolic side effects have been of considerable concern to clinicians, patients and the FDA. In 2003, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) required all manufacturers of atypical antipsychotics to change their labeling to include a warning about the risks of <a href="/wiki/Hyperglycemia" title="Hyperglycemia">hyperglycemia</a> and <a href="/wiki/Diabetes" title="Diabetes">diabetes</a> with atypical antipsychotics. It must also be pointed out that although all atypicals must carry the warning on their labeling, some evidence shows that atypicals are not equal in their effects on weight and <a href="/wiki/Insulin_sensitivity" class="mw-redirect" title="Insulin sensitivity">insulin sensitivity</a>.<sup id="cite_ref-pmid14747245_68-0" class="reference"><a href="#cite_note-pmid14747245-68"><span class="cite-bracket">&#91;</span>68<span class="cite-bracket">&#93;</span></a></sup> The general consensus is that clozapine and olanzapine are associated with the greatest effects on weight gain and decreased insulin sensitivity, followed by risperidone and quetiapine.<sup id="cite_ref-pmid14747245_68-1" class="reference"><a href="#cite_note-pmid14747245-68"><span class="cite-bracket">&#91;</span>68<span class="cite-bracket">&#93;</span></a></sup> Ziprasidone and aripiprazole are thought to have the smallest effects on weight and <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>, but clinical experience with these newer agents is not as developed as that with the older agents.<sup id="cite_ref-pmid14747245_68-2" class="reference"><a href="#cite_note-pmid14747245-68"><span class="cite-bracket">&#91;</span>68<span class="cite-bracket">&#93;</span></a></sup> The mechanism of these adverse effects is not completely understood but it is believed to result from a complex interaction between a number of pharmacologic actions of these drugs. Their effects on weight are believed to mostly derive from their actions on the <a href="/wiki/Histamine_H1_receptor" title="Histamine H1 receptor">H<sub>1</sub></a> and <a href="/wiki/5-HT2C_receptor" title="5-HT2C receptor">5-HT<sub>2C</sub></a> receptors, while their effects on insulin sensitivity are believed to be the result of a combination of their effects on body weight (as increased body mass is known to be a risk factor for insulin resistance) and their antagonistic effects on the <a href="/wiki/Muscarinic_acetylcholine_receptor_M3" title="Muscarinic acetylcholine receptor M3">M<sub>3</sub> receptor</a>. Some of the newer agents, however, such as risperidone and its metabolite paliperidone, ziprasidone, lurasidone, aripiprazole, asenapine and iloperidone, have clinically insignificant effects on the <a href="/wiki/Muscarinic_acetylcholine_receptor_M3" title="Muscarinic acetylcholine receptor M3">M<sub>3</sub></a> receptor and appear to carry a lower risk of insulin resistance. Whereas clozapine, olanzapine and quetiapine (indirectly via its active metabolite, norquetiapine) all antagonise the M<sub>3</sub> receptor at therapeutic-relevant concentrations.<sup id="cite_ref-GG_69-0" class="reference"><a href="#cite_note-GG-69"><span class="cite-bracket">&#91;</span>69<span class="cite-bracket">&#93;</span></a></sup> </p><p>Recent evidence suggests a role of the <a href="/wiki/Alpha-1_adrenergic_receptor" title="Alpha-1 adrenergic receptor">α<sub>1</sub> adrenoceptor</a> and <a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub> receptor</a> in the metabolic effects of atypical antipsychotics. The <a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub> receptor</a>, however, is also believed to play a crucial role in the therapeutic advantages of atypical antipsychotics over their predecessors, the typical antipsychotics.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span class="cite-bracket">&#91;</span>70<span class="cite-bracket">&#93;</span></a></sup> </p><p>The two atypical antipsychotics with trials showing that had a low incidence of weight gain in large meta-analysis were lurasidone and aripiprazole.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71"><span class="cite-bracket">&#91;</span>71<span class="cite-bracket">&#93;</span></a></sup> In a meta-analysis of 18 antipsychotics, olanzapine and clozapine exhibited the worst metabolic parameters and aripiprazole, brexpiprazole, cariprazine, lurasidone, and ziprasidone the most benign parameters.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span class="cite-bracket">&#91;</span>72<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a> and <a href="/wiki/Lurasidone" title="Lurasidone">lurasidone</a> have low propensity to cause weight gain.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span class="cite-bracket">&#91;</span>73<span class="cite-bracket">&#93;</span></a></sup> Lumateperone was found to cause minimal weight gain in a long-term 12 month follow-up study.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span class="cite-bracket">&#91;</span>74<span class="cite-bracket">&#93;</span></a></sup> </p><p>A study by Sernyak and colleagues found that the prevalence of diabetes in atypical antipsychotic treatments was statistically significantly higher than that of conventional treatment.<sup id="cite_ref-pmid15156241_56-2" class="reference"><a href="#cite_note-pmid15156241-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup> The authors of this study suggest that there is a causal relationship between atypical antipsychotics and diabetes, however Kabinoff et al. argue that the findings only suggest a temporal association.<sup id="cite_ref-pmid15156241_56-3" class="reference"><a href="#cite_note-pmid15156241-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup> Kabinoff et al. suggest that there is insufficient data from large studies to demonstrate a consistent or significant difference in the risk of insulin resistance during treatment with various atypical antipsychotics.<sup id="cite_ref-pmid15156241_56-4" class="reference"><a href="#cite_note-pmid15156241-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup> Prescribing <a href="/wiki/Topiramate" title="Topiramate">topiramate</a>, <a href="/wiki/Zonisamide" title="Zonisamide">zonisamide</a>, <a href="/wiki/Metformin" title="Metformin">metformin</a>, <a href="/wiki/GLP-1_receptor_agonist" title="GLP-1 receptor agonist">GLP-1 receptor agonists</a>, or <a href="/wiki/Nizatidine" title="Nizatidine">nizatidine</a> alongside an antipsychotic significantly reduces weight gain.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span class="cite-bracket">&#91;</span>75<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Comparison_table_of_adverse_effects">Comparison table of adverse effects</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=16" title="Edit section: Comparison table of adverse effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <table class="wikitable collapsible collapsed" style="width:100%;"> <tbody><tr> <th colspan="15"><span style="font-size:115%;">Comparison of side effects for atypical antipsychotics</span> </th></tr> <tr> <th>Generic Name</th> <th>Weight gain</th> <th><a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">Metabolic Effects</a></th> <th><a href="/wiki/Extrapyramidal_symptoms" title="Extrapyramidal symptoms">EPS</a></th> <th><a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">High <br />prolactin</a></th> <th>Sedation</th> <th><a href="/wiki/Hypotension" title="Hypotension">Hypotension</a> / <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">Orthostasis</a></th> <th><a href="/wiki/QT_interval" title="QT interval">QTc</a> prolongation</th> <th><a href="/wiki/Anticholinergic" title="Anticholinergic">Anti-ACh</a> effects</th> <th>Other adverse effects </th></tr> <tr> <th><a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a> </th> <td><style data-mw-deduplicate="TemplateStyles:r1239334494">@media screen{html.skin-theme-clientpref-night .mw-parser-output div:not(.notheme)>.tmp-color,html.skin-theme-clientpref-night .mw-parser-output p>.tmp-color,html.skin-theme-clientpref-night .mw-parser-output table:not(.notheme) .tmp-color{color:inherit!important}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output div:not(.notheme)>.tmp-color,html.skin-theme-clientpref-os .mw-parser-output p>.tmp-color,html.skin-theme-clientpref-os .mw-parser-output table:not(.notheme) .tmp-color{color:inherit!important}}</style><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td>-</td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td>-</td> <td><a href="/wiki/Seizures" class="mw-redirect" title="Seizures">Seizures</a>, <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">suicidal ideation</a> </td></tr> <tr> <th><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-0" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-1" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-2" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">-</span><sup id="cite_ref-wolters_76-3" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-4" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-5" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-</td> <td>-</td> <td>Seizures (0.1–0.3%), <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>, <a href="/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</a> (&lt;0.1%), <a href="/wiki/Agranulocytosis" title="Agranulocytosis">agranulocytosis</a> (&lt;1%), <a href="/wiki/Leukopenia" title="Leukopenia">leukopenia</a>, <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a>, suicidal ideation, <a href="/wiki/Angioedema" title="Angioedema">angioedema</a> (0.1–1%) </td></tr> <tr> <th><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-6" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">20%</span><sup id="cite_ref-wolters_76-7" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-8" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-9" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-10" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-11" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>-</td> <td><a href="/wiki/Hypersensitivity_reaction" class="mw-redirect" title="Hypersensitivity reaction">Immune hypersensitivity reaction</a>, angioedema, suicidal ideation </td></tr> <tr> <th><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td> </td></tr> <tr> <th><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-12" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–15%</span><sup id="cite_ref-wolters_76-13" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">-</span><sup id="cite_ref-wolters_76-14" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">-</span><sup id="cite_ref-wolters_76-15" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-16" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-17" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td>Seizures (3–5%), agranulocytosis (1.3%), leukopenia, <a href="/wiki/Pneumonia_severity_index" title="Pneumonia severity index">pneumonia</a>, <a href="/wiki/Respiratory_arrest" title="Respiratory arrest">respiratory arrest</a>, <a href="/wiki/Angle_closure_glaucoma" class="mw-redirect" title="Angle closure glaucoma">angle-closure glaucoma</a>, <a href="/wiki/Eosinophilia" title="Eosinophilia">eosinophilia</a> (1%), <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a>, <a href="/wiki/Stevens%E2%80%93Johnson_syndrome" title="Stevens–Johnson syndrome">Stevens–Johnson syndrome</a>, <a href="/wiki/Myocarditis" title="Myocarditis">myocarditis</a>, <a href="/wiki/Erythema_multiforme" title="Erythema multiforme">erythema multiforme</a> and abnormal peristalsis </td></tr> <tr> <th><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-18" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-19" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-20" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-21" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-22" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-23" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td>-</td> <td>Suicidal ideation (0.4–1.1%), <a href="/wiki/Syncope_(medicine)" title="Syncope (medicine)">syncope</a> (0.4%) </td></tr> <tr> <th><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a> </th> <td>-<sup id="cite_ref-wolters_76-24" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-25" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-26" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-27" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-28" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-29" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>Agranulocytosis, seizures (&lt;1%), elevated serum <a href="/wiki/Creatinine" title="Creatinine">creatinine</a> (2–4%) </td></tr> <tr> <th><a href="/wiki/Melperone" title="Melperone">Melperone</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span>/<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span>/<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td>-</td> <td><a href="/wiki/Agranulocytosis" title="Agranulocytosis">Agranulocytosis</a>, <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a> and <a href="/wiki/Leukopenia" title="Leukopenia">leukopenia</a> </td></tr> <tr> <th><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-30" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–15%</span><sup id="cite_ref-wolters_76-31" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20-30%</span><sup id="cite_ref-wolters_76-32" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-33" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-34" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-35" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><a href="/wiki/Pancreatitis" title="Pancreatitis">Acute haemorrhagic pancreatitis</a>, immune hypersensitivity reaction, seizures (0.9%), <a href="/wiki/Status_epilepticus" title="Status epilepticus">status epilepticus</a>, suicidal ideation (0.1–1%) </td></tr> <tr> <th><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-36" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-37" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-38" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-39" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-40" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-41" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/- (7%)</span></td> <td>-</td> <td>Agranulocytosis, leukopenia, <a href="/wiki/Priapism" title="Priapism">priapism</a>, <a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>, <a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">hyperprolactinaemia</a>, <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a><sup id="cite_ref-Prolactin_SD_77-0" class="reference"><a href="#cite_note-Prolactin_SD-77"><span class="cite-bracket">&#91;</span>77<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <th><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a> </th> <td>?</td> <td>?</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-onrust_78-0" class="reference"><a href="#cite_note-onrust-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>?</td> <td>-</td> <td>Insomnia in up to 23%,<sup id="cite_ref-onrust_78-1" class="reference"><a href="#cite_note-onrust-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Creatine_phosphokinase" class="mw-redirect" title="Creatine phosphokinase">CPK</a> elevation<sup id="cite_ref-onrust_78-2" class="reference"><a href="#cite_note-onrust-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a><sup id="cite_ref-onrust_78-3" class="reference"><a href="#cite_note-onrust-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <th><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-42" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–15%</span><sup id="cite_ref-wolters_76-43" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-44" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-45" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-46" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-47" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>Agranulocytosis, leukopenia, neutropenia (0.3%), anaphylaxis, seizures (0.05–0.5%), <a href="/wiki/Priapism" title="Priapism">priapism</a>, <a href="/wiki/Tardive_dyskinesia" title="Tardive dyskinesia">tardive dyskinesia</a> (0.1–5%), suicidal ideation, pancreatitis, syncope (0.3–1%) </td></tr> <tr> <th><a href="/wiki/Remoxipride" title="Remoxipride">Remoxipride</a><sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span class="cite-bracket">&#91;</span>79<span class="cite-bracket">&#93;</span></a></sup> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>-</td> <td>-</td> <td>-<sup id="cite_ref-pmid11873706_55-2" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>?</td> <td>-</td> <td>There is a risk of <a href="/wiki/Aplastic_anaemia" class="mw-redirect" title="Aplastic anaemia">aplastic anaemia</a> risk which is what led to its removal from the market. </td></tr> <tr> <th><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">10–20%</span><sup id="cite_ref-wolters_76-48" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-49" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-50" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-51" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">&gt;30%</span><sup id="cite_ref-wolters_76-52" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-53" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>-</td> <td>Syncope (1%), pancreatitis, hypothermia, agranulocytosis, leukopenia, neutropenia, thrombocytopenia, <a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">hyperprolactinaemia</a>, <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a>,<sup id="cite_ref-Prolactin_SD_77-1" class="reference"><a href="#cite_note-Prolactin_SD-77"><span class="cite-bracket">&#91;</span>77<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">thrombotic thrombocytopenic purpura</a>, <a href="/wiki/Cerebrovascular_incident" class="mw-redirect" title="Cerebrovascular incident">cerebrovascular incident</a> (&lt;5%), tardive dyskinesia (&lt;5%), priapism, neuroleptic malignant syndrome (&lt;1%), <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a>, galactorrhea<sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span class="cite-bracket">&#91;</span>80<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <th><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">+/-</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td>-</td> <td>- </td></tr> <tr> <th><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td>-</td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:firebrick">+++</span></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:green">+</span></td> <td>-</td> <td>Jaundice </td></tr> <tr> <th><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a> </th> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-54" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-55" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-56" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td>-<sup id="cite_ref-wolters_76-57" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">20–30%</span><sup id="cite_ref-wolters_76-58" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:blue">0–10%</span><sup id="cite_ref-wolters_76-59" class="reference"><a href="#cite_note-wolters-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup></td> <td><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239334494" /><span class="tmp-color" style="color:#A65E00">++</span></td> <td>-</td> <td>Syncope (0.6%), dysphagia (0.1–2%), bone marrow suppression, seizure (0.4%), priapism </td></tr></tbody></table> <div class="mw-heading mw-heading3"><h3 id="Discontinuation">Discontinuation</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=17" title="Edit section: Discontinuation"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The <a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a> recommends a gradual withdrawal when discontinuing antipsychotics to avoid acute withdrawal syndrome or rapid relapse.<sup id="cite_ref-Group_2009_192_81-0" class="reference"><a href="#cite_note-Group_2009_192-81"><span class="cite-bracket">&#91;</span>81<span class="cite-bracket">&#93;</span></a></sup> Symptoms of withdrawal commonly include nausea, vomiting, and loss of appetite.<sup id="cite_ref-Had2004_82-0" class="reference"><a href="#cite_note-Had2004-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> Other symptoms may include restlessness, increased sweating, and trouble sleeping.<sup id="cite_ref-Had2004_82-1" class="reference"><a href="#cite_note-Had2004-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> Less commonly there may be a feeling of the world spinning, numbness, or muscle pains.<sup id="cite_ref-Had2004_82-2" class="reference"><a href="#cite_note-Had2004-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> Symptoms generally resolve after a short period of time.<sup id="cite_ref-Had2004_82-3" class="reference"><a href="#cite_note-Had2004-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> </p><p>There is tentative evidence that discontinuation of antipsychotics can result in psychosis.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83"><span class="cite-bracket">&#91;</span>83<span class="cite-bracket">&#93;</span></a></sup> It may also result in reoccurrence of the condition that is being treated.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span class="cite-bracket">&#91;</span>84<span class="cite-bracket">&#93;</span></a></sup> Rarely tardive dyskinesia can occur when the medication is stopped.<sup id="cite_ref-Had2004_82-4" class="reference"><a href="#cite_note-Had2004-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Pharmacology">Pharmacology</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=18" title="Edit section: Pharmacology"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Pharmacodynamics">Pharmacodynamics</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=19" title="Edit section: Pharmacodynamics"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The atypical antipsychotics integrate with the <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> (5-HT), <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> (α, β), and <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> (DA) receptors in order to effectively treat schizophrenia.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span class="cite-bracket">&#91;</span>85<span class="cite-bracket">&#93;</span></a></sup> </p><p><a href="/wiki/Dopamine_receptor_D2" title="Dopamine receptor D2">D<sub>2</sub> Receptor</a>: Hyperactive dopaminergic activity on <a href="/wiki/Dopamine_receptor_D2" title="Dopamine receptor D2">D<sub>2</sub> receptors</a> in the mesolimbic pathway is responsible for the positive symptoms of schizophrenia (hallucinations, delusions, paranoia). After taking an antipsychotic, <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonism</a> of D<sub>2</sub> receptors occurs throughout the entire brain, leading to a number of deleterious side effects from D<sub>2</sub> receptor antagonism throughout the entire <a href="/wiki/Dopaminergic_pathways" title="Dopaminergic pathways">dopamine pathway</a> system. It's not possible to affect D<sub>2</sub> receptors only in the <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>,<sup id="cite_ref-Stahl_AP_Explained_1_86-0" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-S1_87-0" class="reference"><a href="#cite_note-S1-87"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 1<span class="cite-bracket">&#93;</span></a></sup> but <a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub> receptor</a> antagonism reverses these side effects to some extent.<sup id="cite_ref-S2_88-0" class="reference"><a href="#cite_note-S2-88"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 2<span class="cite-bracket">&#93;</span></a></sup> Reducing D<sub>2</sub> dopaminergic activity in the mesolimbic pathway also results in an <a href="/wiki/Anhedonia" title="Anhedonia">anhedonic</a> effect, reducing pleasure and motivation. In the mesocortical pathway to the <a href="/wiki/DLPFC" class="mw-redirect" title="DLPFC">DLPFC</a> and <a href="/wiki/VMPFC" class="mw-redirect" title="VMPFC">VMPFC</a>, endogenous D<sub>2</sub> receptor dopamine activity is sometimes low in schizophrenia, resulting in cognitive, affective, and, broadly, the negative symptoms of schizophrenia. D<sub>2</sub> receptor antagonism further compounds these problems. In the <a href="/wiki/Nigrostriatal_pathway" title="Nigrostriatal pathway">nigrostriatal pathway</a>, D<sub>2</sub> receptor antagonism results in <a href="/wiki/Extrapyramidal_symptoms" title="Extrapyramidal symptoms">extrapyramidal symptoms</a>. If this antagonism occurs long enough, symptoms of EPS may become permanent, even if antipsychotic use is discontinued. In the <a href="/wiki/Tuberoinfundibular_pathway" title="Tuberoinfundibular pathway">tuberoinfundibular pathway</a>, D<sub>2</sub> receptor antagonism results in elevated <a href="/wiki/Prolactin" title="Prolactin">prolactin</a>. If prolactin levels become high enough, <a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">hyperprolactinaemia</a> may occur, resulting in sexual dysfunction, weight gain, more rapid demineralization of bones, and possibly <a href="/wiki/Galactorrhea" title="Galactorrhea">galactorrhea</a> and <a href="/wiki/Amenorrhea" title="Amenorrhea">amenorrhea</a>.<sup id="cite_ref-S1_87-1" class="reference"><a href="#cite_note-S1-87"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 1<span class="cite-bracket">&#93;</span></a></sup> </p><p><a href="/wiki/5-HT2A" class="mw-redirect" title="5-HT2A">5-HT<sub>2A</sub> Receptor</a>: When <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> is released on to <a href="/wiki/Chemical_synapse#Signaling_in_chemical_synapses" title="Chemical synapse">postsynaptic</a> 5-HT<sub>2A</sub> receptors, the dopamine neuron is inhibited, thus acting as a brake on dopamine release.<sup id="cite_ref-S2_88-1" class="reference"><a href="#cite_note-S2-88"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 2<span class="cite-bracket">&#93;</span></a></sup> This brake is disrupted through action of a 5-HT<sub>2A</sub> antagonist, which disinhibits the dopamine neuron, stimulating dopamine release. The result of this is that dopamine competes with antipsychotic D<sub>2</sub> antagonistic action at D<sub>2</sub> receptors, thereby reducing antagonistic binding there and eliminating or lowering D<sub>2</sub> antagonistic effects in several pathways of the dopamine system.<sup id="cite_ref-S2_88-2" class="reference"><a href="#cite_note-S2-88"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 2<span class="cite-bracket">&#93;</span></a></sup> In the nigrostratial pathway, it reduces EPS. In the tuberoinfundibular pathway, it reduces or eliminates prolactin elevation.<sup id="cite_ref-S3_89-0" class="reference"><a href="#cite_note-S3-89"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 3<span class="cite-bracket">&#93;</span></a></sup> Dopamine release in the mesolimbic pathway from 5-HT<sub>2A</sub> antagonism does not appear to be as robust as in the other pathways of the dopamine system, thereby accounting for why atypical antipsychotics still retain part of their efficacy against the positive symptoms of schizophrenia through their D<sub>2</sub> antagonism.<sup id="cite_ref-S3_89-1" class="reference"><a href="#cite_note-S3-89"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 3<span class="cite-bracket">&#93;</span></a></sup> When 5-HT<sub>2A</sub> antagonistic agent particles occupy 5-HT<sub>2A</sub> receptors in the mesocortical pathway and in the prefrontal cortex, the negative symptoms of schizophrenia, affective symptoms, and cognitive deficits and abnormalities are treated and reduced.<sup id="cite_ref-S3_89-2" class="reference"><a href="#cite_note-S3-89"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 3<span class="cite-bracket">&#93;</span></a></sup> Furthermore, 5-HT<sub>2A</sub> receptor antagonism blocks the serotonergic excitation of cortical pyramidal cells, reducing <a href="/wiki/Glutamic_acid" title="Glutamic acid">glutamate</a> release, which in turn lowers hyperactive dopaminergic D<sub>2</sub> receptor activity in the mesolimbic pathway, reducing or eliminating the positive symptoms of schizophrenia.<sup id="cite_ref-S3_89-3" class="reference"><a href="#cite_note-S3-89"><span class="cite-bracket">&#91;</span>Stahl AP Explained 1 - 3<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span class="cite-bracket">&#91;</span>87<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-91" class="reference"><a href="#cite_note-91"><span class="cite-bracket">&#91;</span>88<span class="cite-bracket">&#93;</span></a></sup> </p><p><a href="/wiki/Brexpiprazole" title="Brexpiprazole">Brexpiprazole</a>, approved by the US FDA in 2015, has a similar binding profile to <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> as a partial D2 <a href="/wiki/Agonist" title="Agonist">agonist</a> with moderate <a href="/wiki/Histamine" title="Histamine">histamine</a> binding, but with brexipiprazole has a higher affinity for serotonin receptor <a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub></a>. </p><p>Some effects of <a href="/wiki/5-HT1A" class="mw-redirect" title="5-HT1A">5-HT<sub>1A</sub></a> receptor activation include decreased aggressive behavior/ideation,<sup id="cite_ref-pmid16310183_92-0" class="reference"><a href="#cite_note-pmid16310183-92"><span class="cite-bracket">&#91;</span>89<span class="cite-bracket">&#93;</span></a></sup> increased sociability, and decreased anxiety and depression.<sup class="noprint Inline-Template noprint Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources" title="Wikipedia:No original research"><span title="This claim needs references to reliable secondary sources. (February 2018)">non-primary source needed</span></a></i>&#93;</sup> Blockade of the 5-HT<sub>2C</sub> receptor increases <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>, releasing norepinephrine and dopamine within the brain.<sup id="cite_ref-Stahl_AP_Explained_1_86-4" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup> But neuronal <a href="/wiki/Reuptake" title="Reuptake">reuptake</a> of norepinephrine is <a href="/wiki/Reuptake_inhibitor" title="Reuptake inhibitor">limited sharply</a> by some antipsychotics, e.g. <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>. Increased norepinephrine can cause increased glucose(blood sugar) levels.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93"><span class="cite-bracket">&#91;</span>90<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-94" class="reference"><a href="#cite_note-94"><span class="cite-bracket">&#91;</span>91<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-95" class="reference"><a href="#cite_note-95"><span class="cite-bracket">&#91;</span>92<span class="cite-bracket">&#93;</span></a></sup> Increased blood sugar levels by increased norepinephrine causes hunger in many humans, which is why weight gain occurs with some antipsychotics if the norepinephrine is not inhibited.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span class="cite-bracket">&#91;</span>93<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-97" class="reference"><a href="#cite_note-97"><span class="cite-bracket">&#91;</span>94<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span class="cite-bracket">&#91;</span>95<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-99" class="reference"><a href="#cite_note-99"><span class="cite-bracket">&#91;</span>96<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-100" class="reference"><a href="#cite_note-100"><span class="cite-bracket">&#91;</span>97<span class="cite-bracket">&#93;</span></a></sup> Inhibition of norepinephrine stabilizes mood in humans.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span class="cite-bracket">&#91;</span>98<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/5-HT6" class="mw-redirect" title="5-HT6">5-HT<sub>6</sub></a> receptor antagonists improve cognition, learning, and memory.<sup id="cite_ref-pmid19086256_102-0" class="reference"><a href="#cite_note-pmid19086256-102"><span class="cite-bracket">&#91;</span>99<span class="cite-bracket">&#93;</span></a></sup> The <a href="/wiki/5-HT7" class="mw-redirect" title="5-HT7">5-HT<sub>7</sub></a> receptor is very potent for the mitigation of bipolar conditions and also yields an antidepressant effect. The antipsychotics <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>,<sup id="cite_ref-pmid18308814_103-0" class="reference"><a href="#cite_note-pmid18308814-103"><span class="cite-bracket">&#91;</span>100<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Lurasidone" title="Lurasidone">lurasidone</a>,<sup id="cite_ref-autogenerated1_104-0" class="reference"><a href="#cite_note-autogenerated1-104"><span class="cite-bracket">&#91;</span>101<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-105" class="reference"><a href="#cite_note-105"><span class="cite-bracket">&#91;</span>102<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>,<sup id="cite_ref-106" class="reference"><a href="#cite_note-106"><span class="cite-bracket">&#91;</span>103<span class="cite-bracket">&#93;</span></a></sup> and <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a><sup id="cite_ref-107" class="reference"><a href="#cite_note-107"><span class="cite-bracket">&#91;</span>104<span class="cite-bracket">&#93;</span></a></sup> are very potent at the 5-HT<sub>7</sub> receptor. <a href="/wiki/Receptor_antagonist#Affinity" title="Receptor antagonist">Antagonistic affinity</a> for the <a href="/wiki/Histamine_H1_receptor" title="Histamine H1 receptor">H<sub>1</sub></a> receptor also has an antidepressant effect. H<sub>1</sub> antagonism blocks serotonin and norepinephrine reuptake. Patients with increased histamine levels have been observed to have lower serotonin levels.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108"><span class="cite-bracket">&#91;</span>105<span class="cite-bracket">&#93;</span></a></sup> However, the H<sub>1</sub> receptor is linked to weight gain. To have partial agonism at the <a href="/wiki/5-HT1A" class="mw-redirect" title="5-HT1A">5-HT<sub>1A</sub></a> receptor can yield absence of weight gain in an antipsychotic. This is very relevant for ziprasidone,<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span class="cite-bracket">&#91;</span>106<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span class="cite-bracket">&#91;</span>107<span class="cite-bracket">&#93;</span></a></sup> but it creates a risk for a prolonged QTc interval.<sup id="cite_ref-111" class="reference"><a href="#cite_note-111"><span class="cite-bracket">&#91;</span>108<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-112" class="reference"><a href="#cite_note-112"><span class="cite-bracket">&#91;</span>109<span class="cite-bracket">&#93;</span></a></sup> On the other hand, blockade of the <a href="/wiki/5-HT3" class="mw-redirect" title="5-HT3">5-HT<sub>3</sub></a> receptor removes the risk for a prolonged QTc interval,<sup id="cite_ref-autogenerated1_104-1" class="reference"><a href="#cite_note-autogenerated1-104"><span class="cite-bracket">&#91;</span>101<span class="cite-bracket">&#93;</span></a></sup> but then creates a larger risk for weight gain. Relation to the 5-HT<sub>3</sub> receptor increases caloric uptake and glucose,<sup id="cite_ref-113" class="reference"><a href="#cite_note-113"><span class="cite-bracket">&#91;</span>110<span class="cite-bracket">&#93;</span></a></sup> which is seen in clozapine and olanzapine.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114"><span class="cite-bracket">&#91;</span>111<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span class="cite-bracket">&#91;</span>112<span class="cite-bracket">&#93;</span></a></sup> Other ways for dopamine to resolve is to have agonism at both the D<sub>2</sub> receptor and 5-HT<sub>1A</sub> receptor, which normalizes the dopamine level in the brain. This occurs with <a href="/wiki/Cariprazine" title="Cariprazine">cariprazine</a> and <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>. </p><p>Whether the anhedonic, loss of pleasure and motivation effect resulting from dopamine insufficiency or blockade at D<sub>2</sub> receptors in the mesolimbic pathway, which is mediated in some part by antipsychotics (and despite dopamine release in the mesocortical pathway from 5-HT<sub>2A</sub> antagonism, which is seen in atypical antipsychotics), or the positive mood, mood stabilization, and cognitive improvement effect resulting from atypical antipsychotic serotonergic activity is greater for the overall quality of life effect of an atypical antipsychotic is a question that is variable between individual experience and the atypical antipsychotic(s) being used.<sup id="cite_ref-Stahl_AP_Explained_1_86-5" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Terms">Terms</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=20" title="Edit section: Terms"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">Inhibition.</a> Disinhibition: The opposite process of inhibition, the turning on of a biological function. <a href="/wiki/Exocytosis" title="Exocytosis">Release</a>: Causes the appropriate neurotransmitters to be discharged in vesicles into the synapse where they attempt to bind to and activate a receptor. <a href="/wiki/Downregulation_and_upregulation" title="Downregulation and upregulation">Downregulation and Upregulation</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2023)">citation needed</span></a></i>&#93;</sup> </p> <div class="mw-heading mw-heading3"><h3 id="Binding_profile">Binding profile</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=21" title="Edit section: Binding profile"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><i><u>Note:</u> Unless otherwise specified, the drugs below serve as antagonists/inverse agonists at the receptors listed.</i> </p> <table class="wikitable sortable"> <tbody><tr> <th>Generic Name<sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span class="cite-bracket">&#91;</span>113<span class="cite-bracket">&#93;</span></a></sup></th> <th><a href="/wiki/Dopamine_receptor_D1" title="Dopamine receptor D1">D<sub>1</sub></a></th> <th><a href="/wiki/Dopamine_receptor_D2" title="Dopamine receptor D2">D<sub>2</sub></a></th> <th><a href="/wiki/Dopamine_receptor_D3" title="Dopamine receptor D3">D<sub>3</sub></a></th> <th><a href="/wiki/Dopamine_receptor_D4" title="Dopamine receptor D4">D<sub>4</sub></a></th> <th><a href="/wiki/5-HT1A_receptor" title="5-HT1A receptor">5-HT<sub>1A</sub></a></th> <th><a href="/wiki/5-HT1B_receptor" title="5-HT1B receptor">5-HT<sub>1B</sub></a></th> <th><a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub></a></th> <th><a href="/wiki/5-HT2C_receptor" title="5-HT2C receptor">5-HT<sub>2C</sub></a></th> <th><a href="/wiki/5-HT6_receptor" title="5-HT6 receptor">5-HT<sub>6</sub></a></th> <th><a href="/wiki/5-HT7_receptor" title="5-HT7 receptor">5-HT<sub>7</sub></a> </th> <th><a href="/wiki/Alpha-1A_adrenergic_receptor" title="Alpha-1A adrenergic receptor">α<sub>1A</sub></a></th> <th><a href="/wiki/Alpha-1_adrenergic_receptor" title="Alpha-1 adrenergic receptor">α<sub>1</sub></a></th> <th><a href="/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">α<sub>2</sub></a></th> <th><a href="/wiki/Muscarinic_acetylcholine_receptor_M1" title="Muscarinic acetylcholine receptor M1">M<sub>1</sub></a></th> <th><a href="/wiki/Muscarinic_acetylcholine_receptor_M3" title="Muscarinic acetylcholine receptor M3">M<sub>3</sub></a></th> <th><a href="/wiki/Histamine_H1_receptor" title="Histamine H1 receptor">H<sub>1</sub></a> </th></tr> <tr> <td><a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></td> <td>-</td> <td>++++</td> <td>++++</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>++/+ </td> <td></td> <td>-</td> <td>+/-</td> <td>-</td> <td>-</td> <td>- </td></tr> <tr> <td><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></td> <td>+</td> <td>++++ (PA)</td> <td>+++ (PA)</td> <td>+ (PA)</td> <td>+++ (PA)</td> <td>+</td> <td>+++</td> <td>++ (PA)</td> <td>+</td> <td>+++ (PA) </td> <td></td> <td>++/+</td> <td>+</td> <td>-</td> <td>-</td> <td>++/+ </td></tr> <tr> <td><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></td> <td>+++</td> <td>+++</td> <td>++++</td> <td>+++</td> <td>+++ (PA)</td> <td>+++</td> <td>++++</td> <td>++++</td> <td>++++</td> <td>++++ </td> <td></td> <td>+++</td> <td>+++</td> <td>-</td> <td>-</td> <td>+++ </td></tr> <tr> <td><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></td> <td>-</td> <td>++++</td> <td>++++</td> <td>+</td> <td>-</td> <td>?</td> <td>+++</td> <td>+</td> <td>+</td> <td>+/- </td> <td></td> <td>+ (RC)</td> <td>+ (RC)</td> <td>+</td> <td>?</td> <td>- </td></tr> <tr> <td><a href="/wiki/Brexpiprazole" title="Brexpiprazole">Brexpiprazole</a></td> <td>++</td> <td>+++++ (PA)</td> <td>++++ (PA)</td> <td>++++</td> <td>+++++ (PA)</td> <td>+++</td> <td>+++++</td> <td>+++ (PA)</td> <td>+++</td> <td>++++ </td> <td>++</td> <td></td> <td></td> <td></td> <td>-</td> <td>+++ </td></tr> <tr> <td><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></td> <td></td> <td>++++ (PA)</td> <td>+++++ (PA)</td> <td></td> <td>++++ (PA)</td> <td></td> <td>+++</td> <td>++</td> <td></td> <td>++ </td> <td></td> <td>++</td> <td></td> <td>-</td> <td>-</td> <td>+++ </td></tr> <tr> <td><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></td> <td>++</td> <td>++</td> <td>++</td> <td>+++</td> <td>++ (PA)</td> <td>++/+</td> <td>++++</td> <td>++++</td> <td>+++</td> <td>+++ </td> <td></td> <td>++++</td> <td>+++</td> <td>++++</td> <td>+++</td> <td>++++ </td></tr> <tr> <td><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></td> <td>+</td> <td>+++</td> <td>+++</td> <td>++</td> <td>+ (PA)</td> <td>+</td> <td>+++</td> <td>+</td> <td>++</td> <td>+ </td> <td></td> <td>++++</td> <td>+++/++</td> <td>-</td> <td>-</td> <td>+++ </td></tr> <tr> <td><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></td> <td>+</td> <td>++++</td> <td>++</td> <td>++</td> <td>+++ (PA)</td> <td>?</td> <td>++++</td> <td>+/-</td> <td>?</td> <td>++++ </td> <td></td> <td>-</td> <td>+++/++</td> <td>-</td> <td>-</td> <td>- </td></tr> <tr> <td><a href="/wiki/Melperone" title="Melperone">Melperone</a></td> <td>?</td> <td>++</td> <td>++++</td> <td>++</td> <td>+ (PA)</td> <td>?</td> <td>++</td> <td>+</td> <td>-</td> <td>++ </td> <td></td> <td>++</td> <td>++</td> <td>-</td> <td>-</td> <td>++ </td></tr> <tr> <td><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></td> <td>+++</td> <td>+++</td> <td>+++</td> <td>+++</td> <td>+ (PA)</td> <td>++</td> <td>++++</td> <td>+++</td> <td>+++</td> <td>++ </td> <td></td> <td>++</td> <td>++</td> <td>++++</td> <td>++++</td> <td>++++ </td></tr> <tr> <td><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></td> <td>++</td> <td>+++</td> <td>+++</td> <td>++</td> <td>+ (PA)</td> <td>+++/++</td> <td>++++</td> <td>+</td> <td>-</td> <td>++++/+++ </td> <td></td> <td>+++</td> <td>+++</td> <td>-</td> <td>-</td> <td>+++/++ </td></tr> <tr> <td><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></td> <td>+</td> <td>++/+</td> <td>++/+</td> <td>+</td> <td>++/+ (PA)</td> <td>+</td> <td>+</td> <td>+</td> <td>++</td> <td>+++/++ </td> <td></td> <td>++++</td> <td>+++/++</td> <td>++</td> <td>+++</td> <td>++++ </td></tr> <tr> <td><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></td> <td>++</td> <td>+++</td> <td>++</td> <td>+++</td> <td>+ (PA)</td> <td>++</td> <td>++++</td> <td>++</td> <td>-</td> <td>+++/++ </td> <td>++</td> <td>+++/++</td> <td>++</td> <td>-</td> <td>-</td> <td>++ </td></tr> <tr> <td><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></td> <td>?</td> <td>+++</td> <td>+++</td> <td>+++</td> <td>++/+ (PA)</td> <td>++</td> <td>++++</td> <td>++++</td> <td>+++</td> <td>++ </td> <td></td> <td>++++/+++</td> <td>+</td> <td>-</td> <td>-</td> <td>++/+ </td></tr> <tr> <td><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a></td> <td>?</td> <td>++++</td> <td>++++</td> <td>+++</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>- </td> <td></td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> <td>- </td></tr> <tr> <td><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></td> <td>+++/++</td> <td>+++</td> <td>+++</td> <td>+++/++</td> <td>+++ (PA)</td> <td>+++ (PA)</td> <td>++++</td> <td>+++(PA)</td> <td>++</td> <td>+++ </td> <td></td> <td>+++/++</td> <td>++</td> <td>-</td> <td>-</td> <td>++ </td></tr> <tr> <td><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></td> <td>+++/++</td> <td>+++</td> <td>++++/+++</td> <td>+++</td> <td>++ (PA)</td> <td>+++</td> <td>++++</td> <td>++++ (RC)</td> <td>++++</td> <td>++++/+++ </td> <td></td> <td>+++</td> <td>+++/++</td> <td>++ (RC)</td> <td>++ (RC)</td> <td>++++ </td></tr></tbody></table> <p><b>Legend:</b> </p> <table style="width: 350px"> <tbody><tr> <td></td> <td>No Affinity or No Data </td></tr> <tr> <td>-</td> <td>Clinically Insignificant </td></tr> <tr> <td>+</td> <td>Low </td></tr> <tr> <td>++</td> <td>Moderate </td></tr> <tr> <td>+++</td> <td>High </td></tr> <tr> <td>++++</td> <td>Very High </td></tr> <tr> <td>+++++</td> <td>Exceptionally High </td></tr> <tr> <td>PA</td> <td>Partial Agonist </td></tr> <tr> <td>RC</td> <td>Cloned Rat Receptor </td></tr></tbody></table> <div class="mw-heading mw-heading3"><h3 id="Pharmacokinetics">Pharmacokinetics</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=22" title="Edit section: Pharmacokinetics"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Atypical antipsychotics are most commonly administered orally.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-3" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> Antipsychotics can also be injected, but this method is not as common.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-4" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> They are lipid-soluble, are readily absorbed from the digestive tract, and can easily pass the blood–brain barrier and placental barriers.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-5" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> Once in the brain, the antipsychotics work at the synapse by binding to the receptor.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span class="cite-bracket">&#91;</span>114<span class="cite-bracket">&#93;</span></a></sup> Antipsychotics are completely metabolized in the body and the metabolites are excreted in urine.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-6" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> These drugs have relatively long half-lives.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-7" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> Each drug has a different half-life, but the occupancy of the D2 receptor falls off within 24 hours with atypical antipsychotics, while lasting over 24 hours for the typical antipsychotics.<sup id="cite_ref-pmid11873706_55-3" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> This may explain why relapse into psychosis happens quicker with atypical antipsychotics than with typical antipsychotics, as the drug is excreted faster and is no longer working in the brain.<sup id="cite_ref-pmid11873706_55-4" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> Physical dependence with these drugs is very rare.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-8" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> However, if the drug is abruptly discontinued, psychotic symptoms, movement disorders, and sleep difficulty may be observed.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-9" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> It is possible that withdrawal is rarely seen because the AAP are stored in body fat tissues and slowly released.<sup id="cite_ref-McKim,_W._2007_pp.241-260_60-10" class="reference"><a href="#cite_note-McKim,_W._2007_pp.241-260-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> </p> <table class="wikitable collapsible collapsed" style="width:100%; font-size:88%"> <tbody><tr> <th colspan="10"><span style="font-size:115%;">Pharmacokinetic parameters of available atypical antipsychotics</span><sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span class="cite-bracket">&#91;</span>115<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-119" class="reference"><a href="#cite_note-119"><span class="cite-bracket">&#91;</span>116<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span class="cite-bracket">&#91;</span>117<span class="cite-bracket">&#93;</span></a></sup> </th></tr> <tr> <th>Drug</th> <th>Route(s) of Administration<sup id="cite_ref-121" class="reference"><a href="#cite_note-121"><span class="cite-bracket">&#91;</span>Note 1<span class="cite-bracket">&#93;</span></a></sup></th> <th>Half-life (t<sub>1/2</sub> in hours)</th> <th>Volume of distribution (V<sub>d</sub> in L/kg)</th> <th>Protein binding</th> <th>Excretion</th> <th>Enzymes involved in metabolism</th> <th>Bioavailability</th> <th>Peak plasma time (h)</th> <th>C<sub>max</sub> (ng/mL) </th></tr> <tr> <td><a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></td> <td>Oral</td> <td>12</td> <td>5.8</td> <td>16%</td> <td>Urine (50%), faeces (20%; 70% of this is as unchanged drug)<sup id="cite_ref-122" class="reference"><a href="#cite_note-122"><span class="cite-bracket">&#91;</span>Note 2<span class="cite-bracket">&#93;</span></a></sup></td> <td>?</td> <td>48%</td> <td>Two peaks: 1 hr &amp; 3-4 hrs post-oral dosing</td> <td>39±3 (1 hr), 54±4 (3-4 hrs) </td></tr> <tr> <td><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></td> <td>Oral, intramuscular (including depot)</td> <td>75 (94 for active metabolite)</td> <td>4.9</td> <td>99%</td> <td>Faeces (55%), urine (25%)</td> <td><a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a> &amp; <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>87% (Oral), 100% (<a href="/wiki/Intramuscular" class="mw-redirect" title="Intramuscular">IM</a>)</td> <td>3-5</td> <td>? </td></tr> <tr> <td><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></td> <td>Sublingual</td> <td>24</td> <td>20-25</td> <td>95%</td> <td>Urine (50%), faeces (40%)</td> <td><a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a> &amp; <a href="/wiki/UGT1A4" title="UGT1A4">UGT1A4</a></td> <td>35% (sublingual), &lt;2% (Oral)</td> <td>0.5-1.5</td> <td>4 </td></tr> <tr> <td><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a><sup id="cite_ref-CNS_Drugs_123-0" class="reference"><a href="#cite_note-CNS_Drugs-123"><span class="cite-bracket">&#91;</span>118<span class="cite-bracket">&#93;</span></a></sup></td> <td>Oral</td> <td>10.7 (single 4&#160;mg dose), 12 (single 8&#160;mg dose), 16.2 (single 12&#160;mg dose), 67.9 (repeated bid dosing)</td> <td>?</td> <td>&gt;99.7%</td> <td>Urine (59%), faeces (30%)</td> <td><a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>84% (Oral)</td> <td>&lt;2</td> <td>0.14 (single 4&#160;mg dose), 0.45 (single 8&#160;mg dose), 0.76 (single 12&#160;mg dose), 0.57 (bid dosing) </td></tr> <tr> <td><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></td> <td>Oral</td> <td>8 hours (single dosing), 12 (twice daily dosing)</td> <td>4.67</td> <td>97%</td> <td>Urine (50%), faeces (30%)</td> <td><a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a>, <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>, <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a></td> <td>50-60%</td> <td>1.5-2.5</td> <td>102–771 </td></tr> <tr> <td><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></td> <td>Oral</td> <td>?</td> <td>1340-2800</td> <td>95%</td> <td>Urine (45-58%), faeces (20-22%)</td> <td><a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a> &amp; <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>96%</td> <td>2-4</td> <td>? </td></tr> <tr> <td><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></td> <td>Oral</td> <td>18</td> <td>6173</td> <td>99%</td> <td>Faeces (80%), urine (9%)</td> <td><a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>9-19%</td> <td>1-3</td> <td>? </td></tr> <tr> <td><a href="/wiki/Melperone" title="Melperone">Melperone</a><sup id="cite_ref-124" class="reference"><a href="#cite_note-124"><span class="cite-bracket">&#91;</span>119<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-125" class="reference"><a href="#cite_note-125"><span class="cite-bracket">&#91;</span>120<span class="cite-bracket">&#93;</span></a></sup></td> <td>Oral, intramuscular</td> <td>3–4 (oral), 6 (IM)</td> <td>7–9.9</td> <td>50%</td> <td>Urine (70% as metabolites; 5–10.4% unchanged drug)</td> <td>?</td> <td>65% (tablet), 87% (IM), 54% (oral syrup)</td> <td>0.5–3</td> <td>75–324 (repeated dosing) </td></tr> <tr> <td><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></td> <td>Oral, intramuscular (including depot)</td> <td>30</td> <td>1000</td> <td>93%</td> <td>Urine (57%), faeces (30%)</td> <td><a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a>, <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a></td> <td>&gt;60%</td> <td>6 (Oral)</td> <td>? </td></tr> <tr> <td><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></td> <td>Oral, intramuscular (including depot)</td> <td>23 (Oral)</td> <td>390-487</td> <td>74%</td> <td>Urine (80%), faeces (11%)</td> <td><a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a>, <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>28%</td> <td>24 (Oral)</td> <td>? </td></tr> <tr> <td><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a><sup id="cite_ref-onrust_78-4" class="reference"><a href="#cite_note-onrust-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup></td> <td>Oral</td> <td>?</td> <td>?</td> <td>92%</td> <td>Urine (0.4% as unchanged drug)</td> <td>?</td> <td>?</td> <td>1.5</td> <td>1.9-5.7 </td></tr> <tr> <td><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></td> <td>Oral</td> <td>6 (IR), 7 (XR)</td> <td>6-14</td> <td>83%</td> <td>Urine (73%), faeces (20%)</td> <td><a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td> <td>100%</td> <td>1.5 (IR), 6 (XR)</td> <td>? </td></tr> <tr> <td><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></td> <td>Oral, intramuscular (including depot)</td> <td>3 (EM) (oral), 20 (PM) (oral)</td> <td>1-2</td> <td>90%, 77% (metabolite)</td> <td>Urine (70%), faeces (14%)</td> <td><a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a></td> <td>70%</td> <td>3 (EM), 17 (PM)</td> <td>? </td></tr> <tr> <td><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></td> <td>Oral</td> <td>72 (55–90)</td> <td>20</td> <td>99.5%</td> <td>Urine (4%), faeces (46-56%)</td> <td><a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a></td> <td>74%</td> <td>10</td> <td>? </td></tr> <tr> <td><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></td> <td>Oral, intramuscular</td> <td>7 (oral)</td> <td>1.5</td> <td>99%</td> <td>Faeces (66%), urine (20%)</td> <td><a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> &amp; <a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a></td> <td>60% (Oral), 100% (IM)</td> <td>6-8</td> <td>? </td></tr> <tr> <td><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a><sup id="cite_ref-126" class="reference"><a href="#cite_note-126"><span class="cite-bracket">&#91;</span>121<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-127" class="reference"><a href="#cite_note-127"><span class="cite-bracket">&#91;</span>122<span class="cite-bracket">&#93;</span></a></sup></td> <td>Oral</td> <td>13.7-15.9</td> <td>10-109</td> <td>97%</td> <td>Urine (17%)</td> <td>?</td> <td>7-13%</td> <td>?</td> <td>? </td></tr> <tr> <td colspan="10"> <p><b>Acronyms used:</b><br /> IR - Immediate release formulation.<br /> XR - Extended release formulation.<br /> EM - Extensive metabolisers.<br /> PM - Poor metabolisers. <br /> C<sub>max</sub> - maximum plasma concentrations of the drug. </p> </td></tr></tbody></table> <table class="wikitable sortable mw-collapsible mw-collapsed" style="font-size:small; margin: 1em auto;"> <caption class="nowrap"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Pharmacokinetics_of_long-acting_injectable_antipsychotics" title="Template:Pharmacokinetics of long-acting injectable antipsychotics"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Pharmacokinetics_of_long-acting_injectable_antipsychotics" title="Template talk:Pharmacokinetics of long-acting injectable antipsychotics"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Pharmacokinetics_of_long-acting_injectable_antipsychotics" title="Special:EditPage/Template:Pharmacokinetics of long-acting injectable antipsychotics"><abbr title="Edit this template">e</abbr></a></li></ul></div> <span style="font-size:105%;">Pharmacokinetics of long-acting injectable antipsychotics</span> </caption> <tbody><tr> <th>Medication</th> <th>Brand name</th> <th>Class</th> <th>Vehicle</th> <th>Dosage</th> <th>T<sub>max</sub></th> <th>t<sub>1/2</sub> single</th> <th>t<sub>1/2</sub> multiple</th> <th>logP<sup>c</sup></th> <th>Ref </th></tr> <tr> <td><a href="/wiki/Aripiprazole_lauroxil" title="Aripiprazole lauroxil">Aripiprazole lauroxil</a></td> <td>Aristada</td> <td>Atypical</td> <td><a href="/wiki/Water" title="Water">Water</a><sup>a</sup></td> <td>441–1064&#160;mg/4–8&#160;weeks</td> <td>24–35&#160;days</td> <td>?</td> <td>54–57&#160;days</td> <td>7.9–10.0</td> <td> </td></tr> <tr> <td><a href="/wiki/Aripiprazole_monohydrate" class="mw-redirect" title="Aripiprazole monohydrate">Aripiprazole monohydrate</a></td> <td>Abilify Maintena</td> <td>Atypical</td> <td><a href="/wiki/Water" title="Water">Water</a><sup>a</sup></td> <td>300–400&#160;mg/4&#160;weeks</td> <td>7&#160;days</td> <td>?</td> <td>30–47&#160;days</td> <td>4.9–5.2</td> <td> </td></tr> <tr> <td><a href="/wiki/Bromperidol_decanoate" title="Bromperidol decanoate">Bromperidol decanoate</a></td> <td>Impromen Decanoas</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>40–300&#160;mg/4&#160;weeks</td> <td>3–9&#160;days</td> <td>?</td> <td>21–25&#160;days</td> <td>7.9</td> <td><sup id="cite_ref-ParentToussaint1983_128-0" class="reference"><a href="#cite_note-ParentToussaint1983-128"><span class="cite-bracket">&#91;</span>123<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Clopentixol_decanoate" class="mw-redirect" title="Clopentixol decanoate">Clopentixol decanoate</a></td> <td>Sordinol Depot</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Viscoleo" title="Viscoleo">Viscoleo</a><sup>b</sup></td> <td>50–600&#160;mg/1–4&#160;weeks</td> <td>4–7&#160;days</td> <td>?</td> <td>19&#160;days</td> <td>9.0</td> <td><sup id="cite_ref-pmid6931472_129-0" class="reference"><a href="#cite_note-pmid6931472-129"><span class="cite-bracket">&#91;</span>124<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Flupentixol_decanoate" class="mw-redirect" title="Flupentixol decanoate">Flupentixol decanoate</a></td> <td>Depixol</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Viscoleo" title="Viscoleo">Viscoleo</a><sup>b</sup></td> <td>10–200&#160;mg/2–4&#160;weeks</td> <td>4–10&#160;days</td> <td>8&#160;days</td> <td>17&#160;days</td> <td>7.2–9.2</td> <td><sup id="cite_ref-pmid6931472_129-1" class="reference"><a href="#cite_note-pmid6931472-129"><span class="cite-bracket">&#91;</span>124<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Reynolds1993_130-0" class="reference"><a href="#cite_note-Reynolds1993-130"><span class="cite-bracket">&#91;</span>125<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Fluphenazine_decanoate" class="mw-redirect" title="Fluphenazine decanoate">Fluphenazine decanoate</a></td> <td>Prolixin Decanoate</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>12.5–100&#160;mg/2–5&#160;weeks</td> <td>1–2&#160;days</td> <td>1–10&#160;days</td> <td>14–100&#160;days</td> <td>7.2–9.0</td> <td><sup id="cite_ref-pmid6143748_131-0" class="reference"><a href="#cite_note-pmid6143748-131"><span class="cite-bracket">&#91;</span>126<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-pmid444352_132-0" class="reference"><a href="#cite_note-pmid444352-132"><span class="cite-bracket">&#91;</span>127<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-YoungEreshefsky1984_133-0" class="reference"><a href="#cite_note-YoungEreshefsky1984-133"><span class="cite-bracket">&#91;</span>128<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Fluphenazine_enanthate" class="mw-redirect" title="Fluphenazine enanthate">Fluphenazine enanthate</a></td> <td>Prolixin Enanthate</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>12.5–100&#160;mg/1–4&#160;weeks</td> <td>2–3&#160;days</td> <td>4&#160;days</td> <td>?</td> <td>6.4–7.4</td> <td><sup id="cite_ref-pmid444352_132-1" class="reference"><a href="#cite_note-pmid444352-132"><span class="cite-bracket">&#91;</span>127<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Fluspirilene" title="Fluspirilene">Fluspirilene</a></td> <td>Imap, Redeptin</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Water" title="Water">Water</a><sup>a</sup></td> <td>2–12&#160;mg/1&#160;week</td> <td>1–8&#160;days</td> <td>7&#160;days</td> <td>?</td> <td>5.2–5.8</td> <td><sup id="cite_ref-pmid4992598_134-0" class="reference"><a href="#cite_note-pmid4992598-134"><span class="cite-bracket">&#91;</span>129<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Haloperidol_decanoate" title="Haloperidol decanoate">Haloperidol decanoate</a></td> <td>Haldol Decanoate</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>20–400&#160;mg/2–4&#160;weeks</td> <td>3–9&#160;days</td> <td colspan="2">18–21&#160;days</td> <td>7.2–7.9</td> <td><sup id="cite_ref-pmid3545764_135-0" class="reference"><a href="#cite_note-pmid3545764-135"><span class="cite-bracket">&#91;</span>130<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-pmid7185768_136-0" class="reference"><a href="#cite_note-pmid7185768-136"><span class="cite-bracket">&#91;</span>131<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Olanzapine_pamoate" class="mw-redirect" title="Olanzapine pamoate">Olanzapine pamoate</a></td> <td>Zyprexa Relprevv</td> <td>Atypical</td> <td><a href="/wiki/Water" title="Water">Water</a><sup>a</sup></td> <td>150–405&#160;mg/2–4&#160;weeks</td> <td>7&#160;days</td> <td>?</td> <td>30&#160;days</td> <td>–</td> <td> </td></tr> <tr> <td><a href="/wiki/Oxyprothepin_decanoate" title="Oxyprothepin decanoate">Oxyprothepin decanoate</a></td> <td>Meclopin</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td>?</td> <td>?</td> <td>?</td> <td>?</td> <td>?</td> <td>8.5–8.7</td> <td> </td></tr> <tr> <td><a href="/wiki/Paliperidone_palmitate" class="mw-redirect" title="Paliperidone palmitate">Paliperidone palmitate</a></td> <td>Invega Sustenna</td> <td>Atypical</td> <td><a href="/wiki/Water" title="Water">Water</a><sup>a</sup></td> <td>39–819&#160;mg/4–12&#160;weeks</td> <td>13–33&#160;days</td> <td>25–139&#160;days</td> <td>?</td> <td>8.1–10.1</td> <td> </td></tr> <tr> <td><a href="/wiki/Perphenazine_decanoate" class="mw-redirect" title="Perphenazine decanoate">Perphenazine decanoate</a></td> <td>Trilafon Dekanoat</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>50–200&#160;mg/2–4&#160;weeks</td> <td>?</td> <td>?</td> <td>27&#160;days</td> <td>8.9</td> <td> </td></tr> <tr> <td><a href="/wiki/Perphenazine_enanthate" title="Perphenazine enanthate">Perphenazine enanthate</a></td> <td>Trilafon Enanthate</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>25–200&#160;mg/2&#160;weeks</td> <td>2–3&#160;days</td> <td>?</td> <td>4–7&#160;days</td> <td>6.4–7.2</td> <td><sup id="cite_ref-LarssonAxelsson1984_137-0" class="reference"><a href="#cite_note-LarssonAxelsson1984-137"><span class="cite-bracket">&#91;</span>132<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Pipotiazine_palmitate" class="mw-redirect" title="Pipotiazine palmitate">Pipotiazine palmitate</a></td> <td>Piportil Longum</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Viscoleo" title="Viscoleo">Viscoleo</a><sup>b</sup></td> <td>25–400&#160;mg/4&#160;weeks</td> <td>9–10&#160;days</td> <td>?</td> <td>14–21&#160;days</td> <td>8.5–11.6</td> <td><sup id="cite_ref-Reynolds1993_130-1" class="reference"><a href="#cite_note-Reynolds1993-130"><span class="cite-bracket">&#91;</span>125<span class="cite-bracket">&#93;</span></a></sup> </td></tr> <tr> <td><a href="/wiki/Pipotiazine_undecylenate" class="mw-redirect" title="Pipotiazine undecylenate">Pipotiazine undecylenate</a></td> <td>Piportil Medium</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Sesame_oil" title="Sesame oil">Sesame oil</a></td> <td>100–200&#160;mg/2&#160;weeks</td> <td>?</td> <td>?</td> <td>?</td> <td>8.4</td> <td> </td></tr> <tr> <td><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></td> <td>Risperdal Consta</td> <td>Atypical</td> <td><a href="/wiki/Microsphere" class="mw-redirect" title="Microsphere">Microspheres</a></td> <td>12.5–75&#160;mg/2&#160;weeks</td> <td>21&#160;days</td> <td>?</td> <td>3–6&#160;days</td> <td>–</td> <td> </td></tr> <tr> <td><a href="/wiki/Zuclopentixol_acetate" class="mw-redirect" title="Zuclopentixol acetate">Zuclopentixol acetate</a></td> <td>Clopixol Acuphase</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Viscoleo" title="Viscoleo">Viscoleo</a><sup>b</sup></td> <td>50–200&#160;mg/1–3&#160;days</td> <td>1–2&#160;days</td> <td colspan="2">1–2 days</td> <td>4.7–4.9</td> <td> </td></tr> <tr> <td><a href="/wiki/Zuclopentixol_decanoate" class="mw-redirect" title="Zuclopentixol decanoate">Zuclopentixol decanoate</a></td> <td>Clopixol Depot</td> <td><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></td> <td><a href="/wiki/Viscoleo" title="Viscoleo">Viscoleo</a><sup>b</sup></td> <td>50–800&#160;mg/2–4&#160;weeks</td> <td>4–9&#160;days</td> <td>?</td> <td>11–21&#160;days</td> <td>7.5–9.0</td> <td> </td></tr> <tr class="sortbottom"> <td colspan="10" style="width: 1px; background-color:#eaecf0; background-color:#eaecf0; text-align: center;"><b>Note:</b> All by <a href="/wiki/Intramuscular_injection" title="Intramuscular injection">intramuscular injection</a>. <b>Footnotes:</b> <sup>a</sup> = <a href="/wiki/Microcrystalline" title="Microcrystalline">Microcrystalline</a> or <a href="/wiki/Nanocrystalline" class="mw-redirect" title="Nanocrystalline">nanocrystalline</a> <a href="/wiki/Aqueous_suspension" class="mw-redirect" title="Aqueous suspension">aqueous suspension</a>. <sup>b</sup> = Low-<a href="/wiki/Viscosity" title="Viscosity">viscosity</a> <a href="/wiki/Vegetable_oil" title="Vegetable oil">vegetable oil</a> (specifically <a href="/wiki/Fractionated_coconut_oil" class="mw-redirect" title="Fractionated coconut oil">fractionated coconut oil</a> with <a href="/wiki/Medium-chain_triglyceride" title="Medium-chain triglyceride">medium-chain triglycerides</a>). <sup>c</sup> = Predicted, from <a href="/wiki/PubChem" title="PubChem">PubChem</a> and <a href="/wiki/DrugBank" title="DrugBank">DrugBank</a>. <b>Sources:</b> <i>Main:</i> See template. </td></tr></tbody></table> <div class="mw-heading mw-heading2"><h2 id="History">History</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=23" title="Edit section: History"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The first major tranquilizer or antipsychotic medication, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a> (Thorazine), a typical antipsychotic, was discovered in 1951 and introduced into clinical practice shortly thereafter. Clozapine (Clozaril), an atypical antipsychotic, fell out of favor due to concerns over drug-induced <a href="/wiki/Agranulocytosis" title="Agranulocytosis">agranulocytosis</a>. Following research indicating its effectiveness in treatment-resistant <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and the development of an adverse event monitoring system, clozapine re-emerged as a viable antipsychotic. According to Barker (2003), the three most-accepted atypical drugs are clozapine, risperidone, and olanzapine. However, he goes on to explain that clozapine is usually the last resort when other drugs fail. Clozapine can cause agranulocytosis (a decreased number of white blood cells), requiring blood monitoring for the patient. Despite the effectiveness of clozapine for treatment-resistant schizophrenia, agents with a more favorable side-effect profile were sought for widespread use. During the 1990s, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, and <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a> were introduced, with <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a> and <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> following in the early 2000s. The atypical antipsychotic <a href="/wiki/Paliperidone" title="Paliperidone">paliperidone</a> was approved by the FDA in late 2006.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138"><span class="cite-bracket">&#91;</span>133<span class="cite-bracket">&#93;</span></a></sup> The atypical antipsychotic <a href="/wiki/Asenapine" title="Asenapine">asenapine</a> (Saphris) was approved by the FDA in 2009.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139"><span class="cite-bracket">&#91;</span>134<span class="cite-bracket">&#93;</span></a></sup> </p><p>The atypical antipsychotics have found favor among clinicians and are now considered to be <a href="/wiki/First-line_treatment" class="mw-redirect" title="First-line treatment">first-line treatments</a> for schizophrenia and are gradually replacing the <a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">typical antipsychotics</a>. In the past, most researchers have agreed that the defining characteristics of atypical antipsychotics are the decreased incidence of <a href="/wiki/Extrapyramidal_symptoms" title="Extrapyramidal symptoms">extrapyramidal</a> side effects (EPS)<sup id="cite_ref-pmid16498489_140-0" class="reference"><a href="#cite_note-pmid16498489-140"><span class="cite-bracket">&#91;</span>135<span class="cite-bracket">&#93;</span></a></sup> and an absence of sustained prolactin elevation.<sup id="cite_ref-pmid11873706_55-5" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> </p><p>The terminology can still be imprecise. The definition of "atypicality" was based upon the absence of extrapyramidal side effects, but there is now a clear understanding that atypical antipsychotics can still induce these effects (though to a lesser degree than typical antipsychotics).<sup id="cite_ref-pmid17242588_141-0" class="reference"><a href="#cite_note-pmid17242588-141"><span class="cite-bracket">&#91;</span>136<span class="cite-bracket">&#93;</span></a></sup> Recent literature focuses more upon specific pharmacological actions and less upon categorization of an agent as "typical" or "atypical". There is no clear dividing line between the typical and atypical antipsychotics therefore categorization based on the action is difficult.<sup id="cite_ref-pmid11873706_55-6" class="reference"><a href="#cite_note-pmid11873706-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup> </p><p>More recent research is questioning the notion that second-generation antipsychotics are superior to first generation typical antipsychotics. Using a number of parameters to assess quality of life, <a href="/wiki/University_of_Manchester" title="University of Manchester">Manchester University</a> researchers found that typical antipsychotics were no worse than atypical antipsychotics. The research was funded by the <a href="/wiki/National_Health_Service" title="National Health Service">National Health Service</a> (NHS) of the UK.<sup id="cite_ref-pmid17015810_142-0" class="reference"><a href="#cite_note-pmid17015810-142"><span class="cite-bracket">&#91;</span>137<span class="cite-bracket">&#93;</span></a></sup> Because each medication (whether first or second generation) has its own profile of desirable and adverse effects, a neuropsychopharmacologist may recommend one of the older ("typical" or first generation) or newer ("atypical" or second generation) antipsychotics alone or in combination with other medications, based on the symptom profile, response pattern, and adverse effects history of the individual patient. </p> <div class="mw-heading mw-heading2"><h2 id="Society_and_culture">Society and culture</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=24" title="Edit section: Society and culture"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Between May 2007 and April 2008, 5.5 million Americans filled at least one prescription for an atypical antipsychotic.<sup id="cite_ref-pmid19727265_46-2" class="reference"><a href="#cite_note-pmid19727265-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup> In patients under the age of 65, 71% of patients were prescribed an atypical antipsychotic to treat Schizophrenia or Bipolar Disorder where this dropped to 38% in patients aged 65 or above.<sup id="cite_ref-pmid19727265_46-3" class="reference"><a href="#cite_note-pmid19727265-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup> </p><p>Despite the name "antipsychotics", the drugs are commonly used for a variety of conditions that do not involve <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>. Some healthcare professionals reported avoiding the name "atypical antipsychotic" when prescribing the drug to patients who had bipolar disorder.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143"><span class="cite-bracket">&#91;</span>138<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Regulatory_status">Regulatory status</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=25" title="Edit section: Regulatory status"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <table class="wikitable collapsible collapsed" style="width:100%"> <tbody><tr> <th colspan="15"><span style="font-size:115%;">Regulatory status of second-generation antipsychotics (SGAs) as of July&#160;2013<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Atypical_antipsychotic&amp;action=edit">&#91;update&#93;</a></sup></span> </th></tr> <tr> <th>Generic name</th> <th><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold">United States</span><br /><a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> approved</th> <th><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r886047488" /><span class="nobold">Canada</span><br /><a href="/wiki/Health_Products_and_Food_Branch" title="Health Products and Food Branch">HPFB</a> approved<sup id="cite_ref-144" class="reference"><a href="#cite_note-144"><span class="cite-bracket">&#91;</span>139<span class="cite-bracket">&#93;</span></a></sup></th> <th><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r886047488" /><span class="nobold">Australia</span><br /><a href="/wiki/Therapeutic_Goods_Administration" title="Therapeutic Goods Administration">TGA</a> approved<sup id="cite_ref-145" class="reference"><a href="#cite_note-145"><span class="cite-bracket">&#91;</span>140<span class="cite-bracket">&#93;</span></a></sup></th> <th><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r886047488" /><span class="nobold">Europe</span><br /><a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">EMA</a> approved<sup id="cite_ref-ema_146-0" class="reference"><a href="#cite_note-ema-146"><span class="cite-bracket">&#91;</span>141<span class="cite-bracket">&#93;</span></a></sup></th> <th><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r886047488" /><span class="nobold">Japan</span><br /><a href="/wiki/Pharmaceuticals_and_Medical_Devices_Agency" title="Pharmaceuticals and Medical Devices Agency">PMDA</a> approved<sup id="cite_ref-147" class="reference"><a href="#cite_note-147"><span class="cite-bracket">&#91;</span>142<span class="cite-bracket">&#93;</span></a></sup></th> <th><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r886047488" /><span class="nobold">United Kingdom</span><br /><a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> approved<sup id="cite_ref-148" class="reference"><a href="#cite_note-148"><span class="cite-bracket">&#91;</span>143<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-149" class="reference"><a href="#cite_note-149"><span class="cite-bracket">&#91;</span>144<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-ema_146-1" class="reference"><a href="#cite_note-ema-146"><span class="cite-bracket">&#91;</span>141<span class="cite-bracket">&#93;</span></a></sup> </th></tr> <tr> <td><a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></td> <td>No</td> <td>No</td> <td>Yes</td> <td>(some members)</td> <td>No</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr> <tr> <td><a href="/wiki/Carpipramine" title="Carpipramine">Carpipramine</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr> <tr> <td><a href="/wiki/Clocapramine" title="Clocapramine">Clocapramine</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr> <tr> <td><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></td> <td>Yes</td> <td>No</td> <td>No</td> <td>Refused</td> <td>No</td> <td>No </td></tr> <tr> <td><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>No</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Melperone" title="Melperone">Melperone</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>No </td></tr> <tr> <td><a href="/wiki/Mosapramine" title="Mosapramine">Mosapramine</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr> <tr> <td><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr> <tr> <td><a href="/wiki/Pimavanserin" title="Pimavanserin">Pimavanserin</a></td> <td>Yes</td> <td>No</td> <td>No</td> <td>Investigational</td> <td>No</td> <td>(No) </td></tr> <tr> <td><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Remoxipride" title="Remoxipride">Remoxipride</a></td> <td>No</td> <td>No</td> <td>No</td> <td>Withdrawn</td> <td>No</td> <td>No </td></tr> <tr> <td><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a></td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>Yes</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>(some members)</td> <td>No</td> <td>Yes </td></tr> <tr> <td><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></td> <td>No</td> <td>No</td> <td>No</td> <td>No</td> <td>Yes</td> <td>No </td></tr></tbody></table> <div class="mw-heading mw-heading2"><h2 id="Notes">Notes</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=26" title="Edit section: Notes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist"> <div class="mw-references-wrap"><ol class="references"> <li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text">The route of administration in this category refers to the standard means of administration when the drug is being used in its capacity as an atypical antipsychotic, not for other purposes. For example, amisulpride can be administered intravenously as an antiemetic drug but this is not its standard route of administration when being used as an antipsychotic</span> </li> <li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text">Note these values are from a study in of which amisulpride was intravenously administered</span> </li> </ol></div></div> <p><br /> <b>Stahl: AP Explained 1</b> </p> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239543626" /><div class="reflist"> <div class="mw-references-wrap"><ol class="references"> <li id="cite_note-S1-87"><span class="mw-cite-backlink">^ <a href="#cite_ref-S1_87-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-S1_87-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">p. 329-336.<sup id="cite_ref-Stahl_AP_Explained_1_86-1" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup></span> </li> <li id="cite_note-S2-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-S2_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-S2_88-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-S2_88-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">p. 346-352.<sup id="cite_ref-Stahl_AP_Explained_1_86-2" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup></span> </li> <li id="cite_note-S3-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-S3_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-S3_89-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-S3_89-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-S3_89-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">p. 355-360.<sup id="cite_ref-Stahl_AP_Explained_1_86-3" class="reference"><a href="#cite_note-Stahl_AP_Explained_1-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup></span> </li> </ol></div></div> <div class="mw-heading mw-heading2"><h2 id="See_also">See also</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=27" title="Edit section: See also"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <ul><li><a href="/wiki/List_of_antidepressants" title="List of antidepressants">List of antidepressants</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="References">References</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=28" title="Edit section: References"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239543626" /><div class="reflist reflist-columns references-column-width" style="column-width: 30em;"> <ol class="references"> <li id="cite_note-Miyake-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-Miyake_1-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite id="CITEREFMiyakeMiyamotoJarskog2012" class="citation journal cs1">Miyake N, Miyamoto S, Jarskog LF (October 2012). "New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?". <i>Clinical Schizophrenia &amp; Related Psychoses</i>. <b>6</b> (3): <span class="nowrap">122–</span>33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3371%2FCSRP.6.3.4">10.3371/CSRP.6.3.4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23006237">23006237</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Schizophrenia+%26+Related+Psychoses&amp;rft.atitle=New+serotonin%2Fdopamine+antagonists+for+the+treatment+of+schizophrenia%3A+are+we+making+real+progress%3F&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E122-%3C%2Fspan%3E33&amp;rft.date=2012-10&amp;rft_id=info%3Adoi%2F10.3371%2FCSRP.6.3.4&amp;rft_id=info%3Apmid%2F23006237&amp;rft.aulast=Miyake&amp;rft.aufirst=N&amp;rft.au=Miyamoto%2C+S&amp;rft.au=Jarskog%2C+LF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSadockSadock,_Virginia_A.Ruiz,_Pedro2014" class="citation book cs1">Sadock BJ, Sadock, Virginia A., Ruiz, Pedro (2014). <i>Kaplan &amp; Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry</i> (11th&#160;ed.). Philadelphia: Wolters Kluwer. p.&#160;318. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-60913-971-1" title="Special:BookSources/978-1-60913-971-1"><bdi>978-1-60913-971-1</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/oclc/881019573">881019573</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Kaplan+%26+Sadock%27s+Synopsis+of+Psychiatry%3A+Behavioral+Sciences%2FClinical+Psychiatry&amp;rft.place=Philadelphia&amp;rft.pages=318&amp;rft.edition=11th&amp;rft.pub=Wolters+Kluwer&amp;rft.date=2014&amp;rft_id=info%3Aoclcnum%2F881019573&amp;rft.isbn=978-1-60913-971-1&amp;rft.aulast=Sadock&amp;rft.aufirst=Benjamin+J.&amp;rft.au=Sadock%2C+Virginia+A.&amp;rft.au=Ruiz%2C+Pedro&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-leucht-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-leucht_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-leucht_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-leucht_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-leucht_3-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLeuchtCorvesArbterEngel2009" class="citation journal cs1">Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (January 2009). "Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis". <i>Lancet</i>. <b>373</b> (9657): <span class="nowrap">31–</span>41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2808%2961764-X">10.1016/S0140-6736(08)61764-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19058842">19058842</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1071537">1071537</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Second-generation+versus+first-generation+antipsychotic+drugs+for+schizophrenia%3A+a+meta-analysis&amp;rft.volume=373&amp;rft.issue=9657&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E31-%3C%2Fspan%3E41&amp;rft.date=2009-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1071537%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19058842&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2808%2961764-X&amp;rft.aulast=Leucht&amp;rft.aufirst=S&amp;rft.au=Corves%2C+C&amp;rft.au=Arbter%2C+D&amp;rft.au=Engel%2C+RR&amp;rft.au=Li%2C+C&amp;rft.au=Davis%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Leucht_2013-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Leucht_2013_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Leucht_2013_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Leucht_2013_4-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLeuchtCiprianiSpineliMavridis2013" class="citation journal cs1">Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et&#160;al. (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". <i>Lancet</i>. <b>382</b> (9896): <span class="nowrap">951–</span>62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2813%2960733-3">10.1016/S0140-6736(13)60733-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23810019">23810019</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32085212">32085212</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Comparative+efficacy+and+tolerability+of+15+antipsychotic+drugs+in+schizophrenia%3A+a+multiple-treatments+meta-analysis&amp;rft.volume=382&amp;rft.issue=9896&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E951-%3C%2Fspan%3E62&amp;rft.date=2013-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32085212%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23810019&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2813%2960733-3&amp;rft.aulast=Leucht&amp;rft.aufirst=S&amp;rft.au=Cipriani%2C+A&amp;rft.au=Spineli%2C+L&amp;rft.au=Mavridis%2C+D&amp;rft.au=Orey%2C+D&amp;rft.au=Richter%2C+F&amp;rft.au=Samara%2C+M&amp;rft.au=Barbui%2C+C&amp;rft.au=Engel%2C+RR&amp;rft.au=Geddes%2C+JR&amp;rft.au=Kissling%2C+W&amp;rft.au=Stapf%2C+MP&amp;rft.au=L%C3%A4ssig%2C+B&amp;rft.au=Salanti%2C+G&amp;rft.au=Davis%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139919">"A roadmap to key pharmacologic principles in using antipsychotics"</a>. <i>Primary Care Companion to the Journal of Clinical Psychiatry</i>. <b>9</b> (6): <span class="nowrap">444–</span>54. 2007. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4088%2FPCC.v09n0607">10.4088/PCC.v09n0607</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139919">2139919</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18185824">18185824</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Primary+Care+Companion+to+the+Journal+of+Clinical+Psychiatry&amp;rft.atitle=A+roadmap+to+key+pharmacologic+principles+in+using+antipsychotics&amp;rft.volume=9&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E444-%3C%2Fspan%3E54&amp;rft.date=2007&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2139919%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18185824&amp;rft_id=info%3Adoi%2F10.4088%2FPCC.v09n0607&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2139919&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTyrerKendall2009" class="citation journal cs1">Tyrer P, Kendall T (January 2009). "The spurious advance of antipsychotic drug therapy". <i>Lancet</i>. <b>373</b> (9657): <span class="nowrap">4–</span>5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2808%2961765-1">10.1016/S0140-6736(08)61765-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19058841">19058841</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19951248">19951248</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=The+spurious+advance+of+antipsychotic+drug+therapy&amp;rft.volume=373&amp;rft.issue=9657&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E4-%3C%2Fspan%3E5&amp;rft.date=2009-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19951248%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19058841&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2808%2961765-1&amp;rft.aulast=Tyrer&amp;rft.aufirst=P&amp;rft.au=Kendall%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-AHFS-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-AHFS_7-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/risperidone.html">"Respiridone"</a>. <i>The American Society of Health-System Pharmacists</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 3,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+American+Society+of+Health-System+Pharmacists&amp;rft.atitle=Respiridone&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Frisperidone.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Off11-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Off11_8-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMaherMaglioneBagleySuttorp2011" class="citation journal cs1">Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, et&#160;al. (September 2011). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2011.1360">"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis"</a>. <i>JAMA</i>. <b>306</b> (12): <span class="nowrap">1359–</span>69. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2011.1360">10.1001/jama.2011.1360</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21954480">21954480</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Efficacy+and+comparative+effectiveness+of+atypical+antipsychotic+medications+for+off-label+uses+in+adults%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=306&amp;rft.issue=12&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1359-%3C%2Fspan%3E69&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2011.1360&amp;rft_id=info%3Apmid%2F21954480&amp;rft.aulast=Maher&amp;rft.aufirst=AR&amp;rft.au=Maglione%2C+M&amp;rft.au=Bagley%2C+S&amp;rft.au=Suttorp%2C+M&amp;rft.au=Hu%2C+JH&amp;rft.au=Ewing%2C+B&amp;rft.au=Wang%2C+Z&amp;rft.au=Timmer%2C+M&amp;rft.au=Sultzer%2C+D&amp;rft.au=Shekelle%2C+PG&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Fjama.2011.1360&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGaretyFreemanBentall2008" class="citation book cs1">Garety PA, Freeman DB, Bentall RP (2008). <i>Persecutory delusions: assessment, theory, and treatment</i>. Oxford [Oxfordshire]: Oxford University Press. p.&#160;313. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-19-920631-5" title="Special:BookSources/978-0-19-920631-5"><bdi>978-0-19-920631-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Persecutory+delusions%3A+assessment%2C+theory%2C+and+treatment&amp;rft.place=Oxford+%5BOxfordshire%5D&amp;rft.pages=313&amp;rft.pub=Oxford+University+Press&amp;rft.date=2008&amp;rft.isbn=978-0-19-920631-5&amp;rft.aulast=Garety&amp;rft.aufirst=PA&amp;rft.au=Freeman%2C+DB&amp;rft.au=Bentall%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAmerican_Geriatrics_Society_2012_Beers_Criteria_Update_Expert_Panel2012" class="citation journal cs1">American Geriatrics Society 2012 Beers Criteria Update Expert Panel (April 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571677">"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults"</a>. <i>Journal of the American Geriatrics Society</i>. <b>60</b> (4): <span class="nowrap">616–</span>31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1532-5415.2012.03923.x">10.1111/j.1532-5415.2012.03923.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571677">3571677</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22376048">22376048</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Geriatrics+Society&amp;rft.atitle=American+Geriatrics+Society+updated+Beers+Criteria+for+potentially+inappropriate+medication+use+in+older+adults&amp;rft.volume=60&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E616-%3C%2Fspan%3E31&amp;rft.date=2012-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571677%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22376048&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1532-5415.2012.03923.x&amp;rft.au=American+Geriatrics+Society+2012+Beers+Criteria+Update+Expert+Panel&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571677&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: CS1 maint: numeric names: authors list (<a href="/wiki/Category:CS1_maint:_numeric_names:_authors_list" title="Category:CS1 maint: numeric names: authors list">link</a>)</span></span> </li> <li id="cite_note-fn_72-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-fn_72_11-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.nice.org.uk/nicemedia/pdf/CG82FullGuideline.pdf">"Schizophrenia: Full national clinical guideline on core interventions in primary and secondary care"</a> <span class="cs1-format">(PDF)</span>. <i>Gaskell and the British Psychological Society</i>. National Collaborating Centre for Mental Health. March 25, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">November 25,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Gaskell+and+the+British+Psychological+Society&amp;rft.atitle=Schizophrenia%3A+Full+national+clinical+guideline+on+core+interventions+in+primary+and+secondary+care&amp;rft.date=2009-03-25&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fnicemedia%2Fpdf%2FCG82FullGuideline.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAlemanLincolnBruggemanMelle2017" class="citation journal cs1">Aleman A, Lincoln TM, Bruggeman R, Melle I, Arends J, Arango C, Knegtering H (August 2017). <a rel="nofollow" class="external text" href="https://pure.rug.nl/ws/files/48756184/1_s2.0_S0920996416302390_main.pdf">"Treatment of negative symptoms: Where do we stand, and where do we go?"</a> <span class="cs1-format">(PDF)</span>. <i>Schizophrenia Research</i>. <b>186</b>: <span class="nowrap">55–</span>62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.schres.2016.05.015">10.1016/j.schres.2016.05.015</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27293137">27293137</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4907333">4907333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Research&amp;rft.atitle=Treatment+of+negative+symptoms%3A+Where+do+we+stand%2C+and+where+do+we+go%3F&amp;rft.volume=186&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E55-%3C%2Fspan%3E62&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4907333%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27293137&amp;rft_id=info%3Adoi%2F10.1016%2Fj.schres.2016.05.015&amp;rft.aulast=Aleman&amp;rft.aufirst=A&amp;rft.au=Lincoln%2C+TM&amp;rft.au=Bruggeman%2C+R&amp;rft.au=Melle%2C+I&amp;rft.au=Arends%2C+J&amp;rft.au=Arango%2C+C&amp;rft.au=Knegtering%2C+H&amp;rft_id=https%3A%2F%2Fpure.rug.nl%2Fws%2Ffiles%2F48756184%2F1_s2.0_S0920996416302390_main.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmc4466178-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmc4466178_13-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFusar-PoliPapanastasiouStahlRocchetti2015" class="citation journal cs1">Fusar-Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, McGuire P (July 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466178">"Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials"</a>. <i>Schizophrenia Bulletin</i>. <b>41</b> (4): <span class="nowrap">892–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fschbul%2Fsbu170">10.1093/schbul/sbu170</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466178">4466178</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25528757">25528757</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Bulletin&amp;rft.atitle=Treatments+of+Negative+Symptoms+in+Schizophrenia%3A+Meta-Analysis+of+168+Randomized+Placebo-Controlled+Trials&amp;rft.volume=41&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E892-%3C%2Fspan%3E9&amp;rft.date=2015-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4466178%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25528757&amp;rft_id=info%3Adoi%2F10.1093%2Fschbul%2Fsbu170&amp;rft.aulast=Fusar-Poli&amp;rft.aufirst=P&amp;rft.au=Papanastasiou%2C+E&amp;rft.au=Stahl%2C+D&amp;rft.au=Rocchetti%2C+M&amp;rft.au=Carpenter%2C+W&amp;rft.au=Shergill%2C+S&amp;rft.au=McGuire%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4466178&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid27802977-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27802977_14-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMurrayQuattroneNatesanvan_Os2016" class="citation journal cs1">Murray RM, Quattrone D, Natesan S, van Os J, Nordentoft M, Howes O, et&#160;al. (November 2016). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/should-psychiatrists-be-more-cautious-about-the-longterm-prophylactic-use-of-antipsychotics(52ba3d1b-990c-4031-b597-d67edc569318).html">"Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?"</a>. <i>The British Journal of Psychiatry</i> (Submitted manuscript). <b>209</b> (5): <span class="nowrap">361–</span>365. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fbjp.bp.116.182683">10.1192/bjp.bp.116.182683</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27802977">27802977</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.atitle=Should+psychiatrists+be+more+cautious+about+the+long-term+prophylactic+use+of+antipsychotics%3F&amp;rft.volume=209&amp;rft.issue=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E361-%3C%2Fspan%3E365&amp;rft.date=2016-11&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.116.182683&amp;rft_id=info%3Apmid%2F27802977&amp;rft.aulast=Murray&amp;rft.aufirst=RM&amp;rft.au=Quattrone%2C+D&amp;rft.au=Natesan%2C+S&amp;rft.au=van+Os%2C+J&amp;rft.au=Nordentoft%2C+M&amp;rft.au=Howes%2C+O&amp;rft.au=Di+Forti%2C+M&amp;rft.au=Taylor%2C+D&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Fshould-psychiatrists-be-more-cautious-about-the-longterm-prophylactic-use-of-antipsychotics%2852ba3d1b-990c-4031-b597-d67edc569318%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Lancet09-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lancet09_15-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFvan_OsKapur2009" class="citation journal cs1">van Os J, Kapur S (August 2009). "Schizophrenia". <i>Lancet</i>. <b>374</b> (9690): <span class="nowrap">635–</span>45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2809%2960995-8">10.1016/S0140-6736(09)60995-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19700006">19700006</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:208792724">208792724</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Schizophrenia&amp;rft.volume=374&amp;rft.issue=9690&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E635-%3C%2Fspan%3E45&amp;rft.date=2009-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A208792724%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19700006&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2809%2960995-8&amp;rft.aulast=van+Os&amp;rft.aufirst=J&amp;rft.au=Kapur%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKaneCorrell2010" class="citation journal cs1">Kane JM, Correll CU (2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085113">"Pharmacologic treatment of schizophrenia"</a>. <i>Dialogues in Clinical Neuroscience</i>. <b>12</b> (3): <span class="nowrap">345–</span>57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.31887%2FDCNS.2010.12.3%2Fjkane">10.31887/DCNS.2010.12.3/jkane</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085113">3085113</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20954430">20954430</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dialogues+in+Clinical+Neuroscience&amp;rft.atitle=Pharmacologic+treatment+of+schizophrenia&amp;rft.volume=12&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E345-%3C%2Fspan%3E57&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3085113%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20954430&amp;rft_id=info%3Adoi%2F10.31887%2FDCNS.2010.12.3%2Fjkane&amp;rft.aulast=Kane&amp;rft.aufirst=JM&amp;rft.au=Correll%2C+CU&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3085113&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-AFP07-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-AFP07_17-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSchultzNorthShields2007" class="citation journal cs1">Schultz SH, North SW, Shields CG (June 2007). "Schizophrenia: a review". <i>American Family Physician</i>. <b>75</b> (12): <span class="nowrap">1821–</span>9. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17619525">17619525</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Family+Physician&amp;rft.atitle=Schizophrenia%3A+a+review&amp;rft.volume=75&amp;rft.issue=12&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1821-%3C%2Fspan%3E9&amp;rft.date=2007-06&amp;rft_id=info%3Apmid%2F17619525&amp;rft.aulast=Schultz&amp;rft.aufirst=SH&amp;rft.au=North%2C+SW&amp;rft.au=Shields%2C+CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-AFP10-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-AFP10_18-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSmithWestonLieberman2010" class="citation journal cs1">Smith T, Weston C, Lieberman J (August 2010). "Schizophrenia (maintenance treatment)". <i>American Family Physician</i>. <b>82</b> (4): <span class="nowrap">338–</span>9. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20704164">20704164</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Family+Physician&amp;rft.atitle=Schizophrenia+%28maintenance+treatment%29&amp;rft.volume=82&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E338-%3C%2Fspan%3E9&amp;rft.date=2010-08&amp;rft_id=info%3Apmid%2F20704164&amp;rft.aulast=Smith&amp;rft.aufirst=T&amp;rft.au=Weston%2C+C&amp;rft.au=Lieberman%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-refac-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-refac_19-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSiskindMcCartneyGoldschlagerKisely2016" class="citation journal cs1">Siskind D, McCartney L, Goldschlager R, Kisely S (November 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fbjp.bp.115.177261">"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis"</a>. <i>The British Journal of Psychiatry</i>. <b>209</b> (5): <span class="nowrap">385–</span>392. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fbjp.bp.115.177261">10.1192/bjp.bp.115.177261</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27388573">27388573</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.atitle=Clozapine+v.+first-+and+second-generation+antipsychotics+in+treatment-refractory+schizophrenia%3A+systematic+review+and+meta-analysis&amp;rft.volume=209&amp;rft.issue=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E385-%3C%2Fspan%3E392&amp;rft.date=2016-11&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.115.177261&amp;rft_id=info%3Apmid%2F27388573&amp;rft.aulast=Siskind&amp;rft.aufirst=D&amp;rft.au=McCartney%2C+L&amp;rft.au=Goldschlager%2C+R&amp;rft.au=Kisely%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1192%252Fbjp.bp.115.177261&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRobinsonGallegoJohnPetrides2015" class="citation journal cs1">Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang JP, Lopez L, Braga RJ, Sevy SM, Addington J, Kellner CH (2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601722">"A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes"</a>. <i>Schizophrenia Bulletin</i>. <b>41</b> (6): <span class="nowrap">1227–</span>1236. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fschbul%2Fsbv125">10.1093/schbul/sbv125</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1745-1701">1745-1701</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601722">4601722</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26338693">26338693</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Bulletin&amp;rft.atitle=A+Randomized+Comparison+of+Aripiprazole+and+Risperidone+for+the+Acute+Treatment+of+First-Episode+Schizophrenia+and+Related+Disorders%3A+3-Month+Outcomes&amp;rft.volume=41&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1227-%3C%2Fspan%3E1236&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4601722%23id-name%3DPMC&amp;rft.issn=1745-1701&amp;rft_id=info%3Apmid%2F26338693&amp;rft_id=info%3Adoi%2F10.1093%2Fschbul%2Fsbv125&amp;rft.aulast=Robinson&amp;rft.aufirst=Delbert+G.&amp;rft.au=Gallego%2C+Juan+A.&amp;rft.au=John%2C+Majnu&amp;rft.au=Petrides%2C+Georgios&amp;rft.au=Hassoun%2C+Youssef&amp;rft.au=Zhang%2C+Jian-Ping&amp;rft.au=Lopez%2C+Leonardo&amp;rft.au=Braga%2C+Raphael+J.&amp;rft.au=Sevy%2C+Serge+M.&amp;rft.au=Addington%2C+Jean&amp;rft.au=Kellner%2C+Charles+H.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4601722&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGómez-RevueltaPelayo-TeránJuncal-RuizVázquez-Bourgon2020" class="citation journal cs1">Gómez-Revuelta M, Pelayo-Terán JM, Juncal-Ruiz M, Vázquez-Bourgon J, Suárez-Pinilla P, Romero-Jiménez R, Setién Suero E, Ayesa-Arriola R, <a href="/wiki/Benedicto_Crespo-Facorro" title="Benedicto Crespo-Facorro">Crespo-Facorro B</a> (April 23, 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177160">"Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>23</b> (4): <span class="nowrap">217–</span>229. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fijnp%2Fpyaa004">10.1093/ijnp/pyaa004</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1469-5111">1469-5111</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177160">7177160</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31974576">31974576</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Neuropsychopharmacology&amp;rft.atitle=Antipsychotic+Treatment+Effectiveness+in+First+Episode+of+Psychosis%3A+PAFIP+3-Year+Follow-Up+Randomized+Clinical+Trials+Comparing+Haloperidol%2C+Olanzapine%2C+Risperidone%2C+Aripiprazole%2C+Quetiapine%2C+and+Ziprasidone&amp;rft.volume=23&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E217-%3C%2Fspan%3E229&amp;rft.date=2020-04-23&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7177160%23id-name%3DPMC&amp;rft.issn=1469-5111&amp;rft_id=info%3Apmid%2F31974576&amp;rft_id=info%3Adoi%2F10.1093%2Fijnp%2Fpyaa004&amp;rft.aulast=G%C3%B3mez-Revuelta&amp;rft.aufirst=Marcos&amp;rft.au=Pelayo-Ter%C3%A1n%2C+Jos%C3%A9+Mar%C3%ADa&amp;rft.au=Juncal-Ruiz%2C+Mar%C3%ADa&amp;rft.au=V%C3%A1zquez-Bourgon%2C+Javier&amp;rft.au=Su%C3%A1rez-Pinilla%2C+Paula&amp;rft.au=Romero-Jim%C3%A9nez%2C+Rodrigo&amp;rft.au=Seti%C3%A9n+Suero%2C+Esther&amp;rft.au=Ayesa-Arriola%2C+Rosa&amp;rft.au=Crespo-Facorro%2C+Benedicto&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7177160&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAlexanderGallagherMascolaMoloney2011" class="citation journal cs1">Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS (February 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069498">"Increasing off-label use of antipsychotic medications in the United States, 1995-2008"</a>. <i>Pharmacoepidemiology and Drug Safety</i>. <b>20</b> (2): <span class="nowrap">177–</span>84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fpds.2082">10.1002/pds.2082</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069498">3069498</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21254289">21254289</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacoepidemiology+and+Drug+Safety&amp;rft.atitle=Increasing+off-label+use+of+antipsychotic+medications+in+the+United+States%2C+1995-2008&amp;rft.volume=20&amp;rft.issue=2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E177-%3C%2Fspan%3E84&amp;rft.date=2011-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3069498%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21254289&amp;rft_id=info%3Adoi%2F10.1002%2Fpds.2082&amp;rft.aulast=Alexander&amp;rft.aufirst=GC&amp;rft.au=Gallagher%2C+SA&amp;rft.au=Mascola%2C+A&amp;rft.au=Moloney%2C+RM&amp;rft.au=Stafford%2C+RS&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3069498&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGeddesFreemantleHarrisonBebbington2000" class="citation journal cs1">Geddes J, Freemantle N, Harrison P, Bebbington P (December 2000). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27538">"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis"</a>. <i>BMJ</i>. <b>321</b> (7273): <span class="nowrap">1371–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.321.7273.1371">10.1136/bmj.321.7273.1371</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27538">27538</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11099280">11099280</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Atypical+antipsychotics+in+the+treatment+of+schizophrenia%3A+systematic+overview+and+meta-regression+analysis&amp;rft.volume=321&amp;rft.issue=7273&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1371-%3C%2Fspan%3E6&amp;rft.date=2000-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC27538%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F11099280&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.321.7273.1371&amp;rft.aulast=Geddes&amp;rft.aufirst=J&amp;rft.au=Freemantle%2C+N&amp;rft.au=Harrison%2C+P&amp;rft.au=Bebbington%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC27538&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLiebermanStroupMcEvoySwartz2005" class="citation journal cs1">Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et&#160;al. (September 2005). <a rel="nofollow" class="external text" href="https://cdr.lib.unc.edu/downloads/g732dk11n">"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia"</a>. <i>The New England Journal of Medicine</i>. <b>353</b> (12): <span class="nowrap">1209–</span>23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa051688">10.1056/NEJMoa051688</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16172203">16172203</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Effectiveness+of+antipsychotic+drugs+in+patients+with+chronic+schizophrenia&amp;rft.volume=353&amp;rft.issue=12&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1209-%3C%2Fspan%3E23&amp;rft.date=2005-09&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa051688&amp;rft_id=info%3Apmid%2F16172203&amp;rft.aulast=Lieberman&amp;rft.aufirst=JA&amp;rft.au=Stroup%2C+TS&amp;rft.au=McEvoy%2C+JP&amp;rft.au=Swartz%2C+MS&amp;rft.au=Rosenheck%2C+RA&amp;rft.au=Perkins%2C+DO&amp;rft.au=Keefe%2C+RS&amp;rft.au=Davis%2C+SM&amp;rft.au=Davis%2C+CE&amp;rft.au=Lebowitz%2C+BD&amp;rft.au=Severe%2C+J&amp;rft.au=Hsiao%2C+JK&amp;rft_id=https%3A%2F%2Fcdr.lib.unc.edu%2Fdownloads%2Fg732dk11n&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStroupLiebermanMcEvoySwartz2006" class="citation journal cs1">Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, et&#160;al. (April 2006). "Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic". <i>The American Journal of Psychiatry</i>. <b>163</b> (4): <span class="nowrap">611–</span>22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.ajp.163.4.611">10.1176/appi.ajp.163.4.611</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16585435">16585435</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Effectiveness+of+olanzapine%2C+quetiapine%2C+risperidone%2C+and+ziprasidone+in+patients+with+chronic+schizophrenia+following+discontinuation+of+a+previous+atypical+antipsychotic&amp;rft.volume=163&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E611-%3C%2Fspan%3E22&amp;rft.date=2006-04&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.163.4.611&amp;rft_id=info%3Apmid%2F16585435&amp;rft.aulast=Stroup&amp;rft.aufirst=TS&amp;rft.au=Lieberman%2C+JA&amp;rft.au=McEvoy%2C+JP&amp;rft.au=Swartz%2C+MS&amp;rft.au=Davis%2C+SM&amp;rft.au=Rosenheck%2C+RA&amp;rft.au=Perkins%2C+DO&amp;rft.au=Keefe%2C+RS&amp;rft.au=Davis%2C+CE&amp;rft.au=Severe%2C+J&amp;rft.au=Hsiao%2C+JK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFVorugantiBakerAwad2008" class="citation journal cs1">Voruganti LP, Baker LK, Awad AG (March 2008). "New generation antipsychotic drugs and compliance behaviour". <i>Current Opinion in Psychiatry</i>. <b>21</b> (2): <span class="nowrap">133–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FYCO.0b013e3282f52851">10.1097/YCO.0b013e3282f52851</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18332660">18332660</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34935">34935</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Psychiatry&amp;rft.atitle=New+generation+antipsychotic+drugs+and+compliance+behaviour&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E133-%3C%2Fspan%3E9&amp;rft.date=2008-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34935%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18332660&amp;rft_id=info%3Adoi%2F10.1097%2FYCO.0b013e3282f52851&amp;rft.aulast=Voruganti&amp;rft.aufirst=LP&amp;rft.au=Baker%2C+LK&amp;rft.au=Awad%2C+AG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPaczynskiAlexanderChinchilliKruszewski2012" class="citation journal cs1">Paczynski RP, Alexander GC, Chinchilli VM, Kruszewski SP (January 2012). "Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications". <i>The International Journal of Risk &amp; Safety in Medicine</i>. <b>24</b> (3): <span class="nowrap">137–</span>46. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJRS-2012-0567">10.3233/JRS-2012-0567</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22936056">22936056</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Risk+%26+Safety+in+Medicine&amp;rft.atitle=Quality+of+evidence+in+drug+compendia+supporting+off-label+use+of+typical+and+atypical+antipsychotic+medications&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E137-%3C%2Fspan%3E46&amp;rft.date=2012-01&amp;rft_id=info%3Adoi%2F10.3233%2FJRS-2012-0567&amp;rft_id=info%3Apmid%2F22936056&amp;rft.aulast=Paczynski&amp;rft.aufirst=RP&amp;rft.au=Alexander%2C+GC&amp;rft.au=Chinchilli%2C+VM&amp;rft.au=Kruszewski%2C+SP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFOwens2008" class="citation journal cs1">Owens DC (2008). <a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fapt.bp.107.003970">"How CATIE brought us back to Kansas: A critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia"</a>. <i>Advances in Psychiatric Treatment</i>. <b>14</b>: <span class="nowrap">17–</span>28. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fapt.bp.107.003970">10.1192/apt.bp.107.003970</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Psychiatric+Treatment&amp;rft.atitle=How+CATIE+brought+us+back+to+Kansas%3A+A+critical+re-evaluation+of+the+concept+of+atypical+antipsychotics+and+their+place+in+the+treatment+of+schizophrenia&amp;rft.volume=14&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E17-%3C%2Fspan%3E28&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1192%2Fapt.bp.107.003970&amp;rft.aulast=Owens&amp;rft.aufirst=DC&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1192%252Fapt.bp.107.003970&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFischer-BarnicolLanquillonHaenZofel2008" class="citation journal cs1">Fischer-Barnicol D, Lanquillon S, Haen E, Zofel P, Koch HJ, Dose M, Klein HE (2008). "Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE)". <i>Neuropsychobiology</i>. <b>57</b> (<span class="nowrap">1–</span>2): <span class="nowrap">80–</span>7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000135641">10.1159/000135641</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18515977">18515977</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2669203">2669203</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychobiology&amp;rft.atitle=Typical+and+atypical+antipsychotics--the+misleading+dichotomy.+Results+from+the+Working+Group+%27Drugs+in+Psychiatry%27+%28AGATE%29&amp;rft.volume=57&amp;rft.issue=%3Cspan+class%3D%22nowrap%22%3E1%E2%80%93%3C%2Fspan%3E2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E80-%3C%2Fspan%3E7&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2669203%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18515977&amp;rft_id=info%3Adoi%2F10.1159%2F000135641&amp;rft.aulast=Fischer-Barnicol&amp;rft.aufirst=D&amp;rft.au=Lanquillon%2C+S&amp;rft.au=Haen%2C+E&amp;rft.au=Zofel%2C+P&amp;rft.au=Koch%2C+HJ&amp;rft.au=Dose%2C+M&amp;rft.au=Klein%2C+HE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWhitaker2010" class="citation book cs1">Whitaker R (2010). <a rel="nofollow" class="external text" href="https://archive.org/details/anatomyofepidemi00whit/page/303"><i>Anatomy of an Epidemic</i></a>. Crown. p.&#160;<a rel="nofollow" class="external text" href="https://archive.org/details/anatomyofepidemi00whit/page/303">303</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0307452412" title="Special:BookSources/978-0307452412"><bdi>978-0307452412</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Anatomy+of+an+Epidemic&amp;rft.pages=303&amp;rft.pub=Crown&amp;rft.date=2010&amp;rft.isbn=978-0307452412&amp;rft.aulast=Whitaker&amp;rft.aufirst=Robert&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fanatomyofepidemi00whit%2Fpage%2F303&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mdedge.com/psychiatry/article/173556/schizophrenia-other-psychotic-disorders/receptor-occupancy-and-drug">"Receptor occupancy and drug response: Understanding the relationship"</a>. <i>www.mdedge.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 14,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.mdedge.com&amp;rft.atitle=Receptor+occupancy+and+drug+response%3A+Understanding+the+relationship&amp;rft_id=https%3A%2F%2Fwww.mdedge.com%2Fpsychiatry%2Farticle%2F173556%2Fschizophrenia-other-psychotic-disorders%2Freceptor-occupancy-and-drug&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Maudsley-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Maudsley_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Maudsley_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Maudsley_32-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylorPatonKapur2012" class="citation book cs1">Taylor D, Paton C, Kapur S (2012). <i>The Maudsley Prescribing Guidelines</i> (12th&#160;ed.). Informa Healthcare. pp.&#160;<span class="nowrap">12–</span>152, <span class="nowrap">173–</span>196, <span class="nowrap">222–</span>235.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Maudsley+Prescribing+Guidelines&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E12-%3C%2Fspan%3E152%2C+%3Cspan+class%3D%22nowrap%22%3E173-%3C%2Fspan%3E196%2C+%3Cspan+class%3D%22nowrap%22%3E222-%3C%2Fspan%3E235&amp;rft.edition=12th&amp;rft.pub=Informa+Healthcare&amp;rft.date=2012&amp;rft.aulast=Taylor&amp;rft.aufirst=D&amp;rft.au=Paton%2C+C&amp;rft.au=Kapur%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSoreffMcInnesAhmedTalavera2013" class="citation web cs1">Soreff S, McInnes LA, Ahmed I, Talavera F (August 5, 2013). <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/286342-treatment">"Bipolar Affective Disorder Treatment &amp; Management"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">October 10,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medscape+Reference&amp;rft.atitle=Bipolar+Affective+Disorder+Treatment+%26+Management&amp;rft.date=2013-08-05&amp;rft.aulast=Soreff&amp;rft.aufirst=S&amp;rft.au=McInnes%2C+LA&amp;rft.au=Ahmed%2C+I&amp;rft.au=Talavera%2C+F&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F286342-treatment&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-UpToDateBPMT-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-UpToDateBPMT_34-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPostKeck2013" class="citation web cs1">Post RM, Keck P (July 30, 2013). <a rel="nofollow" class="external text" href="http://www.uptodate.com/contents/bipolar-disorder-in-adults-maintenance-treatment">"Bipolar Disorder in adults: Maintenance treatment"</a>. <i>UpToDate</i>. Wolters Kluwer Health<span class="reference-accessdate">. Retrieved <span class="nowrap">October 10,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UpToDate&amp;rft.atitle=Bipolar+Disorder+in+adults%3A+Maintenance+treatment&amp;rft.date=2013-07-30&amp;rft.aulast=Post&amp;rft.aufirst=RM&amp;rft.au=Keck%2C+P&amp;rft_id=http%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fbipolar-disorder-in-adults-maintenance-treatment&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Coch-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-Coch_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Coch_35-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKomossaDeppingGaudchauKissling2010" class="citation journal cs1">Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S (December 2010). "Second-generation antipsychotics for major depressive disorder and dysthymia". <i>The Cochrane Database of Systematic Reviews</i> (12): CD008121. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008121.pub2">10.1002/14651858.CD008121.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21154393">21154393</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Second-generation+antipsychotics+for+major+depressive+disorder+and+dysthymia&amp;rft.issue=12&amp;rft.pages=CD008121&amp;rft.date=2010-12&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008121.pub2&amp;rft_id=info%3Apmid%2F21154393&amp;rft.aulast=Komossa&amp;rft.aufirst=K&amp;rft.au=Depping%2C+AM&amp;rft.au=Gaudchau%2C+A&amp;rft.au=Kissling%2C+W&amp;rft.au=Leucht%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid23554581-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid23554581_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid23554581_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSpielmansBermanLinardatosRosenlicht2013" class="citation journal cs1">Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595214">"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes"</a>. <i>PLOS Medicine</i>. <b>10</b> (3): e1001403. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pmed.1001403">10.1371/journal.pmed.1001403</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595214">3595214</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23554581">23554581</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Medicine&amp;rft.atitle=Adjunctive+atypical+antipsychotic+treatment+for+major+depressive+disorder%3A+a+meta-analysis+of+depression%2C+quality+of+life%2C+and+safety+outcomes&amp;rft.volume=10&amp;rft.issue=3&amp;rft.pages=e1001403&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3595214%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23554581&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.1001403&amp;rft.aulast=Spielmans&amp;rft.aufirst=GI&amp;rft.au=Berman%2C+MI&amp;rft.au=Linardatos%2C+E&amp;rft.au=Rosenlicht%2C+NZ&amp;rft.au=Perry%2C+A&amp;rft.au=Tsai%2C+AC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3595214&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-AmJPsych-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-AmJPsych_37-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNelsonPapakostas2009" class="citation journal cs1">Nelson JC, Papakostas GI (September 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.ajp.2009.09030312">"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials"</a>. <i>The American Journal of Psychiatry</i>. <b>166</b> (9): <span class="nowrap">980–</span>91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.ajp.2009.09030312">10.1176/appi.ajp.2009.09030312</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19687129">19687129</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Atypical+antipsychotic+augmentation+in+major+depressive+disorder%3A+a+meta-analysis+of+placebo-controlled+randomized+trials&amp;rft.volume=166&amp;rft.issue=9&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E980-%3C%2Fspan%3E91&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.2009.09030312&amp;rft_id=info%3Apmid%2F19687129&amp;rft.aulast=Nelson&amp;rft.aufirst=JC&amp;rft.au=Papakostas%2C+GI&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1176%252Fappi.ajp.2009.09030312&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFResearch" class="citation web cs1">Research Cf. <a rel="nofollow" class="external text" href="https://www.fda.gov/Drugs/InformationOnDrugs/ucm456977.htm">"Drug Approvals and Databases - Drug Trials Snapshots: REXULTI for the treatment of major depressive disorder"</a>. <i>www.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 18,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.fda.gov&amp;rft.atitle=Drug+Approvals+and+Databases+-+Drug+Trials+Snapshots%3A+REXULTI+for+the+treatment+of+major+depressive+disorder&amp;rft.aulast=Research&amp;rft.aufirst=Center+for+Drug+Evaluation+and&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FDrugs%2FInformationOnDrugs%2Fucm456977.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPapakostasFavaBaerSwee2015" class="citation journal cs1">Papakostas GI, Fava M, Baer L, Swee MB, Jaeger A, Bobo WV, Shelton RC (December 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843798">"Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study"</a>. <i>The American Journal of Psychiatry</i>. <b>172</b> (12): <span class="nowrap">1251–</span>8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.ajp.2015.14101251">10.1176/appi.ajp.2015.14101251</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843798">4843798</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26085041">26085041</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Ziprasidone+Augmentation+of+Escitalopram+for+Major+Depressive+Disorder%3A+Efficacy+Results+From+a+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Study&amp;rft.volume=172&amp;rft.issue=12&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1251-%3C%2Fspan%3E8&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4843798%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26085041&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.2015.14101251&amp;rft.aulast=Papakostas&amp;rft.aufirst=GI&amp;rft.au=Fava%2C+M&amp;rft.au=Baer%2C+L&amp;rft.au=Swee%2C+MB&amp;rft.au=Jaeger%2C+A&amp;rft.au=Bobo%2C+WV&amp;rft.au=Shelton%2C+RC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4843798&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFManeetonManeetonSrisurapanontMartin2012" class="citation journal cs1">Maneeton N, Maneeton B, Srisurapanont M, Martin SD (September 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549283">"Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials"</a>. <i>BMC Psychiatry</i>. <b>12</b>: 160. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1471-244X-12-160">10.1186/1471-244X-12-160</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549283">3549283</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23017200">23017200</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Psychiatry&amp;rft.atitle=Quetiapine+monotherapy+in+acute+phase+for+major+depressive+disorder%3A+a+meta-analysis+of+randomized%2C+placebo-controlled+trials&amp;rft.volume=12&amp;rft.pages=160&amp;rft.date=2012-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549283%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23017200&amp;rft_id=info%3Adoi%2F10.1186%2F1471-244X-12-160&amp;rft.aulast=Maneeton&amp;rft.aufirst=N&amp;rft.au=Maneeton%2C+B&amp;rft.au=Srisurapanont%2C+M&amp;rft.au=Martin%2C+SD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549283&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-DD-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-DD_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DD_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Truven Health Analytics, Inc. DRUGDEX System (Internet) [cited 2013 Oct 10]. Greenwood Village, CO: Thomsen Healthcare; 2013.</span> </li> <li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRothschildWilliamsonTohenSchatzberg2004" class="citation journal cs1">Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, et&#160;al. (August 2004). "A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features". <i>Journal of Clinical Psychopharmacology</i>. <b>24</b> (4): <span class="nowrap">365–</span>73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.jcp.0000130557.08996.7a">10.1097/01.jcp.0000130557.08996.7a</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15232326">15232326</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36295165">36295165</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.atitle=A+double-blind%2C+randomized+study+of+olanzapine+and+olanzapine%2Ffluoxetine+combination+for+major+depression+with+psychotic+features&amp;rft.volume=24&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E365-%3C%2Fspan%3E73&amp;rft.date=2004-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36295165%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15232326&amp;rft_id=info%3Adoi%2F10.1097%2F01.jcp.0000130557.08996.7a&amp;rft.aulast=Rothschild&amp;rft.aufirst=AJ&amp;rft.au=Williamson%2C+DJ&amp;rft.au=Tohen%2C+MF&amp;rft.au=Schatzberg%2C+A&amp;rft.au=Andersen%2C+SW&amp;rft.au=Van+Campen%2C+LE&amp;rft.au=Sanger%2C+TM&amp;rft.au=Tollefson%2C+GD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid25963405-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid25963405_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid25963405_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRobertsLohanoEl-Mallakh2016" class="citation journal cs1">Roberts RJ, Lohano KK, El-Mallakh RS (September 2016). "Antipsychotics as antidepressants". <i>Asia-Pacific Psychiatry</i>. <b>8</b> (3): <span class="nowrap">179–</span>88. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fappy.12186">10.1111/appy.12186</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25963405">25963405</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24264818">24264818</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Asia-Pacific+Psychiatry&amp;rft.atitle=Antipsychotics+as+antidepressants&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E179-%3C%2Fspan%3E88&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24264818%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25963405&amp;rft_id=info%3Adoi%2F10.1111%2Fappy.12186&amp;rft.aulast=Roberts&amp;rft.aufirst=RJ&amp;rft.au=Lohano%2C+KK&amp;rft.au=El-Mallakh%2C+RS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.otsuka-us.com/discover/fda-approves-otsukalundbecks-rexulti-as-adjunctive-treatment-for-adults-with-mdd-and-schizophrenia">"U.S. FDA Approves Otsuka and Lundbeck's REXULTI (Brexpiprazole) as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia | Discover Otsuka"</a>. <i>Otsuka in the U.S</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 18,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Otsuka+in+the+U.S.&amp;rft.atitle=U.S.+FDA+Approves+Otsuka+and+Lundbeck%27s+REXULTI+%28Brexpiprazole%29+as+Adjunctive+Treatment+for+Adults+with+Major+Depressive+Disorder+and+as+a+Treatment+for+Adults+with+Schizophrenia+%7C+Discover+Otsuka&amp;rft_id=https%3A%2F%2Fwww.otsuka-us.com%2Fdiscover%2Ffda-approves-otsukalundbecks-rexulti-as-adjunctive-treatment-for-adults-with-mdd-and-schizophrenia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db730b06-6351-47fd-8183-e61e61bbead5">"DailyMed - CAPLYTA- lumateperone capsule"</a>. <i>dailymed.nlm.nih.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 11,</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=dailymed.nlm.nih.gov&amp;rft.atitle=DailyMed+-+CAPLYTA-+lumateperone+capsule&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3Ddb730b06-6351-47fd-8183-e61e61bbead5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid19727265-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19727265_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19727265_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19727265_46-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid19727265_46-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCascadeKalaliCummings2008" class="citation journal cs1">Cascade E, Kalali AH, Cummings JL (July 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695730">"Use of atypical antipsychotics in the elderly"</a>. <i>Psychiatry</i>. <b>5</b> (7): <span class="nowrap">28–</span>31. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695730">2695730</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19727265">19727265</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatry&amp;rft.atitle=Use+of+atypical+antipsychotics+in+the+elderly&amp;rft.volume=5&amp;rft.issue=7&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E28-%3C%2Fspan%3E31&amp;rft.date=2008-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2695730%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19727265&amp;rft.aulast=Cascade&amp;rft.aufirst=E&amp;rft.au=Kalali%2C+AH&amp;rft.au=Cummings%2C+JL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2695730&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid21191528-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21191528_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21191528_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFVentimigliaKalaliVahiaJeste2010" class="citation journal cs1">Ventimiglia J, Kalali AH, Vahia IV, Jeste DV (November 2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010964">"An analysis of the intended use of atypical antipsychotics in dementia"</a>. <i>Psychiatry</i>. <b>7</b> (11): <span class="nowrap">14–</span>7. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010964">3010964</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21191528">21191528</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatry&amp;rft.atitle=An+analysis+of+the+intended+use+of+atypical+antipsychotics+in+dementia&amp;rft.volume=7&amp;rft.issue=11&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E14-%3C%2Fspan%3E7&amp;rft.date=2010-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3010964%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21191528&amp;rft.aulast=Ventimiglia&amp;rft.aufirst=J&amp;rft.au=Kalali%2C+AH&amp;rft.au=Vahia%2C+IV&amp;rft.au=Jeste%2C+DV&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3010964&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCiprianiBarbuiSalantiRendell2011" class="citation journal cs1">Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et&#160;al. (October 2011). "Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis". <i>Lancet</i>. <b>378</b> (9799): <span class="nowrap">1306–</span>15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2811%2960873-8">10.1016/S0140-6736(11)60873-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21851976">21851976</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25512763">25512763</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Comparative+efficacy+and+acceptability+of+antimanic+drugs+in+acute+mania%3A+a+multiple-treatments+meta-analysis&amp;rft.volume=378&amp;rft.issue=9799&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1306-%3C%2Fspan%3E15&amp;rft.date=2011-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25512763%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21851976&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2811%2960873-8&amp;rft.aulast=Cipriani&amp;rft.aufirst=A&amp;rft.au=Barbui%2C+C&amp;rft.au=Salanti%2C+G&amp;rft.au=Rendell%2C+J&amp;rft.au=Brown%2C+R&amp;rft.au=Stockton%2C+S&amp;rft.au=Purgato%2C+M&amp;rft.au=Spineli%2C+LM&amp;rft.au=Goodwin%2C+GM&amp;rft.au=Geddes%2C+JR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmc2762364-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmc2762364_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBisharaTaylor2009" class="citation journal cs1">Bishara D, Taylor D (2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762364">"Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder"</a>. <i>Neuropsychiatric Disease and Treatment</i>. <b>5</b>: <span class="nowrap">483–</span>90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2147%2Fndt.s5742">10.2147/ndt.s5742</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762364">2762364</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19851515">19851515</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatric+Disease+and+Treatment&amp;rft.atitle=Asenapine+monotherapy+in+the+acute+treatment+of+both+schizophrenia+and+bipolar+I+disorder&amp;rft.volume=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E483-%3C%2Fspan%3E90&amp;rft.date=2009&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2762364%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19851515&amp;rft_id=info%3Adoi%2F10.2147%2Fndt.s5742&amp;rft.aulast=Bishara&amp;rft.aufirst=D&amp;rft.au=Taylor%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2762364&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-BPD-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-BPD_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BPD_50-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BPD_50-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BPD_50-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-BPD_50-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-BPD_50-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylorCorneliusSmithYoung2014" class="citation journal cs1">Taylor DM, Cornelius V, Smith L, Young AH (December 2014). "Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis". <i>Acta Psychiatrica Scandinavica</i>. <b>130</b> (6): <span class="nowrap">452–</span>69. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Facps.12343">10.1111/acps.12343</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25283309">25283309</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23324764">23324764</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.atitle=Comparative+efficacy+and+acceptability+of+drug+treatments+for+bipolar+depression%3A+a+multiple-treatments+meta-analysis&amp;rft.volume=130&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E452-%3C%2Fspan%3E69&amp;rft.date=2014-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23324764%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25283309&amp;rft_id=info%3Adoi%2F10.1111%2Facps.12343&amp;rft.aulast=Taylor&amp;rft.aufirst=DM&amp;rft.au=Cornelius%2C+V&amp;rft.au=Smith%2C+L&amp;rft.au=Young%2C+AH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSzegediZhaovan_WilligenburgNations2011" class="citation journal cs1">Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J (June 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152513">"Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials"</a>. <i>BMC Psychiatry</i>. <b>11</b>: 101. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1471-244X-11-101">10.1186/1471-244X-11-101</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152513">3152513</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21689438">21689438</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Psychiatry&amp;rft.atitle=Effects+of+asenapine+on+depressive+symptoms+in+patients+with+bipolar+I+disorder+experiencing+acute+manic+or+mixed+episodes%3A+a+post+hoc+analysis+of+two+3-week+clinical+trials&amp;rft.volume=11&amp;rft.pages=101&amp;rft.date=2011-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3152513%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21689438&amp;rft_id=info%3Adoi%2F10.1186%2F1471-244X-11-101&amp;rft.aulast=Szegedi&amp;rft.aufirst=A&amp;rft.au=Zhao%2C+J&amp;rft.au=van+Willigenburg%2C+A&amp;rft.au=Nations%2C+KR&amp;rft.au=Mackle%2C+M&amp;rft.au=Panagides%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3152513&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKishiIwata2013" class="citation journal cs1">Kishi T, Iwata N (September 2013). "Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials". <i>CNS Drugs</i>. <b>27</b> (9): <span class="nowrap">731–</span>41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-013-0085-7">10.1007/s40263-013-0085-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23812802">23812802</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11543666">11543666</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Efficacy+and+tolerability+of+perospirone+in+schizophrenia%3A+a+systematic+review+and+meta-analysis+of+randomized+controlled+trials&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E731-%3C%2Fspan%3E41&amp;rft.date=2013-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11543666%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23812802&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-013-0085-7&amp;rft.aulast=Kishi&amp;rft.aufirst=T&amp;rft.au=Iwata%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-TD08-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-TD08_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TD08_53-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCorrellSchenk2008" class="citation journal cs1">Correll CU, Schenk EM (March 2008). "Tardive dyskinesia and new antipsychotics". <i>Current Opinion in Psychiatry</i>. <b>21</b> (2): <span class="nowrap">151–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FYCO.0b013e3282f53132">10.1097/YCO.0b013e3282f53132</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18332662">18332662</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:37288246">37288246</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Psychiatry&amp;rft.atitle=Tardive+dyskinesia+and+new+antipsychotics&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E151-%3C%2Fspan%3E6&amp;rft.date=2008-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37288246%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18332662&amp;rft_id=info%3Adoi%2F10.1097%2FYCO.0b013e3282f53132&amp;rft.aulast=Correll&amp;rft.aufirst=CU&amp;rft.au=Schenk%2C+EM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-UpToDateSchiz-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-UpToDateSchiz_54-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStroupMarderStein2013" class="citation web cs1">Stroup TS, Marder S, Stein MB (October 23, 2013). <a rel="nofollow" class="external text" href="http://www.uptodate.com/contents/pharmacotherapy-for-schizophrenia-acute-and-maintenance-phase-treatment">"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment"</a>. <i>UpToDate</i>. Wolters Kluwer<span class="reference-accessdate">. Retrieved <span class="nowrap">October 10,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UpToDate&amp;rft.atitle=Pharmacotherapy+for+schizophrenia%3A+Acute+and+maintenance+phase+treatment&amp;rft.date=2013-10-23&amp;rft.aulast=Stroup&amp;rft.aufirst=TS&amp;rft.au=Marder%2C+S&amp;rft.au=Stein%2C+MB&amp;rft_id=http%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fpharmacotherapy-for-schizophrenia-acute-and-maintenance-phase-treatment&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid11873706-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11873706_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid11873706_55-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSeeman2002" class="citation journal cs1">Seeman P (February 2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F070674370204700106">"Atypical antipsychotics: mechanism of action"</a>. <i>Canadian Journal of Psychiatry</i>. <b>47</b> (1): <span class="nowrap">27–</span>38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F070674370204700106">10.1177/070674370204700106</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11873706">11873706</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Journal+of+Psychiatry&amp;rft.atitle=Atypical+antipsychotics%3A+mechanism+of+action&amp;rft.volume=47&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E27-%3C%2Fspan%3E38&amp;rft.date=2002-02&amp;rft_id=info%3Adoi%2F10.1177%2F070674370204700106&amp;rft_id=info%3Apmid%2F11873706&amp;rft.aulast=Seeman&amp;rft.aufirst=P&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1177%252F070674370204700106&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid15156241-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15156241_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15156241_56-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15156241_56-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15156241_56-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15156241_56-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKabinoffToalsonHealeyMcGuire2003" class="citation journal cs1">Kabinoff GS, Toalson PA, Healey KM, McGuire HC, Hay DP (February 2003). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC353028">"Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths"</a>. <i>Primary Care Companion to the Journal of Clinical Psychiatry</i>. <b>5</b> (1): <span class="nowrap">6–</span>14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4088%2FPCC.v05n0103">10.4088/PCC.v05n0103</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC353028">353028</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15156241">15156241</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Primary+Care+Companion+to+the+Journal+of+Clinical+Psychiatry&amp;rft.atitle=Metabolic+Issues+With+Atypical+Antipsychotics+in+Primary+Care%3A+Dispelling+the+Myths&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E6-%3C%2Fspan%3E14&amp;rft.date=2003-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC353028%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15156241&amp;rft_id=info%3Adoi%2F10.4088%2FPCC.v05n0103&amp;rft.aulast=Kabinoff&amp;rft.aufirst=GS&amp;rft.au=Toalson%2C+PA&amp;rft.au=Healey%2C+KM&amp;rft.au=McGuire%2C+HC&amp;rft.au=Hay%2C+DP&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC353028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDíaz-Domínguezde_la_Rosa-DonlucasRomans-DemariaGrajales-Almeida2013" class="citation journal cs1">Díaz-Domínguez DA, de la Rosa-Donlucas F, Romans-Demaria L, Grajales-Almeida JR, Sauer-Vera T, Sotelo-Monroy GE (December 1, 2013). <a rel="nofollow" class="external text" href="https://www.tandfonline.com/doi/abs/10.2753/IMH0020-7411420405">"Prevalence of Metabolic Syndrome and Associated Risk Factors in Hospitalized Patients with Schizophrenia in Mexico"</a>. <i>International Journal of Mental Health</i>. <b>42</b> (4): <span class="nowrap">95–</span>104. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2753%2FIMH0020-7411420405">10.2753/IMH0020-7411420405</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0020-7411">0020-7411</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Mental+Health&amp;rft.atitle=Prevalence+of+Metabolic+Syndrome+and+Associated+Risk+Factors+in+Hospitalized+Patients+with+Schizophrenia+in+Mexico&amp;rft.volume=42&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E95-%3C%2Fspan%3E104&amp;rft.date=2013-12-01&amp;rft_id=info%3Adoi%2F10.2753%2FIMH0020-7411420405&amp;rft.issn=0020-7411&amp;rft.aulast=D%C3%ADaz-Dom%C3%ADnguez&amp;rft.aufirst=Daniel+Alejandro&amp;rft.au=de+la+Rosa-Donlucas%2C+Francisco&amp;rft.au=Romans-Demaria%2C+Laura&amp;rft.au=Grajales-Almeida%2C+Jos%C3%A9+Ram%C3%B3n&amp;rft.au=Sauer-Vera%2C+Tizb%C3%A9&amp;rft.au=Sotelo-Monroy%2C+Gabriel+Eugenio&amp;rft_id=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.2753%2FIMH0020-7411420405&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGoldsteinBauneBondChen2020" class="citation journal cs1">Goldstein BI, Baune BT, Bond DJ, Chen PH, Eyler L, Fagiolini A, Gomes F, Hajek T, Hatch J, McElroy SL, McIntyre RS, Prieto M, Sylvia LG, Tsai SY, Kcomt A, Fiedorowicz JG (August 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522687">"Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders"</a>. <i>Bipolar Disorders</i>. <b>22</b> (5): <span class="nowrap">440–</span>460. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fbdi.12921">10.1111/bdi.12921</a></span>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/11343%2F251495">11343/251495</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522687">7522687</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32356562">32356562</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bipolar+Disorders&amp;rft.atitle=Call+to+action+regarding+the+vascular-bipolar+link%3A+A+report+from+the+Vascular+Task+Force+of+the+International+Society+for+Bipolar+Disorders&amp;rft.volume=22&amp;rft.issue=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E440-%3C%2Fspan%3E460&amp;rft.date=2020-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7522687%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32356562&amp;rft_id=info%3Ahdl%2F11343%2F251495&amp;rft_id=info%3Adoi%2F10.1111%2Fbdi.12921&amp;rft.aulast=Goldstein&amp;rft.aufirst=Benjamin+I.&amp;rft.au=Baune%2C+Bernhard+T.&amp;rft.au=Bond%2C+David+J.&amp;rft.au=Chen%2C+Pao-Huan&amp;rft.au=Eyler%2C+Lisa&amp;rft.au=Fagiolini%2C+Andrea&amp;rft.au=Gomes%2C+Fabiano&amp;rft.au=Hajek%2C+Tomas&amp;rft.au=Hatch%2C+Jessica&amp;rft.au=McElroy%2C+Susan+L.&amp;rft.au=McIntyre%2C+Roger+S.&amp;rft.au=Prieto%2C+Miguel&amp;rft.au=Sylvia%2C+Louisa+G.&amp;rft.au=Tsai%2C+Shang-Ying&amp;rft.au=Kcomt%2C+Andrew&amp;rft.au=Fiedorowicz%2C+Jess+G.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7522687&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFUçokGaebel2008" class="citation journal cs1">Uçok A, Gaebel W (February 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2327229">"Side effects of atypical antipsychotics: a brief overview"</a>. <i>World Psychiatry</i>. <b>7</b> (1): <span class="nowrap">58–</span>62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fj.2051-5545.2008.tb00154.x">10.1002/j.2051-5545.2008.tb00154.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2327229">2327229</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18458771">18458771</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Psychiatry&amp;rft.atitle=Side+effects+of+atypical+antipsychotics%3A+a+brief+overview&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E58-%3C%2Fspan%3E62&amp;rft.date=2008-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2327229%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18458771&amp;rft_id=info%3Adoi%2F10.1002%2Fj.2051-5545.2008.tb00154.x&amp;rft.aulast=U%C3%A7ok&amp;rft.aufirst=A&amp;rft.au=Gaebel%2C+W&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2327229&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-McKim,_W._2007_pp.241-260-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-McKim,_W._2007_pp.241-260_60-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMcKim2007" class="citation book cs1">McKim W (2007). "Antipsychotics". <a rel="nofollow" class="external text" href="https://archive.org/details/drugsbehaviorint0000mcki_z4z0"><i>Drugs and Behavior: An Introduction to Behavioral Pharmacology</i></a> (6th&#160;ed.). Prentice Hall. pp.&#160;<span class="nowrap">241–</span>260. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-13-219788-5" title="Special:BookSources/978-0-13-219788-5"><bdi>978-0-13-219788-5</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/oclc/1301978997">1301978997</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Antipsychotics&amp;rft.btitle=Drugs+and+Behavior%3A+An+Introduction+to+Behavioral+Pharmacology&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E241-%3C%2Fspan%3E260&amp;rft.edition=6th&amp;rft.pub=Prentice+Hall&amp;rft.date=2007&amp;rft_id=info%3Aoclcnum%2F1301978997&amp;rft.isbn=978-0-13-219788-5&amp;rft.aulast=McKim&amp;rft.aufirst=William&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fdrugsbehaviorint0000mcki_z4z0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-dorsey-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-dorsey_61-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDorseyRabbaniGallagherConti2010" class="citation journal cs1">Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC (January 2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598075">"Impact of FDA black box advisory on antipsychotic medication use"</a>. <i>Archives of Internal Medicine</i>. <b>170</b> (1): <span class="nowrap">96–</span>103. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinternmed.2009.456">10.1001/archinternmed.2009.456</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598075">4598075</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20065205">20065205</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Impact+of+FDA+black+box+advisory+on+antipsychotic+medication+use&amp;rft.volume=170&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E96-%3C%2Fspan%3E103&amp;rft.date=2010-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4598075%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20065205&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2009.456&amp;rft.aulast=Dorsey&amp;rft.aufirst=ER&amp;rft.au=Rabbani%2C+A&amp;rft.au=Gallagher%2C+SA&amp;rft.au=Conti%2C+RM&amp;rft.au=Alexander%2C+GC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4598075&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGerhardHuybrechtsOlfsonSchneeweiss2014" class="citation journal cs1">Gerhard T, Huybrechts K, Olfson M, Schneeweiss S, Bobo WV, Doraiswamy PM, et&#160;al. (July 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fbjp.bp.112.122499">"Comparative mortality risks of antipsychotic medications in community-dwelling older adults"</a>. <i>The British Journal of Psychiatry</i>. <b>205</b> (1): <span class="nowrap">44–</span>51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1192%2Fbjp.bp.112.122499">10.1192/bjp.bp.112.122499</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23929443">23929443</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.atitle=Comparative+mortality+risks+of+antipsychotic+medications+in+community-dwelling+older+adults&amp;rft.volume=205&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E44-%3C%2Fspan%3E51&amp;rft.date=2014-07&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.112.122499&amp;rft_id=info%3Apmid%2F23929443&amp;rft.aulast=Gerhard&amp;rft.aufirst=T&amp;rft.au=Huybrechts%2C+K&amp;rft.au=Olfson%2C+M&amp;rft.au=Schneeweiss%2C+S&amp;rft.au=Bobo%2C+WV&amp;rft.au=Doraiswamy%2C+PM&amp;rft.au=Devanand%2C+DP&amp;rft.au=Lucas%2C+JA&amp;rft.au=Huang%2C+C&amp;rft.au=Malka%2C+ES&amp;rft.au=Levin%2C+R&amp;rft.au=Crystal%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1192%252Fbjp.bp.112.122499&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSteinbergLyketsos2012" class="citation journal cs1">Steinberg M, Lyketsos CG (September 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516138">"Atypical antipsychotic use in patients with dementia: managing safety concerns"</a>. <i>The American Journal of Psychiatry</i>. <b>169</b> (9): <span class="nowrap">900–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.ajp.2012.12030342">10.1176/appi.ajp.2012.12030342</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516138">3516138</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22952071">22952071</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Atypical+antipsychotic+use+in+patients+with+dementia%3A+managing+safety+concerns&amp;rft.volume=169&amp;rft.issue=9&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E900-%3C%2Fspan%3E6&amp;rft.date=2012-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3516138%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22952071&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.2012.12030342&amp;rft.aulast=Steinberg&amp;rft.aufirst=M&amp;rft.au=Lyketsos%2C+CG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3516138&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAlevizosPapageorgiouChristodoulou2004" class="citation journal cs1">Alevizos B, Papageorgiou C, Christodoulou GN (September 1, 2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS1461145704004456">"Obsessive-compulsive symptoms with olanzapine"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>7</b> (3): <span class="nowrap">375–</span>377. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS1461145704004456">10.1017/S1461145704004456</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1461-1457">1461-1457</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15231024">15231024</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+International+Journal+of+Neuropsychopharmacology&amp;rft.atitle=Obsessive-compulsive+symptoms+with+olanzapine&amp;rft.volume=7&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E375-%3C%2Fspan%3E377&amp;rft.date=2004-09-01&amp;rft.issn=1461-1457&amp;rft_id=info%3Apmid%2F15231024&amp;rft_id=info%3Adoi%2F10.1017%2FS1461145704004456&amp;rft.aulast=Alevizos&amp;rft.aufirst=Basil&amp;rft.au=Papageorgiou%2C+Charalambos&amp;rft.au=Christodoulou%2C+George+N.&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1017%252FS1461145704004456&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKulkarniNarayanaswamyMath2012" class="citation journal cs1">Kulkarni G, Narayanaswamy JC, Math SB (January 1, 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803">"Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia"</a>. <i>Indian Journal of Pharmacology</i>. <b>44</b> (5): <span class="nowrap">649–</span>650. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4103%2F0253-7613.100406">10.4103/0253-7613.100406</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0253-7613">0253-7613</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803">3480803</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23112432">23112432</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+Journal+of+Pharmacology&amp;rft.atitle=Olanzapine+induced+de-novo+obsessive+compulsive+disorder+in+a+patient+with+schizophrenia&amp;rft.volume=44&amp;rft.issue=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E649-%3C%2Fspan%3E650&amp;rft.date=2012-01-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3480803%23id-name%3DPMC&amp;rft.issn=0253-7613&amp;rft_id=info%3Apmid%2F23112432&amp;rft_id=info%3Adoi%2F10.4103%2F0253-7613.100406&amp;rft.aulast=Kulkarni&amp;rft.aufirst=Gajanan&amp;rft.au=Narayanaswamy%2C+Janardhanan+C.&amp;rft.au=Math%2C+Suresh+Bada&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3480803&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLykourasZervasGournellisMalliori2000" class="citation journal cs1">Lykouras L, Zervas IM, Gournellis R, Malliori M, Rabavilas A (September 1, 2000). "Olanzapine and obsessive-compulsive symptoms". <i>European Neuropsychopharmacology</i>. <b>10</b> (5): <span class="nowrap">385–</span>387. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0924-977x%2800%2900096-1">10.1016/s0924-977x(00)00096-1</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0924-977X">0924-977X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10974610">10974610</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:276209">276209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Neuropsychopharmacology&amp;rft.atitle=Olanzapine+and+obsessive-compulsive+symptoms&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E385-%3C%2Fspan%3E387&amp;rft.date=2000-09-01&amp;rft.issn=0924-977X&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A276209%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10974610&amp;rft_id=info%3Adoi%2F10.1016%2Fs0924-977x%2800%2900096-1&amp;rft.aulast=Lykouras&amp;rft.aufirst=L.&amp;rft.au=Zervas%2C+I.+M.&amp;rft.au=Gournellis%2C+R.&amp;rft.au=Malliori%2C+M.&amp;rft.au=Rabavilas%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSchirmbeckZink2012" class="citation journal cs1">Schirmbeck F, Zink M (March 1, 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286851">"Clozapine-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Critical Review"</a>. <i>Current Neuropharmacology</i>. <b>10</b> (1): <span class="nowrap">88–</span>95. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F157015912799362724">10.2174/157015912799362724</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1570-159X">1570-159X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286851">3286851</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22942882">22942882</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Clozapine-Induced+Obsessive-Compulsive+Symptoms+in+Schizophrenia%3A+A+Critical+Review&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E88-%3C%2Fspan%3E95&amp;rft.date=2012-03-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3286851%23id-name%3DPMC&amp;rft.issn=1570-159X&amp;rft_id=info%3Apmid%2F22942882&amp;rft_id=info%3Adoi%2F10.2174%2F157015912799362724&amp;rft.aulast=Schirmbeck&amp;rft.aufirst=Frederike&amp;rft.au=Zink%2C+Mathias&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3286851&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid14747245-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid14747245_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid14747245_68-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid14747245_68-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="https://doi.org/10.2337%2Fdiacare.27.2.596">"Consensus development conference on antipsychotic drugs and obesity and diabetes"</a>. <i>Diabetes Care</i>. <b>27</b> (2): <span class="nowrap">596–</span>601. February 2004. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2337%2Fdiacare.27.2.596">10.2337/diacare.27.2.596</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14747245">14747245</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Care&amp;rft.atitle=Consensus+development+conference+on+antipsychotic+drugs+and+obesity+and+diabetes&amp;rft.volume=27&amp;rft.issue=2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E596-%3C%2Fspan%3E601&amp;rft.date=2004-02&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.27.2.596&amp;rft_id=info%3Apmid%2F14747245&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.2337%252Fdiacare.27.2.596&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-GG-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-GG_69-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBruntonChabnerKnollman2010" class="citation book cs1">Brunton L, Chabner B, Knollman B (2010). <i>Goodman and Gilman's The Pharmacological Basis of Therapeutics</i> (12th&#160;ed.). McGraw Hill Professional. pp.&#160;<span class="nowrap">417–</span>455.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Goodman+and+Gilman%27s+The+Pharmacological+Basis+of+Therapeutics&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E417-%3C%2Fspan%3E455&amp;rft.edition=12th&amp;rft.pub=McGraw+Hill+Professional&amp;rft.date=2010&amp;rft.aulast=Brunton&amp;rft.aufirst=L&amp;rft.au=Chabner%2C+B&amp;rft.au=Knollman%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGuenetteGiaccaHahnTeo2013" class="citation journal cs1">Guenette MD, Giacca A, Hahn M, Teo C, Lam L, Chintoh A, et&#160;al. (May 2013). "Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: an animal model". <i>Schizophrenia Research</i>. <b>146</b> (<span class="nowrap">1–</span>3): <span class="nowrap">162–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.schres.2013.02.023">10.1016/j.schres.2013.02.023</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23499243">23499243</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43719333">43719333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Research&amp;rft.atitle=Atypical+antipsychotics+and+effects+of+adrenergic+and+serotonergic+receptor+binding+on+insulin+secretion+in-vivo%3A+an+animal+model&amp;rft.volume=146&amp;rft.issue=%3Cspan+class%3D%22nowrap%22%3E1%E2%80%93%3C%2Fspan%3E3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E162-%3C%2Fspan%3E9&amp;rft.date=2013-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43719333%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23499243&amp;rft_id=info%3Adoi%2F10.1016%2Fj.schres.2013.02.023&amp;rft.aulast=Guenette&amp;rft.aufirst=MD&amp;rft.au=Giacca%2C+A&amp;rft.au=Hahn%2C+M&amp;rft.au=Teo%2C+C&amp;rft.au=Lam%2C+L&amp;rft.au=Chintoh%2C+A&amp;rft.au=Arenovich%2C+T&amp;rft.au=Remington%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNg-MakTongbramNdiranguRajagopalan2018" class="citation journal cs1">Ng-Mak D, Tongbram V, Ndirangu K, Rajagopalan K, Loebel A (August 1, 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.2217%2Fcer-2018-0016">"Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis"</a>. <i>Journal of Comparative Effectiveness Research</i>. <b>7</b> (8): <span class="nowrap">737–</span>748. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2217%2Fcer-2018-0016">10.2217/cer-2018-0016</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2042-6305">2042-6305</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29697278">29697278</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13769615">13769615</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Comparative+Effectiveness+Research&amp;rft.atitle=Efficacy+and+metabolic+effects+of+lurasidone+versus+brexpiprazole+in+schizophrenia%3A+a+network+meta-analysis&amp;rft.volume=7&amp;rft.issue=8&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E737-%3C%2Fspan%3E748&amp;rft.date=2018-08-01&amp;rft.issn=2042-6305&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13769615%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29697278&amp;rft_id=info%3Adoi%2F10.2217%2Fcer-2018-0016&amp;rft.aulast=Ng-Mak&amp;rft.aufirst=Daisy&amp;rft.au=Tongbram%2C+Vanita&amp;rft.au=Ndirangu%2C+Kerigo&amp;rft.au=Rajagopalan%2C+Krithika&amp;rft.au=Loebel%2C+Antony&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.2217%252Fcer-2018-0016&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPillingerMcCutcheonVanoMizuno2020" class="citation journal cs1">Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD (January 1, 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029416">"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis"</a>. <i>The Lancet Psychiatry</i>. <b>7</b> (1): <span class="nowrap">64–</span>77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS2215-0366%2819%2930416-X">10.1016/S2215-0366(19)30416-X</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2215-0366">2215-0366</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029416">7029416</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31860457">31860457</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:209434994">209434994</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Psychiatry&amp;rft.atitle=Comparative+effects+of+18+antipsychotics+on+metabolic+function+in+patients+with+schizophrenia%2C+predictors+of+metabolic+dysregulation%2C+and+association+with+psychopathology%3A+a+systematic+review+and+network+meta-analysis&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E64-%3C%2Fspan%3E77&amp;rft.date=2020-01-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7029416%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A209434994%23id-name%3DS2CID&amp;rft_id=info%3Adoi%2F10.1016%2FS2215-0366%2819%2930416-X&amp;rft.issn=2215-0366&amp;rft_id=info%3Apmid%2F31860457&amp;rft.aulast=Pillinger&amp;rft.aufirst=Toby&amp;rft.au=McCutcheon%2C+Robert+A.&amp;rft.au=Vano%2C+Luke&amp;rft.au=Mizuno%2C+Yuya&amp;rft.au=Arumuham%2C+Atheeshaan&amp;rft.au=Hindley%2C+Guy&amp;rft.au=Beck%2C+Katherine&amp;rft.au=Natesan%2C+Sridhar&amp;rft.au=Efthimiou%2C+Orestis&amp;rft.au=Cipriani%2C+Andrea&amp;rft.au=Howes%2C+Oliver+D.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7029416&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDayabandaraHanwellaRatnatungaSeneviratne2017" class="citation journal cs1">Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574691">"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence"</a>. <i>Neuropsychiatr Dis Treat</i>. <b>13</b>: <span class="nowrap">2231–</span>2241. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FNDT.S113099">10.2147/NDT.S113099</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574691">5574691</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28883731">28883731</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatr+Dis+Treat&amp;rft.atitle=Antipsychotic-associated+weight+gain%3A+management+strategies+and+impact+on+treatment+adherence&amp;rft.volume=13&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E2231-%3C%2Fspan%3E2241&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5574691%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28883731&amp;rft_id=info%3Adoi%2F10.2147%2FNDT.S113099&amp;rft.aulast=Dayabandara&amp;rft.aufirst=M&amp;rft.au=Hanwella%2C+R&amp;rft.au=Ratnatunga%2C+S&amp;rft.au=Seneviratne%2C+S&amp;rft.au=Suraweera%2C+C&amp;rft.au=de+Silva%2C+VA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5574691&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSatlinDurgamVanoverDavis2020" class="citation journal cs1">Satlin A, Durgam S, Vanover KE, Davis RE, Huo J, Mates S, Correll C (May 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234755">"M205. Long-Term Safety of Lumateperone (ITI-007): Metabolic Effects in a 1-Year Study"</a>. <i>Schizophr Bull</i>. <b>46</b> (Suppl 1): S214. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fschbul%2Fsbaa030.517">10.1093/schbul/sbaa030.517</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234755">7234755</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophr+Bull&amp;rft.atitle=M205.+Long-Term+Safety+of+Lumateperone+%28ITI-007%29%3A+Metabolic+Effects+in+a+1-Year+Study&amp;rft.volume=46&amp;rft.issue=Suppl+1&amp;rft.pages=S214&amp;rft.date=2020-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7234755%23id-name%3DPMC&amp;rft_id=info%3Adoi%2F10.1093%2Fschbul%2Fsbaa030.517&amp;rft.aulast=Satlin&amp;rft.aufirst=A&amp;rft.au=Durgam%2C+S&amp;rft.au=Vanover%2C+KE&amp;rft.au=Davis%2C+RE&amp;rft.au=Huo%2C+J&amp;rft.au=Mates%2C+S&amp;rft.au=Correll%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7234755&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWangWangChengFang2021" class="citation journal cs1">Wang Y, Wang D, Cheng J, Fang X, Chen Y, Yu L, Ren J, Tian Y, Zhang C (September 2021). "Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis". <i>Journal of Psychopharmacology</i>. <b>35</b> (9): <span class="nowrap">1111–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F02698811211035391">10.1177/02698811211035391</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34311625">34311625</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:236451973">236451973</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychopharmacology&amp;rft.atitle=Efficacy+and+tolerability+of+pharmacological+interventions+on+metabolic+disturbance+induced+by+atypical+antipsychotics+in+adults%3A+A+systematic+review+and+network+meta-analysis&amp;rft.volume=35&amp;rft.issue=9&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1111-%3C%2Fspan%3E9&amp;rft.date=2021-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A236451973%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F34311625&amp;rft_id=info%3Adoi%2F10.1177%2F02698811211035391&amp;rft.aulast=Wang&amp;rft.aufirst=Yewei&amp;rft.au=Wang%2C+Dandan&amp;rft.au=Cheng%2C+Jie&amp;rft.au=Fang%2C+Xinyu&amp;rft.au=Chen%2C+Yan&amp;rft.au=Yu%2C+Lingfang&amp;rft.au=Ren%2C+Juanjuan&amp;rft.au=Tian%2C+Yuan&amp;rft.au=Zhang%2C+Chen&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-wolters-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-wolters_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-wolters_76-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-wolters_76-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-wolters_76-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-wolters_76-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-wolters_76-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-wolters_76-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-wolters_76-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-wolters_76-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-wolters_76-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-wolters_76-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-wolters_76-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-wolters_76-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-wolters_76-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-wolters_76-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-wolters_76-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-wolters_76-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-wolters_76-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-wolters_76-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-wolters_76-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-wolters_76-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-wolters_76-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-wolters_76-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-wolters_76-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-wolters_76-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-wolters_76-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-wolters_76-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-wolters_76-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-wolters_76-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-wolters_76-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-wolters_76-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-wolters_76-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-wolters_76-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-wolters_76-33"><sup><i><b>ah</b></i></sup></a> <a href="#cite_ref-wolters_76-34"><sup><i><b>ai</b></i></sup></a> <a href="#cite_ref-wolters_76-35"><sup><i><b>aj</b></i></sup></a> <a href="#cite_ref-wolters_76-36"><sup><i><b>ak</b></i></sup></a> <a href="#cite_ref-wolters_76-37"><sup><i><b>al</b></i></sup></a> <a href="#cite_ref-wolters_76-38"><sup><i><b>am</b></i></sup></a> <a href="#cite_ref-wolters_76-39"><sup><i><b>an</b></i></sup></a> <a href="#cite_ref-wolters_76-40"><sup><i><b>ao</b></i></sup></a> <a href="#cite_ref-wolters_76-41"><sup><i><b>ap</b></i></sup></a> <a href="#cite_ref-wolters_76-42"><sup><i><b>aq</b></i></sup></a> <a href="#cite_ref-wolters_76-43"><sup><i><b>ar</b></i></sup></a> <a href="#cite_ref-wolters_76-44"><sup><i><b>as</b></i></sup></a> <a href="#cite_ref-wolters_76-45"><sup><i><b>at</b></i></sup></a> <a href="#cite_ref-wolters_76-46"><sup><i><b>au</b></i></sup></a> <a href="#cite_ref-wolters_76-47"><sup><i><b>av</b></i></sup></a> <a href="#cite_ref-wolters_76-48"><sup><i><b>aw</b></i></sup></a> <a href="#cite_ref-wolters_76-49"><sup><i><b>ax</b></i></sup></a> <a href="#cite_ref-wolters_76-50"><sup><i><b>ay</b></i></sup></a> <a href="#cite_ref-wolters_76-51"><sup><i><b>az</b></i></sup></a> <a href="#cite_ref-wolters_76-52"><sup><i><b>ba</b></i></sup></a> <a href="#cite_ref-wolters_76-53"><sup><i><b>bb</b></i></sup></a> <a href="#cite_ref-wolters_76-54"><sup><i><b>bc</b></i></sup></a> <a href="#cite_ref-wolters_76-55"><sup><i><b>bd</b></i></sup></a> <a href="#cite_ref-wolters_76-56"><sup><i><b>be</b></i></sup></a> <a href="#cite_ref-wolters_76-57"><sup><i><b>bf</b></i></sup></a> <a href="#cite_ref-wolters_76-58"><sup><i><b>bg</b></i></sup></a> <a href="#cite_ref-wolters_76-59"><sup><i><b>bh</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="http://www.wolterskluwercdi.com/facts-comparisons-online/">"Comparison of Common Side Effects of Second Generation Atypical Antipsychotics"</a></span>. <i>Facts &amp; Comparisons</i>. Wolters Kluwer Health<span class="reference-accessdate">. Retrieved <span class="nowrap">March 31,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Facts+%26+Comparisons&amp;rft.atitle=Comparison+of+Common+Side+Effects+of+Second+Generation+Atypical+Antipsychotics&amp;rft_id=http%3A%2F%2Fwww.wolterskluwercdi.com%2Ffacts-comparisons-online%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Prolactin_SD-77"><span class="mw-cite-backlink">^ <a href="#cite_ref-Prolactin_SD_77-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Prolactin_SD_77-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFParkKimLee2012" class="citation journal cs1">Park YW, Kim Y, Lee JH (December 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623530">"Antipsychotic-induced sexual dysfunction and its management"</a>. <i>The World Journal of Men's Health</i>. <b>30</b> (3): <span class="nowrap">153–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5534%2Fwjmh.2012.30.3.153">10.5534/wjmh.2012.30.3.153</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623530">3623530</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23596605">23596605</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+World+Journal+of+Men%27s+Health&amp;rft.atitle=Antipsychotic-induced+sexual+dysfunction+and+its+management&amp;rft.volume=30&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E153-%3C%2Fspan%3E9&amp;rft.date=2012-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3623530%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23596605&amp;rft_id=info%3Adoi%2F10.5534%2Fwjmh.2012.30.3.153&amp;rft.aulast=Park&amp;rft.aufirst=YW&amp;rft.au=Kim%2C+Y&amp;rft.au=Lee%2C+JH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3623530&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-onrust-78"><span class="mw-cite-backlink">^ <a href="#cite_ref-onrust_78-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-onrust_78-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-onrust_78-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-onrust_78-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-onrust_78-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFOnrustMcClellan2001" class="citation journal cs1">Onrust SV, McClellan K (2001). "Perospirone". <i>CNS Drugs</i>. <b>15</b> (4): <span class="nowrap">329–</span>37, discussion 338. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00023210-200115040-00006">10.2165/00023210-200115040-00006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11463136">11463136</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:262520276">262520276</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Perospirone&amp;rft.volume=15&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E329-%3C%2Fspan%3E37%2C+discussion+338&amp;rft.date=2001&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A262520276%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11463136&amp;rft_id=info%3Adoi%2F10.2165%2F00023210-200115040-00006&amp;rft.aulast=Onrust&amp;rft.aufirst=SV&amp;rft.au=McClellan%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHolmEdsmanLundbergOdlind1993" class="citation journal cs1">Holm AC, Edsman I, Lundberg T, Odlind B (June 1993). "Tolerability of remoxipride in the long term treatment of schizophrenia. An overview". <i>Drug Safety</i>. <b>8</b> (6): <span class="nowrap">445–</span>56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00002018-199308060-00005">10.2165/00002018-199308060-00005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8329149">8329149</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43855244">43855244</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Safety&amp;rft.atitle=Tolerability+of+remoxipride+in+the+long+term+treatment+of+schizophrenia.+An+overview&amp;rft.volume=8&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E445-%3C%2Fspan%3E56&amp;rft.date=1993-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43855244%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F8329149&amp;rft_id=info%3Adoi%2F10.2165%2F00002018-199308060-00005&amp;rft.aulast=Holm&amp;rft.aufirst=AC&amp;rft.au=Edsman%2C+I&amp;rft.au=Lundberg%2C+T&amp;rft.au=Odlind%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://allnurses.com/psychiatric-nursing/risperdal-gynecomastia-galactorrhea-74429.html">"Risperdal, gynecomastia and galactorrhea in adolescent males"</a>. <i>Allnurses.com</i>. August 2, 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Allnurses.com&amp;rft.atitle=Risperdal%2C+gynecomastia+and+galactorrhea+in+adolescent+males&amp;rft.date=2004-08-02&amp;rft_id=http%3A%2F%2Fallnurses.com%2Fpsychiatric-nursing%2Frisperdal-gynecomastia-galactorrhea-74429.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Group_2009_192-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-Group_2009_192_81-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJoint_Formulary_Committee2009" class="citation book cs1">Joint Formulary Committee B, ed. (March 2009). "4.2.1". <i>British National Formulary</i> (57&#160;ed.). United Kingdom: Royal Pharmaceutical Society of Great Britain. p.&#160;192. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-85369-845-6" title="Special:BookSources/978-0-85369-845-6"><bdi>978-0-85369-845-6</bdi></a>. <q>Withdrawal of antipsychotic drugs after long-term therapy should always be gradual and closely monitored to avoid the risk of acute withdrawal syndromes or rapid relapse.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=4.2.1&amp;rft.btitle=British+National+Formulary&amp;rft.place=United+Kingdom&amp;rft.pages=192&amp;rft.edition=57&amp;rft.pub=Royal+Pharmaceutical+Society+of+Great+Britain&amp;rft.date=2009-03&amp;rft.isbn=978-0-85369-845-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Had2004-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-Had2004_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Had2004_82-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Had2004_82-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Had2004_82-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Had2004_82-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHaddadHaddadDursunDeakin2004" class="citation book cs1">Haddad P, Haddad PM, Dursun S, Deakin B (2004). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=CWR7DwAAQBAJ&amp;pg=PA207"><i>Adverse Syndromes and Psychiatric Drugs: A Clinical Guide</i></a>. OUP Oxford. pp.&#160;<span class="nowrap">207–</span>216. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780198527480" title="Special:BookSources/9780198527480"><bdi>9780198527480</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Adverse+Syndromes+and+Psychiatric+Drugs%3A+A+Clinical+Guide&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E207-%3C%2Fspan%3E216&amp;rft.pub=OUP+Oxford&amp;rft.date=2004&amp;rft.isbn=9780198527480&amp;rft.aulast=Haddad&amp;rft.aufirst=Peter&amp;rft.au=Haddad%2C+Peter+M.&amp;rft.au=Dursun%2C+Serdar&amp;rft.au=Deakin%2C+Bill&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DCWR7DwAAQBAJ%26pg%3DPA207&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMoncrieff2006" class="citation journal cs1">Moncrieff J (July 2006). "Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse". <i>Acta Psychiatrica Scandinavica</i>. <b>114</b> (1): <span class="nowrap">3–</span>13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0447.2006.00787.x">10.1111/j.1600-0447.2006.00787.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16774655">16774655</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6267180">6267180</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.atitle=Does+antipsychotic+withdrawal+provoke+psychosis%3F+Review+of+the+literature+on+rapid+onset+psychosis+%28supersensitivity+psychosis%29+and+withdrawal-related+relapse&amp;rft.volume=114&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E3-%3C%2Fspan%3E13&amp;rft.date=2006-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6267180%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16774655&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.2006.00787.x&amp;rft.aulast=Moncrieff&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSacchettiVitaSiracusanoFleischhacker2013" class="citation book cs1">Sacchetti E, Vita A, Siracusano A, Fleischhacker W (2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=odE-AgAAQBAJ&amp;pg=PA85"><i>Adherence to Antipsychotics in Schizophrenia</i></a>. Springer Science &amp; Business Media. p.&#160;85. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9788847026797" title="Special:BookSources/9788847026797"><bdi>9788847026797</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Adherence+to+Antipsychotics+in+Schizophrenia&amp;rft.pages=85&amp;rft.pub=Springer+Science+%26+Business+Media&amp;rft.date=2013&amp;rft.isbn=9788847026797&amp;rft.aulast=Sacchetti&amp;rft.aufirst=Emilio&amp;rft.au=Vita%2C+Antonio&amp;rft.au=Siracusano%2C+Alberto&amp;rft.au=Fleischhacker%2C+Wolfgang&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DodE-AgAAQBAJ%26pg%3DPA85&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStahl2008" class="citation book cs1">Stahl SM (March 27, 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=jwfrLrYc7d0C&amp;q=5ht"><i>Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology, 3rd Edition</i></a>. Cambridge University Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-521-88664-2" title="Special:BookSources/978-0-521-88664-2"><bdi>978-0-521-88664-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antipsychotics+and+Mood+Stabilizers%3A+Stahl%27s+Essential+Psychopharmacology%2C+3rd+Edition&amp;rft.pub=Cambridge+University+Press&amp;rft.date=2008-03-27&amp;rft.isbn=978-0-521-88664-2&amp;rft.aulast=Stahl&amp;rft.aufirst=Stephen+M.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DjwfrLrYc7d0C%26q%3D5ht&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Stahl_AP_Explained_1-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-Stahl_AP_Explained_1_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Stahl_AP_Explained_1_86-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Stahl_AP_Explained_1_86-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Stahl_AP_Explained_1_86-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Stahl_AP_Explained_1_86-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Stahl_AP_Explained_1_86-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStahl" class="citation book cs1">Stahl S. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20171107024320/https://universitypsychiatry.com/clientuploads/stahl/Stahl_3rd_ch10_Part1.pdf"><i>Antipsychotics Explained 1</i></a> <span class="cs1-format">(PDF)</span>. University Psychiatry. Archived from <a rel="nofollow" class="external text" href="https://universitypsychiatry.com/clientuploads/stahl/Stahl_3rd_ch10_Part1.pdf">the original</a> <span class="cs1-format">(PDF)</span> on November 7, 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antipsychotics+Explained+1&amp;rft.pub=University+Psychiatry&amp;rft.aulast=Stahl&amp;rft.aufirst=Steven&amp;rft_id=https%3A%2F%2Funiversitypsychiatry.com%2Fclientuploads%2Fstahl%2FStahl_3rd_ch10_Part1.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStephen_M._Stahl2008" class="citation book cs1">Stephen M. Stahl (March 27, 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=jwfrLrYc7d0C&amp;q=5ht2a++release+dopamine&amp;pg=PA105"><i>Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology .</i></a> Cambridge University Press. p.&#160;105. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780521886642" title="Special:BookSources/9780521886642"><bdi>9780521886642</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antipsychotics+and+Mood+Stabilizers%3A+Stahl%27s+Essential+Psychopharmacology+..&amp;rft.pages=105&amp;rft.pub=Cambridge+University+Press&amp;rft.date=2008-03-27&amp;rft.isbn=9780521886642&amp;rft.au=Stephen+M.+Stahl&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DjwfrLrYc7d0C%26q%3D5ht2a%2B%2Brelease%2Bdopamine%26pg%3DPA105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFEgertonAhmadHiraniGrasby2008" class="citation journal cs1">Egerton A, Ahmad R, Hirani E, Grasby PM (November 2008). "Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat". <i>Psychopharmacology</i>. <b>200</b> (4): <span class="nowrap">487–</span>96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00213-008-1226-4">10.1007/s00213-008-1226-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18597077">18597077</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11800154">11800154</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychopharmacology&amp;rft.atitle=Modulation+of+striatal+dopamine+release+by+5-HT2A+and+5-HT2C+receptor+antagonists%3A+%5B11C%5Draclopride+PET+studies+in+the+rat&amp;rft.volume=200&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E487-%3C%2Fspan%3E96&amp;rft.date=2008-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11800154%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18597077&amp;rft_id=info%3Adoi%2F10.1007%2Fs00213-008-1226-4&amp;rft.aulast=Egerton&amp;rft.aufirst=A&amp;rft.au=Ahmad%2C+R&amp;rft.au=Hirani%2C+E&amp;rft.au=Grasby%2C+PM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid16310183-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16310183_92-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFde_BoerKoolhaas2005" class="citation journal cs1">de Boer SF, Koolhaas JM (December 2005). "5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis". <i>European Journal of Pharmacology</i>. <b>526</b> (<span class="nowrap">1–</span>3): <span class="nowrap">125–</span>39. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejphar.2005.09.065">10.1016/j.ejphar.2005.09.065</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16310183">16310183</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Pharmacology&amp;rft.atitle=5-HT1A+and+5-HT1B+receptor+agonists+and+aggression%3A+a+pharmacological+challenge+of+the+serotonin+deficiency+hypothesis&amp;rft.volume=526&amp;rft.issue=%3Cspan+class%3D%22nowrap%22%3E1%E2%80%93%3C%2Fspan%3E3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E125-%3C%2Fspan%3E39&amp;rft.date=2005-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejphar.2005.09.065&amp;rft_id=info%3Apmid%2F16310183&amp;rft.aulast=de+Boer&amp;rft.aufirst=SF&amp;rft.au=Koolhaas%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cardiosmart.org/Healthwise/d003/23/d00323">"norepinephrine"</a>. <i>Cardiosmart.org</i>. December 15, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Cardiosmart.org&amp;rft.atitle=norepinephrine&amp;rft.date=2010-12-15&amp;rft_id=https%3A%2F%2Fwww.cardiosmart.org%2FHealthwise%2Fd003%2F23%2Fd00323&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFVevesMalik2008" class="citation book cs1">Veves A, Malik RA (February 1, 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=dMKoFySox7kC&amp;pg=PA401"><i>Diabetic Neuropathy: Clinical Management</i></a>. Springer. p.&#160;401. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9781597453110" title="Special:BookSources/9781597453110"><bdi>9781597453110</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Diabetic+Neuropathy%3A+Clinical+Management&amp;rft.pages=401&amp;rft.pub=Springer&amp;rft.date=2008-02-01&amp;rft.isbn=9781597453110&amp;rft.aulast=Veves&amp;rft.aufirst=Aristidis&amp;rft.au=Malik%2C+Rayaz+A&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DdMKoFySox7kC%26pg%3DPA401&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20161013053954/https://www.boundless.com/biology/textbooks/boundless-biology-textbook/osmotic-regulation-and-the-excretory-system-41/hormonal-control-of-osmoregulatory-functions-232/epinephrine-and-norepinephrine-867-12114/">"Epinephrine and Norepinephrine"</a>. <i>Boundless.com</i>. Archived from <a rel="nofollow" class="external text" href="https://www.boundless.com/biology/textbooks/boundless-biology-textbook/osmotic-regulation-and-the-excretory-system-41/hormonal-control-of-osmoregulatory-functions-232/epinephrine-and-norepinephrine-867-12114/">the original</a> on October 13, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Boundless.com&amp;rft.atitle=Epinephrine+and+Norepinephrine&amp;rft_id=https%3A%2F%2Fwww.boundless.com%2Fbiology%2Ftextbooks%2Fboundless-biology-textbook%2Fosmotic-regulation-and-the-excretory-system-41%2Fhormonal-control-of-osmoregulatory-functions-232%2Fepinephrine-and-norepinephrine-867-12114%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.rxwiki.com/cariprazine">"Cariprazine - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol"</a>. <i>RxWiki.com</i>. September 17, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=RxWiki.com&amp;rft.atitle=Cariprazine+-+Side+Effects%2C+Uses%2C+Dosage%2C+Overdose%2C+Pregnancy%2C+Alcohol&amp;rft.date=2015-09-17&amp;rft_id=http%3A%2F%2Fwww.rxwiki.com%2Fcariprazine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160817063943/http://www.invega.com/side-effects-schizophrenia-treatment">"INVEGA Side Effects - Schizophrenia Treatment – INVEGA (paliperidone)"</a>. <i>Invega.com</i>. May 17, 2016. Archived from <a rel="nofollow" class="external text" href="http://www.invega.com/side-effects-schizophrenia-treatment">the original</a> on August 17, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Invega.com&amp;rft.atitle=INVEGA+Side+Effects+-+Schizophrenia+Treatment+%E2%80%93+INVEGA+%28paliperidone%29&amp;rft.date=2016-05-17&amp;rft_id=http%3A%2F%2Fwww.invega.com%2Fside-effects-schizophrenia-treatment&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://diabetesupdate.blogspot.se/2007/08/hunger-is-symptom.html">"Diabetes Update: Hunger is a Symptom"</a>. <i>Diabetesupdate.blogspot.se</i>. August 8, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Diabetesupdate.blogspot.se&amp;rft.atitle=Diabetes+Update%3A+Hunger+is+a+Symptom&amp;rft.date=2007-08-08&amp;rft_id=http%3A%2F%2Fdiabetesupdate.blogspot.se%2F2007%2F08%2Fhunger-is-symptom.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://healthvermont.gov/prevent/diabetes/high_low_sugar.aspx">"High &amp; Low Blood Sugar"</a>. <i>Healthvermont.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Healthvermont.gov&amp;rft.atitle=High+%26+Low+Blood+Sugar&amp;rft_id=http%3A%2F%2Fhealthvermont.gov%2Fprevent%2Fdiabetes%2Fhigh_low_sugar.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://rexulti.com/us/mdd/important-safety-information/">"REXULTI (brexpiprazole) &#124; Important Safety Information"</a>. <i>Rexulti.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Rexulti.com&amp;rft.atitle=REXULTI+%28brexpiprazole%29+%26%23124%3B+Important+Safety+Information&amp;rft_id=https%3A%2F%2Frexulti.com%2Fus%2Fmdd%2Fimportant-safety-information%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStephen_M._Stahl2008" class="citation book cs1">Stephen M. Stahl (March 27, 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=jwfrLrYc7d0C&amp;pg=PA172"><i>Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology .</i></a> Cambridge University Press. p.&#160;172. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780521886642" title="Special:BookSources/9780521886642"><bdi>9780521886642</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antipsychotics+and+Mood+Stabilizers%3A+Stahl%27s+Essential+Psychopharmacology+..&amp;rft.pages=172&amp;rft.pub=Cambridge+University+Press&amp;rft.date=2008-03-27&amp;rft.isbn=9780521886642&amp;rft.au=Stephen+M.+Stahl&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DjwfrLrYc7d0C%26pg%3DPA172&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid19086256-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19086256_102-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKingMarsdenFone2008" class="citation journal cs1">King MV, Marsden CA, Fone KC (September 2008). "A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory". <i>Trends in Pharmacological Sciences</i>. <b>29</b> (9): <span class="nowrap">482–</span>92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2008.07.001">10.1016/j.tips.2008.07.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19086256">19086256</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Pharmacological+Sciences&amp;rft.atitle=A+role+for+the+5-HT%281A%29%2C+5-HT4+and+5-HT6+receptors+in+learning+and+memory&amp;rft.volume=29&amp;rft.issue=9&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E482-%3C%2Fspan%3E92&amp;rft.date=2008-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tips.2008.07.001&amp;rft_id=info%3Apmid%2F19086256&amp;rft.aulast=King&amp;rft.aufirst=MV&amp;rft.au=Marsden%2C+CA&amp;rft.au=Fone%2C+KC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid18308814-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18308814_103-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFShahidWalkerZornWong2009" class="citation journal cs1">Shahid M, Walker GB, Zorn SH, Wong EH (January 2009). "Asenapine: a novel psychopharmacologic agent with a unique human receptor signature". <i>Journal of Psychopharmacology</i>. <b>23</b> (1): <span class="nowrap">65–</span>73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F0269881107082944">10.1177/0269881107082944</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18308814">18308814</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:206489515">206489515</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychopharmacology&amp;rft.atitle=Asenapine%3A+a+novel+psychopharmacologic+agent+with+a+unique+human+receptor+signature&amp;rft.volume=23&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E65-%3C%2Fspan%3E73&amp;rft.date=2009-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A206489515%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18308814&amp;rft_id=info%3Adoi%2F10.1177%2F0269881107082944&amp;rft.aulast=Shahid&amp;rft.aufirst=M&amp;rft.au=Walker%2C+GB&amp;rft.au=Zorn%2C+SH&amp;rft.au=Wong%2C+EH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-autogenerated1-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-autogenerated1_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-autogenerated1_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/200603Orig1s000PharmR.pdf">"Pharmcology Reviews&#160;: 200603"</a> <span class="cs1-format">(PDF)</span>. <i>Accessdata.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Accessdata.fda.gov&amp;rft.atitle=Pharmcology+Reviews+%3A+200603&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2010%2F200603Orig1s000PharmR.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFIshibashiHorisawaTokudaIshiyama2010" class="citation journal cs1">Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, Tagashira R, et&#160;al. (July 2010). "Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>334</b> (1): <span class="nowrap">171–</span>81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1124%2Fjpet.110.167346">10.1124/jpet.110.167346</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20404009">20404009</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12893717">12893717</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Pharmacological+profile+of+lurasidone%2C+a+novel+antipsychotic+agent+with+potent+5-hydroxytryptamine+7+%285-HT7%29+and+5-HT1A+receptor+activity&amp;rft.volume=334&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E171-%3C%2Fspan%3E81&amp;rft.date=2010-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12893717%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20404009&amp;rft_id=info%3Adoi%2F10.1124%2Fjpet.110.167346&amp;rft.aulast=Ishibashi&amp;rft.aufirst=T&amp;rft.au=Horisawa%2C+T&amp;rft.au=Tokuda%2C+K&amp;rft.au=Ishiyama%2C+T&amp;rft.au=Ogasa%2C+M&amp;rft.au=Tagashira%2C+R&amp;rft.au=Matsumoto%2C+K&amp;rft.au=Nishikawa%2C+H&amp;rft.au=Ueda%2C+Y&amp;rft.au=Toma%2C+S&amp;rft.au=Oki%2C+H&amp;rft.au=Tanno%2C+N&amp;rft.au=Saji%2C+I&amp;rft.au=Ito%2C+A&amp;rft.au=Ohno%2C+Y&amp;rft.au=Nakamura%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text">National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 10]. ChapelHill (NC): University of North Carolina. 1998-2013. Available from: <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20131108013656/http://pdsp.med.unc.edu/pdsp.php">"PDSP Database - UNC"</a>. Archived from <a rel="nofollow" class="external text" href="http://pdsp.med.unc.edu/pdsp.php">the original</a> on November 8, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">May 16,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PDSP+Database+-+UNC&amp;rft_id=http%3A%2F%2Fpdsp.med.unc.edu%2Fpdsp.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHemmingsEgan2013" class="citation book cs1">Hemmings HC, Egan TD (2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=s8CXrbimviMC&amp;pg=PT209"><i>Pharmacology and Physiology for Anesthesia: Foundations and Clinical .</i></a> Elsevier Health Sciences. p.&#160;209. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1437716795" title="Special:BookSources/978-1437716795"><bdi>978-1437716795</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacology+and+Physiology+for+Anesthesia%3A+Foundations+and+Clinical+..&amp;rft.pages=209&amp;rft.pub=Elsevier+Health+Sciences&amp;rft.date=2013&amp;rft.isbn=978-1437716795&amp;rft.aulast=Hemmings&amp;rft.aufirst=Hugh+C.&amp;rft.au=Egan%2C+Talmage+D.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Ds8CXrbimviMC%26pg%3DPT209&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMargaret_Jordan_Halter2014" class="citation book cs1">Margaret Jordan Halter (March 12, 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=59fsAwAAQBAJ&amp;pg=PA61"><i>Varcarolis' Foundations of Psychiatric Mental Health Nursing: A Clinical .</i></a> Elsevier Health Sciences. p.&#160;61. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9781455728886" title="Special:BookSources/9781455728886"><bdi>9781455728886</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Varcarolis%27+Foundations+of+Psychiatric+Mental+Health+Nursing%3A+A+Clinical+..&amp;rft.pages=61&amp;rft.pub=Elsevier+Health+Sciences&amp;rft.date=2014-03-12&amp;rft.isbn=9781455728886&amp;rft.au=Margaret+Jordan+Halter&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D59fsAwAAQBAJ%26pg%3DPA61&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTasmanKayFirstLieberman2015" class="citation book cs1">Tasman A, Kay J, First MB, Lieberman JA, Riba M (March 30, 2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=YEkoBgAAQBAJ&amp;pg=PA2096"><i>Psychiatry, 2 Volume Set</i></a>. John Wiley &amp; Sons. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-118-84547-9" title="Special:BookSources/978-1-118-84547-9"><bdi>978-1-118-84547-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Psychiatry%2C+2+Volume+Set&amp;rft.pub=John+Wiley+%26+Sons&amp;rft.date=2015-03-30&amp;rft.isbn=978-1-118-84547-9&amp;rft.aulast=Tasman&amp;rft.aufirst=Allan&amp;rft.au=Kay%2C+Jerald&amp;rft.au=First%2C+Michael+B.&amp;rft.au=Lieberman%2C+Jeffrey+A.&amp;rft.au=Riba%2C+Michelle&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DYEkoBgAAQBAJ%26pg%3DPA2096&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/ohrms/dockets/ac/00/backgrd/3619b1a.pdf">"FDA&#160;: Psychopharmacological Drugs Advisory Committee&#160;: Briefing Document for ZELDOX CAPSULES (Ziprasidone HCl)"</a> <span class="cs1-format">(PDF)</span>. <i>Fda.gov</i>. July 19, 2000<span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fda.gov&amp;rft.atitle=FDA+%3A+Psychopharmacological+Drugs+Advisory+Committee+%3A+Briefing+Document+for+ZELDOX+CAPSULES+%28Ziprasidone+HCl%29&amp;rft.date=2000-07-19&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F00%2Fbackgrd%2F3619b1a.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWoutersTulpBevan1988" class="citation journal cs1">Wouters W, Tulp MT, Bevan P (May 1988). "Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors". <i>European Journal of Pharmacology</i>. <b>149</b> (3): <span class="nowrap">213–</span>23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0014-2999%2888%2990651-6">10.1016/0014-2999(88)90651-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2842163">2842163</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Pharmacology&amp;rft.atitle=Flesinoxan+lowers+blood+pressure+and+heart+rate+in+cats+via+5-HT1A+receptors&amp;rft.volume=149&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E213-%3C%2Fspan%3E23&amp;rft.date=1988-05&amp;rft_id=info%3Adoi%2F10.1016%2F0014-2999%2888%2990651-6&amp;rft_id=info%3Apmid%2F2842163&amp;rft.aulast=Wouters&amp;rft.aufirst=W&amp;rft.au=Tulp%2C+MT&amp;rft.au=Bevan%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHoriuchiMcDowallDampney2008" class="citation journal cs1">Horiuchi J, McDowall LM, Dampney RA (November 2008). "Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation". <i>Autonomic Neuroscience</i>. <b>142</b> (<span class="nowrap">1–</span>2): <span class="nowrap">71–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.autneu.2008.06.004">10.1016/j.autneu.2008.06.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18667366">18667366</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20878941">20878941</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autonomic+Neuroscience&amp;rft.atitle=Role+of+5-HT%281A%29+receptors+in+the+lower+brainstem+on+the+cardiovascular+response+to+dorsomedial+hypothalamus+activation&amp;rft.volume=142&amp;rft.issue=%3Cspan+class%3D%22nowrap%22%3E1%E2%80%93%3C%2Fspan%3E2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E71-%3C%2Fspan%3E6&amp;rft.date=2008-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20878941%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18667366&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autneu.2008.06.004&amp;rft.aulast=Horiuchi&amp;rft.aufirst=J&amp;rft.au=McDowall%2C+LM&amp;rft.au=Dampney%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWeberVolynetsKanuriBergheim2009" class="citation journal cs1">Weber S, Volynets V, Kanuri G, Bergheim I, Bischoff SC (December 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fijo.2009.191">"Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice"</a>. <i>International Journal of Obesity</i>. <b>33</b> (12): <span class="nowrap">1339–</span>47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fijo.2009.191">10.1038/ijo.2009.191</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19823183">19823183</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Obesity&amp;rft.atitle=Treatment+with+the+5-HT3+antagonist+tropisetron+modulates+glucose-induced+obesity+in+mice&amp;rft.volume=33&amp;rft.issue=12&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1339-%3C%2Fspan%3E47&amp;rft.date=2009-12&amp;rft_id=info%3Adoi%2F10.1038%2Fijo.2009.191&amp;rft_id=info%3Apmid%2F19823183&amp;rft.aulast=Weber&amp;rft.aufirst=S&amp;rft.au=Volynets%2C+V&amp;rft.au=Kanuri%2C+G&amp;rft.au=Bergheim%2C+I&amp;rft.au=Bischoff%2C+SC&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fijo.2009.191&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGobbiJaniri1999" class="citation journal cs1"><a href="/wiki/Gabriella_Gobbi" title="Gabriella Gobbi">Gobbi G</a>, Janiri L (December 1999). "Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic study". <i>European Neuropsychopharmacology</i>. <b>10</b> (1): <span class="nowrap">43–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0924-977X%2899%2900055-3">10.1016/S0924-977X(99)00055-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10647096">10647096</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24251712">24251712</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Neuropsychopharmacology&amp;rft.atitle=Clozapine+blocks+dopamine%2C+5-HT2+and+5-HT3+responses+in+the+medial+prefrontal+cortex%3A+an+in+vivo+microiontophoretic+study&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E43-%3C%2Fspan%3E9&amp;rft.date=1999-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24251712%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10647096&amp;rft_id=info%3Adoi%2F10.1016%2FS0924-977X%2899%2900055-3&amp;rft.aulast=Gobbi&amp;rft.aufirst=G&amp;rft.au=Janiri%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNavari2014" class="citation journal cs1">Navari RM (January 2014). "Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting". <i>European Journal of Pharmacology</i>. <b>722</b>: <span class="nowrap">180–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejphar.2013.08.048">10.1016/j.ejphar.2013.08.048</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24157985">24157985</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Pharmacology&amp;rft.atitle=Olanzapine+for+the+prevention+and+treatment+of+chronic+nausea+and+chemotherapy-induced+nausea+and+vomiting&amp;rft.volume=722&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E180-%3C%2Fspan%3E6&amp;rft.date=2014-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejphar.2013.08.048&amp;rft_id=info%3Apmid%2F24157985&amp;rft.aulast=Navari&amp;rft.aufirst=RM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRothDriscol" class="citation web cs1"><a href="/wiki/Bryan_Roth" title="Bryan Roth">Roth BL</a>, Driscol J. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20131108013656/http://pdsp.med.unc.edu/pdsp.php">"PDSP Ki Database"</a>. <i>Psychoactive Drug Screening Program (PDSP)</i>. University of North Carolina. Archived from <a rel="nofollow" class="external text" href="http://pdsp.med.unc.edu/pdsp.php">the original</a> on November 8, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">October 10,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Psychoactive+Drug+Screening+Program+%28PDSP%29&amp;rft.atitle=PDSP+Ki+Database&amp;rft.aulast=Roth&amp;rft.aufirst=BL&amp;rft.au=Driscol%2C+J&amp;rft_id=http%3A%2F%2Fpdsp.med.unc.edu%2Fpdsp.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text">Culpepper, 2007<sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citing_sources#What_information_to_include" title="Wikipedia:Citing sources"><span title="A complete citation is needed. (August 2013)">full citation needed</span></a></i>&#93;</sup></span> </li> <li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://reference.medscape.com/medscapetoday">"Medscape Multispecialty – Home page"</a>. <i><a href="/wiki/WebMD" title="WebMD">WebMD</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=WebMD&amp;rft.atitle=Medscape+Multispecialty+%E2%80%93+Home+page&amp;rft_id=http%3A%2F%2Freference.medscape.com%2Fmedscapetoday&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citing_sources#What_information_to_include" title="Wikipedia:Citing sources"><span title="A complete citation is needed. (August 2015)">full citation needed</span></a></i>&#93;</sup></span> </li> <li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ebs.tga.gov.au/">"Therapeutic Goods Administration – Home page"</a>. <a href="/wiki/Department_of_Health_(Australia)" class="mw-redirect" title="Department of Health (Australia)">Department of Health (Australia)</a><span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Therapeutic+Goods+Administration+%E2%80%93+Home+page&amp;rft.pub=Department+of+Health+%28Australia%29&amp;rft_id=https%3A%2F%2Fwww.ebs.tga.gov.au%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citing_sources#What_information_to_include" title="Wikipedia:Citing sources"><span title="A complete citation is needed. (August 2015)">full citation needed</span></a></i>&#93;</sup></span> </li> <li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://dailymed.nlm.nih.gov/dailymed/index.cfm">"Daily Med – Home page"</a>. <a href="/wiki/United_States_National_Library_of_Medicine" title="United States National Library of Medicine">U.S. National Library of Medicine</a><span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Daily+Med+%E2%80%93+Home+page&amp;rft.pub=U.S.+National+Library+of+Medicine&amp;rft_id=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2Findex.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citing_sources#What_information_to_include" title="Wikipedia:Citing sources"><span title="A complete citation is needed. (August 2015)">full citation needed</span></a></i>&#93;</sup></span> </li> <li id="cite_note-CNS_Drugs-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-CNS_Drugs_123-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDeeksKeating2010" class="citation journal cs1">Deeks ED, Keating GM (January 2010). "Blonanserin: a review of its use in the management of schizophrenia". <i>CNS Drugs</i>. <b>24</b> (1): <span class="nowrap">65–</span>84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F11202620-000000000-00000">10.2165/11202620-000000000-00000</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20030420">20030420</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23464075">23464075</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Blonanserin%3A+a+review+of+its+use+in+the+management+of+schizophrenia&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E65-%3C%2Fspan%3E84&amp;rft.date=2010-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23464075%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20030420&amp;rft_id=info%3Adoi%2F10.2165%2F11202620-000000000-00000&amp;rft.aulast=Deeks&amp;rft.aufirst=ED&amp;rft.au=Keating%2C+GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text">Product Information: Eunerpan(R), Melperonhydrochlorid. Knoll Deutschland GmbH, Ludwigshafen, 1995.</span> </li> <li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBorgströmLarssonMolander1982" class="citation journal cs1">Borgström L, Larsson H, Molander L (1982). "Pharmacokinetics of parenteral and oral melperone in man". <i>European Journal of Clinical Pharmacology</i>. <b>23</b> (2): <span class="nowrap">173–</span>6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF00545974">10.1007/BF00545974</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7140807">7140807</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36697288">36697288</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Clinical+Pharmacology&amp;rft.atitle=Pharmacokinetics+of+parenteral+and+oral+melperone+in+man&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E173-%3C%2Fspan%3E6&amp;rft.date=1982&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36697288%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F7140807&amp;rft_id=info%3Adoi%2F10.1007%2FBF00545974&amp;rft.aulast=Borgstr%C3%B6m&amp;rft.aufirst=L&amp;rft.au=Larsson%2C+H&amp;rft.au=Molander%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text">Product Information: Nipolept(R), zotepine. Klinge Pharma GmbH, Munich, 1996.</span> </li> <li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTanakaKondoOtaniYasui1998" class="citation journal cs1">Tanaka O, Kondo T, Otani K, Yasui N, Tokinaga N, Kaneko S (February 1998). "Single oral dose kinetics of zotepine and its relationship to prolactin response and side effects". <i>Therapeutic Drug Monitoring</i>. <b>20</b> (1): <span class="nowrap">117–</span>9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00007691-199802000-00021">10.1097/00007691-199802000-00021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9485566">9485566</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Drug+Monitoring&amp;rft.atitle=Single+oral+dose+kinetics+of+zotepine+and+its+relationship+to+prolactin+response+and+side+effects&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E117-%3C%2Fspan%3E9&amp;rft.date=1998-02&amp;rft_id=info%3Adoi%2F10.1097%2F00007691-199802000-00021&amp;rft_id=info%3Apmid%2F9485566&amp;rft.aulast=Tanaka&amp;rft.aufirst=O&amp;rft.au=Kondo%2C+T&amp;rft.au=Otani%2C+K&amp;rft.au=Yasui%2C+N&amp;rft.au=Tokinaga%2C+N&amp;rft.au=Kaneko%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-ParentToussaint1983-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-ParentToussaint1983_128-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFParentToussaintGilson1983" class="citation journal cs1">Parent M, Toussaint C, Gilson H (1983). "Long-term treatment of chronic psychotics with bromperidol decanoate: clinical and pharmacokinetic evaluation". <i>Current Therapeutic Research</i>. <b>34</b> (1): <span class="nowrap">1–</span>6.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Therapeutic+Research&amp;rft.atitle=Long-term+treatment+of+chronic+psychotics+with+bromperidol+decanoate%3A+clinical+and+pharmacokinetic+evaluation.&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1-%3C%2Fspan%3E6&amp;rft.date=1983&amp;rft.aulast=Parent&amp;rft.aufirst=M&amp;rft.au=Toussaint%2C+C&amp;rft.au=Gilson%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid6931472-129"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid6931472_129-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid6931472_129-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJørgensenOverø1980" class="citation journal cs1">Jørgensen A, Overø KF (1980). "Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels". <i>Acta Psychiatrica Scandinavica. Supplementum</i>. <b>279</b>: <span class="nowrap">41–</span>54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0447.1980.tb07082.x">10.1111/j.1600-0447.1980.tb07082.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6931472">6931472</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica.+Supplementum&amp;rft.atitle=Clopenthixol+and+flupenthixol+depot+preparations+in+outpatient+schizophrenics.+III.+Serum+levels&amp;rft.volume=279&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E41-%3C%2Fspan%3E54&amp;rft.date=1980&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1980.tb07082.x&amp;rft_id=info%3Apmid%2F6931472&amp;rft.aulast=J%C3%B8rgensen&amp;rft.aufirst=A&amp;rft.au=Over%C3%B8%2C+KF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-Reynolds1993-130"><span class="mw-cite-backlink">^ <a href="#cite_ref-Reynolds1993_130-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Reynolds1993_130-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFReynolds1993" class="citation book cs1">Reynolds JE (1993). "Anxiolytic sedatives, hypnotics and neuroleptics.". <i>Martindale: The Extra Pharmacopoeia</i> (30th&#160;ed.). London: Pharmaceutical Press. pp.&#160;<span class="nowrap">364–</span>623.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Anxiolytic+sedatives%2C+hypnotics+and+neuroleptics.&amp;rft.btitle=Martindale%3A+The+Extra+Pharmacopoeia&amp;rft.place=London&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E364-%3C%2Fspan%3E623&amp;rft.edition=30th&amp;rft.pub=Pharmaceutical+Press&amp;rft.date=1993&amp;rft.aulast=Reynolds&amp;rft.aufirst=JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid6143748-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6143748_131-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFEreshefskySakladJannDavis1984" class="citation journal cs1">Ereshefsky L, Saklad SR, Jann MW, Davis CM, Richards A, Seidel DR (May 1984). "Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches". <i>The Journal of Clinical Psychiatry</i>. <b>45</b> (5 Pt 2): <span class="nowrap">50–</span>9. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6143748">6143748</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.atitle=Future+of+depot+neuroleptic+therapy%3A+pharmacokinetic+and+pharmacodynamic+approaches&amp;rft.volume=45&amp;rft.issue=5+Pt+2&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E50-%3C%2Fspan%3E9&amp;rft.date=1984-05&amp;rft_id=info%3Apmid%2F6143748&amp;rft.aulast=Ereshefsky&amp;rft.aufirst=L&amp;rft.au=Saklad%2C+SR&amp;rft.au=Jann%2C+MW&amp;rft.au=Davis%2C+CM&amp;rft.au=Richards%2C+A&amp;rft.au=Seidel%2C+DR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid444352-132"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid444352_132-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid444352_132-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCurryWhelptonde_SchepperVranckx1979" class="citation journal cs1">Curry SH, Whelpton R, de Schepper PJ, Vranckx S, Schiff AA (April 1979). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429660">"Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>7</b> (4): <span class="nowrap">325–</span>31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2125.1979.tb00941.x">10.1111/j.1365-2125.1979.tb00941.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429660">1429660</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/444352">444352</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=Kinetics+of+fluphenazine+after+fluphenazine+dihydrochloride%2C+enanthate+and+decanoate+administration+to+man&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E325-%3C%2Fspan%3E31&amp;rft.date=1979-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1429660%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F444352&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.1979.tb00941.x&amp;rft.aulast=Curry&amp;rft.aufirst=SH&amp;rft.au=Whelpton%2C+R&amp;rft.au=de+Schepper%2C+PJ&amp;rft.au=Vranckx%2C+S&amp;rft.au=Schiff%2C+AA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1429660&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-YoungEreshefsky1984-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-YoungEreshefsky1984_133-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFYoungEreshefskySakladJann1984" class="citation conference cs1">Young D, Ereshefsky L, Saklad SR, Jann MW, Garcia N (1984). <i>Explaining the pharmacokinetics of fluphenazine through computer simulations. (Abstract.)</i>. 19th Annual Midyear Clinical Meeting of the American Society of Hospital Pharmacists. Dallas, Texas.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=conference&amp;rft.btitle=Explaining+the+pharmacokinetics+of+fluphenazine+through+computer+simulations.+%28Abstract.%29&amp;rft.place=Dallas%2C+Texas&amp;rft.date=1984&amp;rft.aulast=Young&amp;rft.aufirst=D&amp;rft.au=Ereshefsky%2C+L&amp;rft.au=Saklad%2C+SR&amp;rft.au=Jann%2C+MW&amp;rft.au=Garcia%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid4992598-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid4992598_134-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJanssenNiemegeersSchellekensLenaerts1970" class="citation journal cs1">Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, van Nueten JM, Marsboom RH, Hérin VV, Schaper WK (November 1970). "The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug". <i>Arzneimittel-Forschung</i>. <b>20</b> (11): <span class="nowrap">1689–</span>98. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/4992598">4992598</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arzneimittel-Forschung&amp;rft.atitle=The+pharmacology+of+fluspirilene+%28R+6218%29%2C+a+potent%2C+long-acting+and+injectable+neuroleptic+drug&amp;rft.volume=20&amp;rft.issue=11&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1689-%3C%2Fspan%3E98&amp;rft.date=1970-11&amp;rft_id=info%3Apmid%2F4992598&amp;rft.aulast=Janssen&amp;rft.aufirst=PA&amp;rft.au=Niemegeers%2C+CJ&amp;rft.au=Schellekens%2C+KH&amp;rft.au=Lenaerts%2C+FM&amp;rft.au=Verbruggen%2C+FJ&amp;rft.au=van+Nueten%2C+JM&amp;rft.au=Marsboom%2C+RH&amp;rft.au=H%C3%A9rin%2C+VV&amp;rft.au=Schaper%2C+WK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid3545764-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3545764_135-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBeresfordWard1987" class="citation journal cs1">Beresford R, Ward A (January 1987). "Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis". <i>Drugs</i>. <b>33</b> (1): <span class="nowrap">31–</span>49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00003495-198733010-00002">10.2165/00003495-198733010-00002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3545764">3545764</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Haloperidol+decanoate.+A+preliminary+review+of+its+pharmacodynamic+and+pharmacokinetic+properties+and+therapeutic+use+in+psychosis&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E31-%3C%2Fspan%3E49&amp;rft.date=1987-01&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-198733010-00002&amp;rft_id=info%3Apmid%2F3545764&amp;rft.aulast=Beresford&amp;rft.aufirst=R&amp;rft.au=Ward%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid7185768-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7185768_136-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFReyntigensHeykantsWoestenborghsGelders1982" class="citation journal cs1">Reyntigens AJ, Heykants JJ, Woestenborghs RJ, Gelders YG, Aerts TJ (1982). "Pharmacokinetics of haloperidol decanoate. A 2-year follow-up". <i>International Pharmacopsychiatry</i>. <b>17</b> (4): <span class="nowrap">238–</span>46. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000468580">10.1159/000468580</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7185768">7185768</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Pharmacopsychiatry&amp;rft.atitle=Pharmacokinetics+of+haloperidol+decanoate.+A+2-year+follow-up&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E238-%3C%2Fspan%3E46&amp;rft.date=1982&amp;rft_id=info%3Adoi%2F10.1159%2F000468580&amp;rft_id=info%3Apmid%2F7185768&amp;rft.aulast=Reyntigens&amp;rft.aufirst=AJ&amp;rft.au=Heykants%2C+JJ&amp;rft.au=Woestenborghs%2C+RJ&amp;rft.au=Gelders%2C+YG&amp;rft.au=Aerts%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-LarssonAxelsson1984-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-LarssonAxelsson1984_137-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLarssonAxelssonForsman1984" class="citation journal cs1">Larsson M, Axelsson R, Forsman A (1984). "On the pharmacokinetics of perphenazine: a clinical study of perphenazine enanthate and decanoate". <i>Current Therapeutic Research</i>. <b>36</b> (6): <span class="nowrap">1071–</span>88.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Therapeutic+Research&amp;rft.atitle=On+the+pharmacokinetics+of+perphenazine%3A+a+clinical+study+of+perphenazine+enanthate+and+decanoate.&amp;rft.volume=36&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1071-%3C%2Fspan%3E88&amp;rft.date=1984&amp;rft.aulast=Larsson&amp;rft.aufirst=M&amp;rft.au=Axelsson%2C+R&amp;rft.au=Forsman%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021999s000_APPROV.pdf">"Approval Letter: 21-999"</a> <span class="cs1-format">(PDF)</span>. <i>accessdata.fda.go</i>. December 19, 2006. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160101215543/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021999s000_APPROV.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on January 1, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">February 22,</span> 2025</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=accessdata.fda.go&amp;rft.atitle=Approval+Letter%3A+21-999&amp;rft.date=2006-12-19&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2006%2F021999s000_APPROV.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20091122102620/http://www.spfiles.com/pisaphrisv1.pdf">"Saphris (asenapine) prescribing information"</a> <span class="cs1-format">(PDF)</span>. Schering Corporation. August 1, 2009. Archived from <a rel="nofollow" class="external text" href="http://www.spfiles.com/pisaphrisv1.pdf">the original</a> <span class="cs1-format">(PDF)</span> on November 22, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">February 5,</span> 2025</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Saphris+%28asenapine%29+prescribing+information&amp;rft.pub=Schering+Corporation&amp;rft.date=2009-08-01&amp;rft_id=http%3A%2F%2Fwww.spfiles.com%2Fpisaphrisv1.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid16498489-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16498489_140-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFarah2005" class="citation journal cs1">Farah A (2005). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1324958">"Atypicality of atypical antipsychotics"</a>. <i>Primary Care Companion to the Journal of Clinical Psychiatry</i>. <b>7</b> (6): <span class="nowrap">268–</span>74. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4088%2FPCC.v07n0602">10.4088/PCC.v07n0602</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1324958">1324958</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16498489">16498489</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Primary+Care+Companion+to+the+Journal+of+Clinical+Psychiatry&amp;rft.atitle=Atypicality+of+atypical+antipsychotics&amp;rft.volume=7&amp;rft.issue=6&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E268-%3C%2Fspan%3E74&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1324958%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16498489&amp;rft_id=info%3Adoi%2F10.4088%2FPCC.v07n0602&amp;rft.aulast=Farah&amp;rft.aufirst=A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1324958&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid17242588-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17242588_141-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWeiden2007" class="citation journal cs1">Weiden PJ (January 2007). "EPS profiles: the atypical antipsychotics are not all the same". <i>Journal of Psychiatric Practice</i>. <b>13</b> (1): <span class="nowrap">13–</span>24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00131746-200701000-00003">10.1097/00131746-200701000-00003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17242588">17242588</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:46319827">46319827</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychiatric+Practice&amp;rft.atitle=EPS+profiles%3A+the+atypical+antipsychotics+are+not+all+the+same&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E13-%3C%2Fspan%3E24&amp;rft.date=2007-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A46319827%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17242588&amp;rft_id=info%3Adoi%2F10.1097%2F00131746-200701000-00003&amp;rft.aulast=Weiden&amp;rft.aufirst=PJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-pmid17015810-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17015810_142-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJonesBarnesDaviesDunn2006" class="citation journal cs1">Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et&#160;al. (October 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchpsyc.63.10.1079">"Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)"</a>. <i>Archives of General Psychiatry</i>. <b>63</b> (10): <span class="nowrap">1079–</span>87. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchpsyc.63.10.1079">10.1001/archpsyc.63.10.1079</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17015810">17015810</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=Randomized+controlled+trial+of+the+effect+on+Quality+of+Life+of+second-+vs+first-generation+antipsychotic+drugs+in+schizophrenia%3A+Cost+Utility+of+the+Latest+Antipsychotic+Drugs+in+Schizophrenia+Study+%28CUtLASS+1%29&amp;rft.volume=63&amp;rft.issue=10&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E1079-%3C%2Fspan%3E87&amp;rft.date=2006-10&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.63.10.1079&amp;rft_id=info%3Apmid%2F17015810&amp;rft.aulast=Jones&amp;rft.aufirst=PB&amp;rft.au=Barnes%2C+TR&amp;rft.au=Davies%2C+L&amp;rft.au=Dunn%2C+G&amp;rft.au=Lloyd%2C+H&amp;rft.au=Hayhurst%2C+KP&amp;rft.au=Murray%2C+RM&amp;rft.au=Markwick%2C+A&amp;rft.au=Lewis%2C+SW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Farchpsyc.63.10.1079&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMattinglyMatthews-HayesPatelKramer2023" class="citation journal cs1">Mattingly G, Matthews-Hayes T, Patel MD, Kramer K, Stahl SM (2023). <a rel="nofollow" class="external text" href="https://www.psychiatrist.com/pcc/do-we-need-a-new-nomenclature-for-atypical-antipsychotics-a-survey-of-health-care-professionals-and-patients/">"Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients"</a>. <i>The Primary Care Companion for CNS Disorders</i>. <b>25</b> (1): 45835. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4088%2FPCC.22m03331">10.4088/PCC.22m03331</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2155-7780">2155-7780</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36821764">36821764</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Primary+Care+Companion+for+CNS+Disorders&amp;rft.atitle=Do+We+Need+a+New+Nomenclature+for+Atypical+Antipsychotics%3F+A+Survey+of+Health+Care+Professionals+and+Patients&amp;rft.volume=25&amp;rft.issue=1&amp;rft.pages=45835&amp;rft.date=2023&amp;rft.issn=2155-7780&amp;rft_id=info%3Apmid%2F36821764&amp;rft_id=info%3Adoi%2F10.4088%2FPCC.22m03331&amp;rft.aulast=Mattingly&amp;rft.aufirst=Greg&amp;rft.au=Matthews-Hayes%2C+Tina&amp;rft.au=Patel%2C+Mehul+D.&amp;rft.au=Kramer%2C+Kenneth&amp;rft.au=Stahl%2C+Stephen+M.&amp;rft_id=https%3A%2F%2Fwww.psychiatrist.com%2Fpcc%2Fdo-we-need-a-new-nomenclature-for-atypical-antipsychotics-a-survey-of-health-care-professionals-and-patients%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://health-products.canada.ca/dpd-bdpp/index-eng.jsp">"Drug Product Database Online Query"</a>. <i>Government of Canada, Health Canada, Public Affairs, Consultation and Regions Branch</i>. April 25, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">February 1,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Government+of+Canada%2C+Health+Canada%2C+Public+Affairs%2C+Consultation+and+Regions+Branch&amp;rft.atitle=Drug+Product+Database+Online+Query&amp;rft.date=2012-04-25&amp;rft_id=https%3A%2F%2Fhealth-products.canada.ca%2Fdpd-bdpp%2Findex-eng.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20170716062519/https://tga-search.clients.funnelback.com/s/search.html?query=&amp;collection=tga-artg">"Search the TGA website"</a>. <i>Australian Government Department of Health, Therapeutic Goods Administration</i>. Archived from <a rel="nofollow" class="external text" href="http://tga-search.clients.funnelback.com/s/search.html?query=&amp;collection=tga-artg">the original</a> on July 16, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Australian+Government+Department+of+Health%2C+Therapeutic+Goods+Administration&amp;rft.atitle=Search+the+TGA+website&amp;rft_id=http%3A%2F%2Ftga-search.clients.funnelback.com%2Fs%2Fsearch.html%3Fquery%3D%26collection%3Dtga-artg&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-ema-146"><span class="mw-cite-backlink">^ <a href="#cite_ref-ema_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ema_146-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120526074920/http://www.ema.europa.eu/ema/">"European Medicines Agency: Search"</a>. <i>European Medicines Agency</i>. Archived from <a rel="nofollow" class="external text" href="http://www.ema.europa.eu/ema/">the original</a> on May 26, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Medicines+Agency&amp;rft.atitle=European+Medicines+Agency%3A+Search&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fema%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span> Search</span> </li> <li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20181116051537/http://ss.pmda.go.jp/en_all/search.x?q%3DSearch">"Search"</a>. <i>Pharmaceuticals and Medical Devices Agency</i>. Archived from <a rel="nofollow" class="external text" href="http://ss.pmda.go.jp/en_all/search.x?q=Search">the original</a> on November 16, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pharmaceuticals+and+Medical+Devices+Agency&amp;rft.atitle=Search&amp;rft_id=http%3A%2F%2Fss.pmda.go.jp%2Fen_all%2Fsearch.x%3Fq%3DSearch&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.mhra.gov.uk/spc-pil/">"Medicines Information: SPC &amp; PILs"</a>. <i>Medicines and Healthcare products Regulatory Agency</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medicines+and+Healthcare+products+Regulatory+Agency&amp;rft.atitle=Medicines+Information%3A+SPC+%26+PILs&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fspc-pil%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> <li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/publications/antipsychotic-medicines-licensed-products-uses-and-side-effects/antipsychotic-medicines">"Guidance: Antipsychotic medicines"</a>. <i>Medicines &amp; Healthcare products Regulatory Agency</i>. August 25, 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">February 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medicines+%26+Healthcare+products+Regulatory+Agency&amp;rft.atitle=Guidance%3A+Antipsychotic+medicines&amp;rft.date=2005-08-25&amp;rft_id=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fantipsychotic-medicines-licensed-products-uses-and-side-effects%2Fantipsychotic-medicines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></span> </li> </ol></div> <div class="mw-heading mw-heading2"><h2 id="Further_reading">Further reading</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=29" title="Edit section: Further reading"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239549316">.mw-parser-output .refbegin{margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li{margin-left:0;padding-left:3.2em;text-indent:-3.2em}.mw-parser-output .refbegin-hanging-indents ul,.mw-parser-output .refbegin-hanging-indents ul li{list-style:none}@media(max-width:720px){.mw-parser-output .refbegin-hanging-indents>ul>li{padding-left:1.6em;text-indent:-1.6em}}.mw-parser-output .refbegin-columns{margin-top:0.3em}.mw-parser-output .refbegin-columns ul{margin-top:0}.mw-parser-output .refbegin-columns li{page-break-inside:avoid;break-inside:avoid-column}@media screen{.mw-parser-output .refbegin{font-size:90%}}</style><div class="refbegin" style=""> <ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFElmorsySmith2015" class="citation journal cs1">Elmorsy E, Smith PA (May 2015). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180722092306/http://eprints.nottingham.ac.uk/43322/8/Bioen%20BBSRC_final.pdf">"Bioenergetic disruption of human micro-vascular endothelial cells by antipsychotics"</a> <span class="cs1-format">(PDF)</span>. <i>Biochemical and Biophysical Research Communications</i>. <b>460</b> (3): <span class="nowrap">857–</span>62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bbrc.2015.03.122">10.1016/j.bbrc.2015.03.122</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25824037">25824037</a>. Archived from <a rel="nofollow" class="external text" href="http://eprints.nottingham.ac.uk/43322/8/Bioen%20BBSRC_final.pdf">the original</a> <span class="cs1-format">(PDF)</span> on July 22, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">December 14,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+and+Biophysical+Research+Communications&amp;rft.atitle=Bioenergetic+disruption+of+human+micro-vascular+endothelial+cells+by+antipsychotics&amp;rft.volume=460&amp;rft.issue=3&amp;rft.pages=%3Cspan+class%3D%22nowrap%22%3E857-%3C%2Fspan%3E62&amp;rft.date=2015-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbrc.2015.03.122&amp;rft_id=info%3Apmid%2F25824037&amp;rft.aulast=Elmorsy&amp;rft.aufirst=E&amp;rft.au=Smith%2C+PA&amp;rft_id=http%3A%2F%2Feprints.nottingham.ac.uk%2F43322%2F8%2FBioen%2520BBSRC_final.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSimpson2005" class="citation journal cs1">Simpson GM (September 2005). "Atypical antipsychotics and the burden of disease". <i>The American Journal of Managed Care</i>. <b>11</b> (8 Suppl): S235-41. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16180961">16180961</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Managed+Care&amp;rft.atitle=Atypical+antipsychotics+and+the+burden+of+disease&amp;rft.volume=11&amp;rft.issue=8+Suppl&amp;rft.pages=S235-41&amp;rft.date=2005-09&amp;rft_id=info%3Apmid%2F16180961&amp;rft.aulast=Simpson&amp;rft.aufirst=GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></li> <li><a rel="nofollow" class="external text" href="https://www.usatoday.com/news/health/2006-05-01-atypical-drugs_x.htm">New antipsychotic drugs carry risks for children (USA Today 2006)</a></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130902024224/http://www.nih.gov/news/pr/sep2005/nimh-19.htm">"NIMH Study to Guide Treatment Choices for Schizophrenia"</a> (Press release). <a href="/wiki/National_Institute_of_Mental_Health" title="National Institute of Mental Health">National Institute of Mental Health</a>. September 19, 2005. Archived from <a rel="nofollow" class="external text" href="http://www.nih.gov/news/pr/sep2005/nimh-19.htm">the original</a> on September 2, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">August 18,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NIMH+Study+to+Guide+Treatment+Choices+for+Schizophrenia&amp;rft.pub=National+Institute+of+Mental+Health&amp;rft.date=2005-09-19&amp;rft_id=http%3A%2F%2Fwww.nih.gov%2Fnews%2Fpr%2Fsep2005%2Fnimh-19.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+antipsychotic" class="Z3988"></span></li></ul> </div> <div class="mw-heading mw-heading2"><h2 id="External_links">External links</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atypical_antipsychotic&amp;action=edit&amp;section=30" title="Edit section: External links"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <ul><li><span class="noviewer" typeof="mw:File"><a href="/wiki/File:Commons-logo.svg" class="mw-file-description"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/20px-Commons-logo.svg.png" decoding="async" width="12" height="16" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></a></span> Media related to <a href="https://commons.wikimedia.org/wiki/Category:Atypical_antipsychotics" class="extiw" title="commons:Category:Atypical antipsychotics">Atypical antipsychotics</a> at Wikimedia Commons</li></ul> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /></div><div role="navigation" class="navbox" aria-labelledby="Antipsychotics_(N05A)453" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Antipsychotics" title="Template:Antipsychotics"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Antipsychotics" title="Template talk:Antipsychotics"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Antipsychotics" title="Special:EditPage/Template:Antipsychotics"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Antipsychotics_(N05A)453" style="font-size:114%;margin:0 4em"><a href="/wiki/Antipsychotic" title="Antipsychotic">Antipsychotics</a> (<a href="/wiki/ATC_code_N05#N05A" title="ATC code N05">N05A</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><b><a href="/wiki/Butyrophenone" title="Butyrophenone">Butyrophenones</a>:</b> <a href="/wiki/Benperidol" title="Benperidol">Benperidol</a></li> <li><a href="/wiki/Bromperidol" title="Bromperidol">Bromperidol</a> <ul><li><a href="/wiki/Bromperidol_decanoate" title="Bromperidol decanoate">Bromperidol decanoate</a></li></ul></li> <li><a href="/wiki/Droperidol" title="Droperidol">Droperidol</a></li> <li><a href="/wiki/Haloperidol" title="Haloperidol">Haloperidol</a><sup>#</sup> <ul><li><a href="/wiki/Haloperidol_decanoate" title="Haloperidol decanoate">Haloperidol decanoate</a></li></ul></li> <li><a href="/wiki/Moperone" title="Moperone">Moperone</a></li> <li><a href="/wiki/Pipamperone" title="Pipamperone">Pipamperone</a></li> <li><a href="/wiki/Spiperone" title="Spiperone">Spiperone</a></li> <li><a href="/wiki/Timiperone" title="Timiperone">Timiperone</a></li> <li><a href="/wiki/Trifluperidol" title="Trifluperidol">Trifluperidol</a></li></ul> <ul><li><b><a href="/wiki/Diphenylbutylpiperidine" title="Diphenylbutylpiperidine">Diphenylbutylpiperidines</a>:</b> <a href="/wiki/Fluspirilene" title="Fluspirilene">Fluspirilene</a></li> <li><a href="/wiki/Penfluridol" title="Penfluridol">Penfluridol</a></li> <li><a href="/wiki/Pimozide" title="Pimozide">Pimozide</a></li></ul> <ul><li><b><a href="/wiki/Phenothiazine" title="Phenothiazine">Phenothiazines</a>:</b> <a href="/wiki/Acepromazine" title="Acepromazine">Acepromazine</a></li> <li><a href="/wiki/Acetophenazine" title="Acetophenazine">Acetophenazine</a></li> <li><a href="/wiki/Butaperazine" title="Butaperazine">Butaperazine</a></li> <li><a href="/wiki/Carfenazine" title="Carfenazine">Carphenazine (carfenazine)</a><sup>‡</sup></li> <li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li> <li><a href="/wiki/Cyamemazine" title="Cyamemazine">Cyamemazine</a></li> <li><a href="/wiki/Dixyrazine" title="Dixyrazine">Dixyrazine</a></li> <li><a href="/wiki/Fluphenazine" title="Fluphenazine">Fluphenazine</a> <ul><li><a href="/wiki/Fluphenazine_decanoate" class="mw-redirect" title="Fluphenazine decanoate">Fluphenazine decanoate</a></li> <li><a href="/wiki/Fluphenazine_enanthate" class="mw-redirect" title="Fluphenazine enanthate">Fluphenazine enanthate</a></li></ul></li> <li><a href="/wiki/Levomepromazine" title="Levomepromazine">Levomepromazine (methotrimeprazine)</a></li> <li><a href="/wiki/Mesoridazine" title="Mesoridazine">Mesoridazine</a></li> <li><a href="/wiki/Perazine" title="Perazine">Perazine</a></li> <li><a href="/wiki/Periciazine" title="Periciazine">Periciazine</a></li> <li><a href="/wiki/Perphenazine" title="Perphenazine">Perphenazine</a> <ul><li><a href="/wiki/BL-1020" title="BL-1020">BL-1020</a></li> <li><a href="/wiki/Perphenazine_decanoate" class="mw-redirect" title="Perphenazine decanoate">Perphenazine decanoate</a></li> <li><a href="/wiki/Perphenazine_enanthate" title="Perphenazine enanthate">Perphenazine enanthate</a></li></ul></li> <li><a href="/wiki/Piperacetazine" title="Piperacetazine">Piperacetazine</a></li> <li><a href="/wiki/Pipotiazine" title="Pipotiazine">Pipotiazine</a> <ul><li><a href="/wiki/Pipotiazine_palmitate" class="mw-redirect" title="Pipotiazine palmitate">Pipotiazine palmitate</a></li> <li><a href="/wiki/Pipotiazine_undecylenate" class="mw-redirect" title="Pipotiazine undecylenate">Pipotiazine undecylenate</a></li></ul></li> <li><a href="/wiki/Prochlorperazine" title="Prochlorperazine">Prochlorperazine</a></li> <li><a href="/wiki/Promazine" title="Promazine">Promazine</a></li> <li><a href="/wiki/Sulforidazine" title="Sulforidazine">Sulforidazine</a></li> <li><a href="/wiki/Thiopropazate" title="Thiopropazate">Thiopropazate</a></li> <li><a href="/wiki/Thioproperazine" title="Thioproperazine">Thioproperazine</a></li> <li><a href="/wiki/Thioridazine" title="Thioridazine">Thioridazine</a></li> <li><a href="/wiki/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li> <li><a href="/wiki/Triflupromazine" title="Triflupromazine">Triflupromazine</a></li></ul> <ul><li><b><a href="/wiki/Thioxanthene" title="Thioxanthene">Thioxanthenes</a>:</b> <a href="/wiki/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li> <li><a href="/wiki/Clopenthixol" title="Clopenthixol">Clopenthixol</a> <ul><li><a href="/wiki/Clopenthixol_decanoate" class="mw-redirect" title="Clopenthixol decanoate">Clopenthixol decanoate</a></li></ul></li> <li><a href="/wiki/Flupentixol" title="Flupentixol">Flupentixol</a> <ul><li><a href="/wiki/Flupentixol_decanoate" class="mw-redirect" title="Flupentixol decanoate">Flupentixol decanoate</a></li></ul></li> <li><a href="/wiki/Tiotixene" title="Tiotixene">Tiotixene (thiothixene)</a></li> <li><a href="/wiki/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a> <ul><li><a href="/wiki/Zuclopenthixol_acetate" class="mw-redirect" title="Zuclopenthixol acetate">Zuclopenthixol acetate</a></li> <li><a href="/wiki/Zuclopenthixol_decanoate" class="mw-redirect" title="Zuclopenthixol decanoate">Zuclopenthixol decanoate</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Disputed</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><b><a href="/wiki/Benzamide" title="Benzamide">Benzamides</a>:</b> <a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></li> <li><a href="/wiki/Levosulpiride" title="Levosulpiride">Levosulpiride</a></li> <li><a href="/wiki/Nemonapride" title="Nemonapride">Nemonapride</a></li> <li><a href="/wiki/Remoxipride" title="Remoxipride">Remoxipride</a><sup>‡</sup></li> <li><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a></li> <li><a href="/wiki/Sultopride" title="Sultopride">Sultopride</a></li> <li><a href="/wiki/Tiapride" title="Tiapride">Tiapride</a></li> <li><a href="/wiki/Veralipride" title="Veralipride">Veralipride</a><sup>‡</sup></li></ul> <ul><li><b><a href="/wiki/Butyrophenone" title="Butyrophenone">Butyrophenones</a>:</b> <a href="/wiki/Melperone" title="Melperone">Melperone</a></li></ul> <ul><li><b><a href="/wiki/Tricyclic" title="Tricyclic">Tricyclics</a>:</b> <a href="/wiki/Carpipramine" title="Carpipramine">Carpipramine</a></li> <li><a href="/wiki/Clocapramine" title="Clocapramine">Clocapramine</a></li> <li><a href="/wiki/Clorotepine" title="Clorotepine">Clorotepine</a></li> <li><a href="/wiki/Clotiapine" title="Clotiapine">Clotiapine</a></li> <li><a href="/wiki/Loxapine" title="Loxapine">Loxapine</a></li> <li><a href="/wiki/Mosapramine" title="Mosapramine">Mosapramine</a></li> <li><a href="/wiki/Oxyprothepin_decanoate" title="Oxyprothepin decanoate">Oxyprothepin decanoate</a></li></ul> <ul><li><b>Others:</b> <a href="/wiki/Molindone" title="Molindone">Molindone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">Atypical</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><b><a href="/wiki/Benzisoxazole" title="Benzisoxazole">Benzisoxazole</a>/<a href="/wiki/Benzisothiazole" class="mw-redirect" title="Benzisothiazole">benzisothiazoles</a>:</b> <a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></li> <li><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></li> <li><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a> <ul><li><a href="/wiki/Paliperidone_palmitate" class="mw-redirect" title="Paliperidone palmitate">Paliperidone palmitate</a></li></ul></li> <li><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a></li> <li><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a><sup>#</sup></li> <li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li></ul> <ul><li><b><a href="/wiki/Butyrophenone" title="Butyrophenone">Butyrophenones</a>:</b> <a href="/wiki/Lumateperone" title="Lumateperone">Lumateperone</a></li></ul> <ul><li><b><a href="/wiki/Phenylpiperazine" title="Phenylpiperazine">Phenylpiperazines</a>/<a href="/wiki/Quinolinone" class="mw-redirect" title="Quinolinone">quinolinones</a>:</b> <a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a> <ul><li><a href="/wiki/Aripiprazole_lauroxil" title="Aripiprazole lauroxil">Aripiprazole lauroxil</a></li></ul></li> <li><a href="/wiki/Brilaroxazine" title="Brilaroxazine">Brilaroxazine</a><sup>†</sup></li> <li><a href="/wiki/Brexpiprazole" title="Brexpiprazole">Brexpiprazole</a></li> <li><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></li></ul> <ul><li><b><a href="/wiki/Tricyclic" title="Tricyclic">Tricyclics</a>:</b> <a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></li> <li><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a><sup>#</sup></li> <li><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a> (<a href="/wiki/Olanzapine/samidorphan" title="Olanzapine/samidorphan">+samidorphan</a>)</li> <li><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></li> <li><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></li></ul> <ul><li><b>Others:</b> <a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></li> <li><a href="/wiki/Pimavanserin" title="Pimavanserin">Pimavanserin</a></li> <li><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><b><a href="/wiki/Monoamine-depleting_agent" title="Monoamine-depleting agent">Monoamine-depleting agents</a>:</b> <a href="/wiki/Oxypertine" title="Oxypertine">Oxypertine</a></li> <li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li> <li><a href="/wiki/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a></li></ul> <ul><li><b><a href="/wiki/Muscarinic_agonist" title="Muscarinic agonist">Muscarinic agonists</a>:</b> <a href="/wiki/Xanomeline/trospium_chloride" title="Xanomeline/trospium chloride">Xanomeline/trospium chloride</a></li></ul> <ul><li><i>Others/unknown:</i> <a href="/wiki/Azacyclonol" title="Azacyclonol">Azacyclonol</a></li></ul> </div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="padding: 0px;"><div><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox" aria-labelledby="Dopamine_receptor_modulators745" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Dopamine_receptor_modulators" title="Template:Dopamine receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Dopamine_receptor_modulators" title="Template talk:Dopamine receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Dopamine_receptor_modulators" title="Special:EditPage/Template:Dopamine receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Dopamine_receptor_modulators745" style="font-size:114%;margin:0 4em"><a href="/wiki/Dopamine_receptor" title="Dopamine receptor">Dopamine receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/D1-like_receptor" title="D1-like receptor">D<sub>1</sub>-like</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Benzazepines</i>: <a href="/wiki/6-Br-APB" title="6-Br-APB">6-Br-APB</a></li> <li><a href="/wiki/Fenoldopam" title="Fenoldopam">Fenoldopam</a></li> <li><a href="/wiki/SKF-38,393" title="SKF-38,393">SKF-38,393</a></li> <li><a href="/wiki/SKF-77,434" title="SKF-77,434">SKF-77,434</a></li> <li><a href="/wiki/SKF-81,297" title="SKF-81,297">SKF-81,297</a></li> <li><a href="/wiki/SKF-82,958" title="SKF-82,958">SKF-82,958</a></li> <li><a href="/wiki/SKF-83,959" title="SKF-83,959">SKF-83,959</a></li> <li><a href="/wiki/Trepipam" title="Trepipam">Trepipam</a></li> <li><a href="/wiki/Zelandopam" title="Zelandopam">Zelandopam</a></li></ul> <ul><li><i>Ergolines</i>: <a href="/wiki/Cabergoline" title="Cabergoline">Cabergoline</a></li> <li><a href="/wiki/CY-208,243" title="CY-208,243">CY-208,243</a></li> <li><a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">Dihydroergocryptine</a></li> <li><a href="/w/index.php?title=LEK-8829&amp;action=edit&amp;redlink=1" class="new" title="LEK-8829 (page does not exist)">LEK-8829</a></li> <li><a href="/wiki/Lisuride" title="Lisuride">Lisuride</a></li> <li><a href="/wiki/Pergolide" title="Pergolide">Pergolide</a></li> <li><a href="/wiki/Terguride" title="Terguride">Terguride</a></li></ul> <ul><li><i>Dihydrexidine derivatives</i>: <a href="/wiki/A-77636" title="A-77636">A-77636</a></li> <li><a href="/wiki/A-86929" title="A-86929">A-86929</a></li> <li><a href="/wiki/Adrogolide" class="mw-redirect" title="Adrogolide">Adrogolide (ABT-431, DAS-431)</a></li> <li><a href="/wiki/Dihydrexidine" title="Dihydrexidine">Dihydrexidine</a></li> <li><a href="/wiki/Dinapsoline" title="Dinapsoline">Dinapsoline</a></li> <li><a href="/wiki/Dinoxyline" title="Dinoxyline">Dinoxyline</a></li> <li><a href="/wiki/Doxanthrine" title="Doxanthrine">Doxanthrine</a></li></ul> <ul><li><i>Phenethylamines</i>: <a href="/w/index.php?title=BCO-001&amp;action=edit&amp;redlink=1" class="new" title="BCO-001 (page does not exist)">BCO-001</a></li> <li><a href="/wiki/Deoxyepinephrine" title="Deoxyepinephrine">Deoxyepinephrine (N-methyldopamine, epinine)</a></li> <li><a href="/wiki/Dopexamine" title="Dopexamine">Dopexamine</a></li> <li><a href="/wiki/Etilevodopa" title="Etilevodopa">Etilevodopa</a></li> <li><a href="/wiki/Ibopamine" title="Ibopamine">Ibopamine</a></li> <li><a href="/wiki/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li> <li><a href="/wiki/Melevodopa" title="Melevodopa">Melevodopa</a></li> <li><a href="/wiki/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li> <li><a href="/wiki/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li> <li><a href="/wiki/XP21279" class="mw-redirect" title="XP21279">XP21279</a></li></ul> <ul><li><i>Others</i>: <a href="/wiki/A-68930" title="A-68930">A-68930</a></li> <li><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a></li> <li><a href="/w/index.php?title=Isocorypalmine&amp;action=edit&amp;redlink=1" class="new" title="Isocorypalmine (page does not exist)">Isocorypalmine</a></li> <li><a href="/wiki/Nuciferine" title="Nuciferine">Nuciferine</a></li> <li><a href="/wiki/PF-6649751" class="mw-redirect" title="PF-6649751">PF-6649751</a></li> <li><a href="/w/index.php?title=PF_6669571&amp;action=edit&amp;redlink=1" class="new" title="PF 6669571 (page does not exist)">PF 6669571</a></li> <li><a href="/wiki/Propylnorapomorphine" title="Propylnorapomorphine">Propylnorapomorphine</a></li> <li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li> <li><a href="/wiki/SKF-89,145" title="SKF-89,145">SKF-89,145</a></li> <li><a href="/w/index.php?title=SKF-89,626&amp;action=edit&amp;redlink=1" class="new" title="SKF-89,626 (page does not exist)">SKF-89,626</a></li> <li><a href="/wiki/Stepholidine" title="Stepholidine">Stepholidine</a></li> <li><a href="/wiki/Tavapadon" title="Tavapadon">Tavapadon</a></li> <li><a href="/wiki/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr title="Positive allosteric modulators">PAMs</abbr></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Tetrahydroisoquinolines</i>: <a href="/w/index.php?title=DETQ&amp;action=edit&amp;redlink=1" class="new" title="DETQ (page does not exist)">DETQ</a></li> <li><a href="/w/index.php?title=DPTQ&amp;action=edit&amp;redlink=1" class="new" title="DPTQ (page does not exist)">DPTQ</a></li> <li><a href="/wiki/Mevidalen" title="Mevidalen">Mevidalen</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Typical antipsychotics</i>: <a href="/wiki/Butaclamol" title="Butaclamol">Butaclamol</a></li> <li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li> <li><a href="/wiki/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li> <li><a href="/wiki/Flupentixol" title="Flupentixol">Flupentixol (flupenthixol)</a> (<a href="/wiki/Flupentixol/melitracen" title="Flupentixol/melitracen">+melitracen</a>)</li> <li><a href="/wiki/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li> <li><a href="/wiki/Loxapine" title="Loxapine">Loxapine</a></li> <li><a href="/wiki/Perphenazine" title="Perphenazine">Perphenazine</a> (<a href="/wiki/Amitriptyline/perphenazine" title="Amitriptyline/perphenazine">+amitriptyline</a>)</li> <li><a href="/w/index.php?title=Pifluthixol&amp;action=edit&amp;redlink=1" class="new" title="Pifluthixol (page does not exist)">Pifluthixol</a></li> <li><a href="/wiki/Thioridazine" title="Thioridazine">Thioridazine</a></li> <li><a href="/wiki/Thiothixene" class="mw-redirect" title="Thiothixene">Thiothixene</a></li> <li><a href="/wiki/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a> (<a href="/wiki/Tranylcypromine/trifluoperazine" title="Tranylcypromine/trifluoperazine">+tranylcypromine</a>)</li> <li><a href="/wiki/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a></li></ul> <ul><li><i>Atypical antipsychotics</i>: <a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></li> <li><a href="/wiki/Clorotepine" title="Clorotepine">Clorotepine</a></li> <li><a href="/wiki/Clotiapine" title="Clotiapine">Clotiapine</a></li> <li><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></li> <li><a href="/wiki/DHA-clozapine" title="DHA-clozapine">DHA-clozapine</a></li> <li><a href="/wiki/Fluperlapine" title="Fluperlapine">Fluperlapine</a></li> <li><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></li> <li><a href="/wiki/Norclozapine" class="mw-redirect" title="Norclozapine">Norclozapine</a></li> <li><a href="/w/index.php?title=Norquetiapine&amp;action=edit&amp;redlink=1" class="new" title="Norquetiapine (page does not exist)">Norquetiapine</a></li> <li><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a> (<a href="/wiki/Olanzapine/fluoxetine" title="Olanzapine/fluoxetine">+fluoxetine</a>)</li> <li><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></li> <li><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></li> <li><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></li> <li><a href="/w/index.php?title=Tefludazine&amp;action=edit&amp;redlink=1" class="new" title="Tefludazine (page does not exist)">Tefludazine</a></li> <li><a href="/wiki/Zicronapine" title="Zicronapine">Zicronapine</a></li> <li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li> <li><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></li></ul> <ul><li><i>Others</i>: <a href="/wiki/Berupipam" title="Berupipam">Berupipam</a></li> <li><a href="/wiki/Ecopipam" title="Ecopipam">Ecopipam</a></li> <li><a href="/wiki/N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline" title="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline">EEDQ</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Odapipam" title="Odapipam">Odapipam</a></li> <li><a href="/wiki/Perlapine" title="Perlapine">Perlapine</a></li> <li><a href="/wiki/SCH-23390" title="SCH-23390">SCH-23390</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/D2-like_receptor" title="D2-like receptor">D<sub>2</sub>-like</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Adamantanes</i>: <a href="/wiki/Amantadine" title="Amantadine">Amantadine</a></li> <li><a href="/wiki/Memantine" title="Memantine">Memantine</a></li> <li><a href="/wiki/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul> <ul><li><i>Aminotetralins</i>: <a href="/wiki/5-OH-DPAT" title="5-OH-DPAT">5-OH-DPAT</a></li> <li><a href="/wiki/7-OH-DPAT" title="7-OH-DPAT">7-OH-DPAT</a></li> <li><a href="/wiki/8-OH-PBZI" title="8-OH-PBZI">8-OH-PBZI</a></li> <li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li> <li><a href="/wiki/UH-232" title="UH-232">UH-232</a></li></ul> <ul><li><i>Ergolines</i>: <a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li> <li><a href="/wiki/Cabergoline" title="Cabergoline">Cabergoline</a></li> <li><a href="/wiki/Chanoclavine" title="Chanoclavine">Chanoclavine</a></li> <li><a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">Dihydroergocryptine</a></li> <li><a href="/wiki/Epicriptine" title="Epicriptine">Epicriptine</a></li> <li><a href="/wiki/Ergocornine" title="Ergocornine">Ergocornine</a></li> <li><a href="/wiki/Lergotrile" title="Lergotrile">Lergotrile</a></li> <li><a href="/wiki/Lisuride" title="Lisuride">Lisuride</a></li> <li><a href="/wiki/LSD" title="LSD">LSD</a></li> <li><a href="/wiki/Pergolide" title="Pergolide">Pergolide</a></li> <li><a href="/wiki/Terguride" title="Terguride">Terguride</a></li></ul> <ul><li><i>Dihydrexidine derivatives</i>: <a href="/wiki/2-OH-NPA" title="2-OH-NPA">2-OH-NPA</a></li> <li><a href="/wiki/Ciladopa" title="Ciladopa">Ciladopa</a></li> <li><a href="/wiki/Dihydrexidine" title="Dihydrexidine">Dihydrexidine</a></li> <li><a href="/wiki/Dinoxyline" title="Dinoxyline">Dinoxyline</a></li> <li><a href="/w/index.php?title=N,N-Propyldihydrexidine&amp;action=edit&amp;redlink=1" class="new" title="N,N-Propyldihydrexidine (page does not exist)">N,N-Propyldihydrexidine</a></li></ul> <ul><li><i>Phenethylamines</i>: <a href="/wiki/Deoxyepinephrine" title="Deoxyepinephrine">Deoxyepinephrine (N-methyldopamine, epinine)</a></li> <li><a href="/wiki/Dopexamine" title="Dopexamine">Dopexamine</a></li> <li><a href="/wiki/Etilevodopa" title="Etilevodopa">Etilevodopa</a></li> <li><a href="/wiki/Ibopamine" title="Ibopamine">Ibopamine</a></li> <li><a href="/wiki/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li> <li><a href="/wiki/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li> <li><a href="/wiki/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li> <li><a href="/wiki/Melevodopa" title="Melevodopa">Melevodopa</a></li> <li><a href="/wiki/XP21279" class="mw-redirect" title="XP21279">XP21279</a></li></ul> <ul><li><i>Atypical antipsychotics</i>: <a href="/wiki/Alentemol" title="Alentemol">Alentemol (U-66444B)</a></li> <li><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a> (<a href="/wiki/Aripiprazole/sertraline" title="Aripiprazole/sertraline">+sertraline</a>)</li> <li><a href="/wiki/Aripiprazole_lauroxil" title="Aripiprazole lauroxil">Aripiprazole lauroxil</a></li> <li><a href="/wiki/Bifeprunox" title="Bifeprunox">Bifeprunox</a></li> <li><a href="/wiki/Brexpiprazole" title="Brexpiprazole">Brexpiprazole</a></li> <li><a href="/wiki/Brilaroxazine" title="Brilaroxazine">Brilaroxazine</a></li> <li><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></li> <li><a href="/wiki/F-15063" title="F-15063">F-15063</a></li> <li><a href="/wiki/Lumateperone" title="Lumateperone">Lumateperone</a></li> <li><a href="/wiki/Norclozapine" class="mw-redirect" title="Norclozapine">Norclozapine</a></li></ul> <ul><li><i>Others</i>: <a href="/wiki/3-PPP" title="3-PPP">3-PPP</a></li> <li><a href="/wiki/A-412997" title="A-412997">A-412997</a></li> <li><a href="/wiki/ABT-670" title="ABT-670">ABT-670</a></li> <li><a href="/wiki/ABT-724" title="ABT-724">ABT-724</a></li> <li><a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a></li> <li><a href="/wiki/Aplindore" title="Aplindore">Aplindore</a></li> <li><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a></li> <li><a href="/wiki/Arketamine" title="Arketamine">Arketamine</a></li> <li><a href="/wiki/Armodafinil" title="Armodafinil">Armodafinil</a></li> <li><a href="/wiki/BP-897" title="BP-897">BP-897</a></li> <li><a href="/wiki/Captodiame" title="Captodiame">Captodiame</a></li> <li><a href="/wiki/CP-226,269" title="CP-226,269">CP-226,269</a></li> <li><a href="/wiki/Dizocilpine" title="Dizocilpine">Dizocilpine</a></li> <li><a href="/wiki/Esketamine" title="Esketamine">Esketamine</a></li> <li><a href="/wiki/Flibanserin" title="Flibanserin">Flibanserin</a></li> <li><a href="/wiki/Ketamine" title="Ketamine">Ketamine</a></li> <li><a href="/wiki/Mesulergine" title="Mesulergine">Mesulergine</a></li> <li><a href="/wiki/Modafinil" title="Modafinil">Modafinil</a></li> <li><a href="/wiki/Naxagolide" title="Naxagolide">Naxagolide</a></li> <li><a href="/wiki/OSU-6162" title="OSU-6162">OSU-6162</a></li> <li><a href="/wiki/Pardoprunox" title="Pardoprunox">Pardoprunox</a></li> <li><a href="/wiki/PD-128,907" title="PD-128,907">PD-128,907</a></li> <li><a href="/wiki/PD-168,077" title="PD-168,077">PD-168,077</a></li> <li><a href="/wiki/PF-219,061" title="PF-219,061">PF-219,061</a></li> <li><a href="/wiki/PF-592,379" title="PF-592,379">PF-592,379</a></li> <li><a href="/wiki/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li> <li><a href="/wiki/Piribedil" title="Piribedil">Piribedil</a></li> <li><a href="/wiki/Pramipexole" title="Pramipexole">Pramipexole</a></li> <li><a href="/wiki/Preclamol" class="mw-redirect" title="Preclamol">Preclamol</a></li> <li><a href="/wiki/Propylnorapomorphine" title="Propylnorapomorphine">Propylnorapomorphine</a></li> <li><a href="/wiki/Pukateine" title="Pukateine">Pukateine</a></li> <li><a href="/wiki/Quinagolide" title="Quinagolide">Quinagolide</a></li> <li><a href="/wiki/Quinelorane" title="Quinelorane">Quinelorane</a></li> <li><a href="/wiki/Quinpirole" title="Quinpirole">Quinpirole</a></li> <li><a href="/wiki/RDS-127" title="RDS-127">RDS-127</a></li> <li><a href="/wiki/Ro10-5824" title="Ro10-5824">Ro10-5824</a></li> <li><a href="/wiki/Ropinirole" title="Ropinirole">Ropinirole</a></li> <li><a href="/wiki/Roxindole" title="Roxindole">Roxindole</a></li> <li><a href="/wiki/Salvinorin_A" title="Salvinorin A">Salvinorin A</a></li> <li><a href="/wiki/SKF-83,959" title="SKF-83,959">SKF-83,959</a></li> <li><a href="/wiki/Sumanirole" title="Sumanirole">Sumanirole</a></li> <li><a href="/wiki/Talipexole" title="Talipexole">Talipexole</a></li> <li><a href="/wiki/Umespirone" title="Umespirone">Umespirone</a></li> <li><a href="/wiki/WAY-100,635" class="mw-redirect" title="WAY-100,635">WAY-100,635</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Typical antipsychotics</i>: <a href="/wiki/Acepromazine" title="Acepromazine">Acepromazine</a></li> <li><a href="/wiki/Acetophenazine" title="Acetophenazine">Acetophenazine</a></li> <li><a href="/wiki/Azaperone" title="Azaperone">Azaperone</a></li> <li><a href="/wiki/Benperidol" title="Benperidol">Benperidol</a></li> <li><a href="/wiki/Bromperidol" title="Bromperidol">Bromperidol</a></li> <li><a href="/wiki/Butaclamol" title="Butaclamol">Butaclamol</a></li> <li><a href="/wiki/Butaperazine" title="Butaperazine">Butaperazine</a></li> <li><a href="/wiki/Chloracizine" class="mw-redirect" title="Chloracizine">Chloracizine</a></li> <li><a href="/wiki/Chlorproethazine" title="Chlorproethazine">Chlorproethazine</a></li> <li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li> <li><a href="/wiki/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li> <li><a href="/wiki/Ciclindole" title="Ciclindole">Ciclindole</a></li> <li><a href="/wiki/Clopenthixol" title="Clopenthixol">Clopenthixol</a></li> <li><a href="/w/index.php?title=Clothixamide&amp;action=edit&amp;redlink=1" class="new" title="Clothixamide (page does not exist)">Clothixamide</a></li> <li><a href="/wiki/Clopimozide" title="Clopimozide">Clopimozide</a></li> <li><a href="/wiki/Droperidol" title="Droperidol">Droperidol</a></li> <li><a href="/wiki/Fluacizine" title="Fluacizine">Fluacizine</a></li> <li><a href="/wiki/Fluanisone" title="Fluanisone">Fluanisone</a></li> <li><a href="/wiki/Flucindole" title="Flucindole">Flucindole</a></li> <li><a href="/wiki/Fluotracen" title="Fluotracen">Fluotracen</a></li> <li><a href="/wiki/Flupentixol" title="Flupentixol">Flupentixol (flupenthixol)</a> (<a href="/wiki/Flupentixol/melitracen" title="Flupentixol/melitracen">+melitracen</a>)</li> <li><a href="/wiki/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li> <li><a href="/w/index.php?title=Fluprothixene&amp;action=edit&amp;redlink=1" class="new" title="Fluprothixene (page does not exist)">Fluprothixene</a></li> <li><a href="/wiki/Fluspirilene" title="Fluspirilene">Fluspirilene</a></li> <li><a href="/wiki/Haloperidol" title="Haloperidol">Haloperidol</a></li> <li><a href="/wiki/Homopipramol" title="Homopipramol">Homopipramol</a></li> <li><a href="/wiki/Lenperone" title="Lenperone">Lenperone</a></li> <li><a href="/wiki/Levomepromazine" title="Levomepromazine">Levomepromazine (methotrimeprazine)</a></li> <li><a href="/wiki/Levosulpiride" title="Levosulpiride">Levosulpiride</a></li> <li><a href="/wiki/Loxapine" title="Loxapine">Loxapine</a></li> <li><a href="/wiki/Mesoridazine" title="Mesoridazine">Mesoridazine</a></li> <li><a href="/wiki/Moperone" title="Moperone">Moperone</a></li> <li><a href="/wiki/Naranol" title="Naranol">Naranol</a></li> <li><a href="/wiki/Nemonapride" title="Nemonapride">Nemonapride</a></li> <li><a href="/wiki/Penfluridol" title="Penfluridol">Penfluridol</a></li> <li><a href="/wiki/Perathiepin" title="Perathiepin">Perathiepin</a></li> <li><a href="/wiki/Perazine" title="Perazine">Perazine</a></li> <li><a href="/wiki/Periciazine" title="Periciazine">Pericyazine (periciazine)</a></li> <li><a href="/wiki/Perphenazine" title="Perphenazine">Perphenazine</a> (<a href="/wiki/Amitriptyline/perphenazine" title="Amitriptyline/perphenazine">+amitriptyline</a>)</li> <li><a href="/w/index.php?title=Piflutixol&amp;action=edit&amp;redlink=1" class="new" title="Piflutixol (page does not exist)">Piflutixol (pifluthixol)</a></li> <li><a href="/wiki/Pimozide" title="Pimozide">Pimozide</a></li> <li><a href="/wiki/Pipamperone" title="Pipamperone">Pipamperone</a></li> <li><a href="/wiki/Preclamol" class="mw-redirect" title="Preclamol">Preclamol</a></li> <li><a href="/wiki/Prochlorperazine" title="Prochlorperazine">Prochlorperazine</a></li> <li><a href="/wiki/Promazine" title="Promazine">Promazine</a></li> <li><a href="/wiki/Prothipendyl" title="Prothipendyl">Prothipendyl</a></li> <li><a href="/wiki/Spiperone" title="Spiperone">Spiperone (spiroperidol)</a></li> <li><a href="/wiki/Sulforidazine" title="Sulforidazine">Sulforidazine</a></li> <li><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a></li> <li><a href="/wiki/Sultopride" title="Sultopride">Sultopride</a></li> <li><a href="/w/index.php?title=Teflutixol&amp;action=edit&amp;redlink=1" class="new" title="Teflutixol (page does not exist)">Teflutixol</a></li> <li><a href="/wiki/Thiopropazate" title="Thiopropazate">Thiopropazate</a></li> <li><a href="/wiki/Thioproperazine" title="Thioproperazine">Thioproperazine</a></li> <li><a href="/wiki/Thioridazine" title="Thioridazine">Thioridazine</a></li> <li><a href="/wiki/Thiothixene" class="mw-redirect" title="Thiothixene">Thiothixene</a></li> <li><a href="/wiki/Timiperone" title="Timiperone">Timiperone</a></li> <li><a href="/wiki/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a> (<a href="/wiki/Tranylcypromine/trifluoperazine" title="Tranylcypromine/trifluoperazine">+tranylcypromine</a>)</li> <li><a href="/wiki/Triflupromazine" title="Triflupromazine">Triflupromazine</a></li> <li><a href="/wiki/Trifluperidol" title="Trifluperidol">Trifluperidol</a></li> <li><a href="/w/index.php?title=Zetidoline&amp;action=edit&amp;redlink=1" class="new" title="Zetidoline (page does not exist)">Zetidoline</a></li> <li><a href="/wiki/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a></li></ul> <ul><li><i>Atypical antipsychotics</i>: <a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></li> <li><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></li> <li><a href="/wiki/BL-1020" title="BL-1020">BL-1020</a></li> <li><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></li> <li><a href="/wiki/Carpipramine" title="Carpipramine">Carpipramine</a></li> <li><a href="/w/index.php?title=Cinuperone&amp;action=edit&amp;redlink=1" class="new" title="Cinuperone (page does not exist)">Cinuperone</a></li> <li><a href="/wiki/Clocapramine" title="Clocapramine">Clocapramine</a></li> <li><a href="/wiki/Clorotepine" title="Clorotepine">Clorotepine</a></li> <li><a href="/wiki/Clotiapine" title="Clotiapine">Clotiapine (clothiapine)</a></li> <li><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></li> <li><a href="/wiki/Cyamemazine" title="Cyamemazine">Cyamemazine</a></li> <li><a href="/wiki/DHA-clozapine" title="DHA-clozapine">DHA-clozapine</a></li> <li><a href="/wiki/Dixyrazine" title="Dixyrazine">Dixyrazine</a></li> <li><a href="/wiki/Elopiprazole" title="Elopiprazole">Elopiprazole</a></li> <li><a href="/wiki/Flumezapine" title="Flumezapine">Flumezapine</a></li> <li><a href="/wiki/Fluperlapine" title="Fluperlapine">Fluperlapine</a></li> <li><a href="/wiki/Gevotroline" title="Gevotroline">Gevotroline</a></li> <li><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></li> <li><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></li> <li><a href="/wiki/Mazapertine" title="Mazapertine">Mazapertine</a></li> <li><a href="/wiki/Melperone" title="Melperone">Melperone</a></li> <li><a href="/wiki/Molindone" title="Molindone">Molindone</a></li> <li><a href="/wiki/Mosapramine" title="Mosapramine">Mosapramine</a></li> <li><a href="/wiki/Ocaperidone" title="Ocaperidone">Ocaperidone</a></li> <li><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a> (<a href="/wiki/Olanzapine/fluoxetine" title="Olanzapine/fluoxetine">+fluoxetine</a>)</li> <li><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></li> <li><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a></li> <li><a href="/wiki/Piperacetazine" title="Piperacetazine">Piperacetazine</a></li> <li><a href="/wiki/Pipotiazine" title="Pipotiazine">Pipotiazine</a></li> <li><a href="/wiki/Piquindone" title="Piquindone">Piquindone</a></li> <li><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></li> <li><a href="/wiki/Remoxipride" title="Remoxipride">Remoxipride</a></li> <li><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></li> <li><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></li> <li><a href="/w/index.php?title=Tefludazine&amp;action=edit&amp;redlink=1" class="new" title="Tefludazine (page does not exist)">Tefludazine</a></li> <li><a href="/wiki/Tenilapine" title="Tenilapine">Tenilapine</a></li> <li><a href="/wiki/Tiospirone" title="Tiospirone">Tiospirone</a></li> <li><a href="/wiki/Veralipride" title="Veralipride">Veralipride</a></li> <li><a href="/wiki/Zicronapine" title="Zicronapine">Zicronapine</a></li> <li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li> <li><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a></li></ul> <ul><li><i>Antiemetics/gastroprokinetics/sedatives</i>: <a href="/wiki/Aceprometazine" title="Aceprometazine">Aceprometazine</a></li> <li><a href="/wiki/AS-8112" title="AS-8112">AS-8112</a></li> <li><a href="/wiki/Alimemazine" title="Alimemazine">Alimemazine</a></li> <li><a href="/wiki/Alizapride" title="Alizapride">Alizapride</a></li> <li><a href="/wiki/Benzquinamide" title="Benzquinamide">Benzquinamide</a></li> <li><a href="/wiki/Bromopride" title="Bromopride">Bromopride</a></li> <li><a href="/wiki/Clebopride" title="Clebopride">Clebopride</a></li> <li><a href="/wiki/Deudomperidone" title="Deudomperidone">Deudomperidone</a></li> <li><a href="/wiki/Domperidone" title="Domperidone">Domperidone</a></li> <li><a href="/wiki/Eticlopride" title="Eticlopride">Eticlopride</a></li> <li><a href="/wiki/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li> <li><a href="/wiki/Itopride" title="Itopride">Itopride</a></li> <li><a href="/wiki/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li> <li><a href="/wiki/Metopimazine" title="Metopimazine">Metopimazine</a></li> <li><a href="/wiki/Promethazine" title="Promethazine">Promethazine</a></li> <li><a href="/wiki/Thiethylperazine" title="Thiethylperazine">Thiethylperazine</a></li> <li><a href="/wiki/Trazpiroben" title="Trazpiroben">Trazpiroben</a></li> <li><a href="/wiki/Trimethobenzamide" title="Trimethobenzamide">Trimethobenzamide</a></li></ul> <ul><li><i>Antidepressants</i>: <a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a></li> <li><a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a></li> <li><a href="/wiki/Opipramol" title="Opipramol">Opipramol</a></li> <li><a href="/wiki/Propiomazine" title="Propiomazine">Propiomazine</a></li> <li><a href="/wiki/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul> <ul><li><i>Others</i>: <a href="/wiki/3-PPP" title="3-PPP">3-PPP</a></li> <li><a href="/wiki/Alpiropride" title="Alpiropride">Alpiropride</a></li> <li><a href="/wiki/Azapride" title="Azapride">Azapride</a></li> <li><a href="/wiki/Bromerguride" title="Bromerguride">Bromerguride</a></li> <li><a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li> <li><a href="/wiki/Buspirone" title="Buspirone">Buspirone</a></li> <li><a href="/wiki/Desmethoxyfallypride" title="Desmethoxyfallypride">Desmethoxyfallypride</a></li> <li><a href="/wiki/N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline" title="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline">EEDQ</a></li> <li><a href="/wiki/F-15063" title="F-15063">F-15063</a></li> <li><a href="/wiki/Fallypride" title="Fallypride">Fallypride</a></li> <li><a href="/wiki/Fananserin" title="Fananserin">Fananserin</a></li> <li><a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a></li> <li><a href="/wiki/Iodobenzamide" title="Iodobenzamide">Iodobenzamide</a></li> <li><a href="/w/index.php?title=Isocorypalmine&amp;action=edit&amp;redlink=1" class="new" title="Isocorypalmine (page does not exist)">Isocorypalmine</a></li> <li><a href="/wiki/L-741,626" title="L-741,626">L-741,626</a></li> <li><a href="/wiki/L-745,870" title="L-745,870">L-745,870</a></li> <li><a href="/wiki/Levofenfluramine" title="Levofenfluramine">Levofenfluramine</a></li> <li><a href="/w/index.php?title=LEK-8829&amp;action=edit&amp;redlink=1" class="new" title="LEK-8829 (page does not exist)">LEK-8829</a></li> <li><a href="/wiki/Metergoline" title="Metergoline">Metergoline</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/N-Methylspiperone" title="N-Methylspiperone">N-Methylspiperone</a></li> <li><a href="/wiki/Nafadotride" title="Nafadotride">Nafadotride</a></li> <li><a href="/wiki/Nuciferine" title="Nuciferine">Nuciferine</a></li> <li><a href="/wiki/PNU-99,194" title="PNU-99,194">PNU-99,194</a></li> <li><a href="/wiki/Pridopidine" title="Pridopidine">Pridopidine</a></li> <li><a href="/wiki/Raclopride" title="Raclopride">Raclopride</a></li> <li><a href="/wiki/Sarizotan" title="Sarizotan">Sarizotan</a></li> <li><a href="/wiki/SB-277,011-A" title="SB-277,011-A">SB-277,011-A</a></li> <li><a href="/w/index.php?title=Seridopidine&amp;action=edit&amp;redlink=1" class="new" title="Seridopidine (page does not exist)">Seridopidine</a></li> <li><a href="/wiki/Sonepiprazole" title="Sonepiprazole">Sonepiprazole</a></li> <li><a href="/wiki/Spiroxatrine" title="Spiroxatrine">Spiroxatrine</a></li> <li><a href="/wiki/Stepholidine" title="Stepholidine">Stepholidine</a></li> <li><a href="/w/index.php?title=SV-293&amp;action=edit&amp;redlink=1" class="new" title="SV-293 (page does not exist)">SV-293</a></li> <li><a href="/wiki/Terguride" title="Terguride">Terguride</a></li> <li><a href="/wiki/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li> <li><a href="/wiki/Tiapride" title="Tiapride">Tiapride</a></li> <li><a href="/wiki/UH-232" title="UH-232">UH-232</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <ul><li><small><i><b>See also:</b> <a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></i></small></li> <li><small><i><a href="/wiki/Template:Adrenergic_receptor_modulators" title="Template:Adrenergic receptor modulators">Adrenergics</a></i></small></li> <li><small><i><a href="/wiki/Template:Serotonin_receptor_modulators" title="Template:Serotonin receptor modulators">Serotonergics</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_reuptake_inhibitors" title="Template:Monoamine reuptake inhibitors">Monoamine reuptake inhibitors</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_releasing_agents" title="Template:Monoamine releasing agents">Monoamine releasing agents</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_metabolism_modulators" title="Template:Monoamine metabolism modulators">Monoamine metabolism modulators</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_neurotoxins" class="mw-redirect" title="Template:Monoamine neurotoxins">Monoamine neurotoxins</a></i></small></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox" aria-labelledby="Serotonin_receptor_modulators871" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Serotonin_receptor_modulators" title="Template:Serotonin receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Serotonin_receptor_modulators" title="Template talk:Serotonin receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Serotonin_receptor_modulators" title="Special:EditPage/Template:Serotonin receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Serotonin_receptor_modulators871" style="font-size:114%;margin:0 4em"><a href="/wiki/5-HT_receptor" title="5-HT receptor">Serotonin receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1_receptor" title="5-HT1 receptor">5-HT<sub>1</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1A_receptor" title="5-HT1A receptor">5-HT<sub>1A</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/8-OH-DPAT" title="8-OH-DPAT">8-OH-DPAT</a></li> <li><a href="/wiki/Adatanserin" title="Adatanserin">Adatanserin</a></li> <li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a></li> <li><a href="/wiki/Antidepressant" title="Antidepressant">Antidepressants</a> (e.g., <a href="/wiki/Etoperidone" title="Etoperidone">etoperidone</a>, <a href="/wiki/Hydroxynefazodone" title="Hydroxynefazodone">hydroxynefazodone</a>, <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a>, <a href="/wiki/Trazodone" title="Trazodone">trazodone</a>, <a href="/wiki/Triazoledione" title="Triazoledione">triazoledione</a>, <a href="/wiki/Vilazodone" title="Vilazodone">vilazodone</a>, <a href="/wiki/Vortioxetine" title="Vortioxetine">vortioxetine</a>)</li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>, <a href="/wiki/Cariprazine" title="Cariprazine">cariprazine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Lurasidone" title="Lurasidone">lurasidone</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li> <li><a href="/wiki/Azapirone" title="Azapirone">Azapirones</a> (e.g., <a href="/wiki/Buspirone" title="Buspirone">buspirone</a>, <a href="/wiki/Eptapirone" title="Eptapirone">eptapirone</a>, <a href="/wiki/Gepirone" title="Gepirone">gepirone</a>, <a href="/wiki/Perospirone" title="Perospirone">perospirone</a>, <a href="/wiki/Tandospirone" title="Tandospirone">tandospirone</a>)</li> <li><a href="/wiki/Bay_R_1531" title="Bay R 1531">Bay R 1531</a></li> <li><a href="/wiki/Befiradol" title="Befiradol">Befiradol</a></li> <li><a href="/wiki/BMY-14802" title="BMY-14802">BMY-14802</a></li> <li><a href="/wiki/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li> <li><a href="/wiki/Dimemebfe" title="Dimemebfe">Dimemebfe</a></li> <li><a href="/wiki/Dopamine" title="Dopamine">Dopamine</a></li> <li><a href="/wiki/Ebalzotan" title="Ebalzotan">Ebalzotan</a></li> <li><a href="/wiki/Eltoprazine" title="Eltoprazine">Eltoprazine</a></li> <li><a href="/wiki/Enciprazine" title="Enciprazine">Enciprazine</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/LSD" title="LSD">LSD</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/F-11,461" title="F-11,461">F-11,461</a></li> <li><a href="/w/index.php?title=F-12826&amp;action=edit&amp;redlink=1" class="new" title="F-12826 (page does not exist)">F-12826</a></li> <li><a href="/w/index.php?title=F-13714&amp;action=edit&amp;redlink=1" class="new" title="F-13714 (page does not exist)">F-13714</a></li> <li><a href="/w/index.php?title=F-14679&amp;action=edit&amp;redlink=1" class="new" title="F-14679 (page does not exist)">F-14679</a></li> <li><a href="/wiki/F-15063" title="F-15063">F-15063</a></li> <li><a href="/wiki/F-15,599" title="F-15,599">F-15,599</a></li> <li><a href="/wiki/Flesinoxan" title="Flesinoxan">Flesinoxan</a></li> <li><a href="/wiki/Flibanserin" title="Flibanserin">Flibanserin</a></li> <li><a href="/wiki/Flumexadol" title="Flumexadol">Flumexadol</a></li> <li><a href="/wiki/Hypidone" title="Hypidone">Hypidone</a></li> <li><a href="/wiki/Lesopitron" title="Lesopitron">Lesopitron</a></li> <li><a href="/wiki/LY-293284" title="LY-293284">LY-293284</a></li> <li><a href="/w/index.php?title=LY-301317&amp;action=edit&amp;redlink=1" class="new" title="LY-301317 (page does not exist)">LY-301317</a></li> <li><a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li> <li><a href="/wiki/Osemozotan" title="Osemozotan">MKC-242</a></li> <li><a href="/wiki/Naluzotan" title="Naluzotan">Naluzotan</a></li> <li><a href="/wiki/NBUMP" title="NBUMP">NBUMP</a></li> <li><a href="/wiki/Osemozotan" title="Osemozotan">Osemozotan</a></li> <li><a href="/wiki/Oxaflozane" title="Oxaflozane">Oxaflozane</a></li> <li><a href="/wiki/Pardoprunox" title="Pardoprunox">Pardoprunox</a></li> <li><a href="/wiki/Piclozotan" title="Piclozotan">Piclozotan</a></li> <li><a href="/wiki/Rauwolscine" title="Rauwolscine">Rauwolscine</a></li> <li><a href="/wiki/Repinotan" title="Repinotan">Repinotan</a></li> <li><a href="/wiki/Roxindole" title="Roxindole">Roxindole</a></li> <li><a href="/wiki/RU-24,969" title="RU-24,969">RU-24,969</a></li> <li><a href="/wiki/S-14,506" title="S-14,506">S-14,506</a></li> <li><a href="/wiki/S-14671" title="S-14671">S-14671</a></li> <li><a href="/wiki/S-15535" title="S-15535">S-15535</a></li> <li><a href="/wiki/Sarizotan" title="Sarizotan">Sarizotan</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/w/index.php?title=SSR-181507&amp;action=edit&amp;redlink=1" class="new" title="SSR-181507 (page does not exist)">SSR-181507</a></li> <li><a href="/wiki/Sunepitron" title="Sunepitron">Sunepitron</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>, <a href="/wiki/Indorenate" title="Indorenate">indorenate</a>, <a href="/wiki/N-Methylserotonin" title="N-Methylserotonin">N-Me-5-HT</a>, <a href="/wiki/Psilocin" title="Psilocin">psilocin</a>, <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a>)</li> <li><a href="/wiki/TGBA01AD" title="TGBA01AD">TGBA01AD</a></li> <li><a href="/wiki/U-92,016-A" title="U-92,016-A">U-92,016-A</a></li> <li><a href="/wiki/Urapidil" title="Urapidil">Urapidil</a></li> <li><a href="/wiki/Vilazodone" title="Vilazodone">Vilazodone</a></li> <li><a href="/wiki/Xaliproden" title="Xaliproden">Xaliproden</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Iloperidone" title="Iloperidone">iloperidone</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Sertindole" title="Sertindole">sertindole</a>)</li> <li><a href="/w/index.php?title=AV965&amp;action=edit&amp;redlink=1" class="new" title="AV965 (page does not exist)">AV965</a></li> <li><a href="/wiki/Beta_blocker" title="Beta blocker">Beta blockers</a> (e.g., <a href="/wiki/Alprenolol" title="Alprenolol">alprenolol</a>, <a href="/wiki/Carteolol" title="Carteolol">carteolol</a>, <a href="/wiki/Cyanopindolol" title="Cyanopindolol">cyanopindolol</a>, <a href="/wiki/Iodocyanopindolol" title="Iodocyanopindolol">iodocyanopindolol</a>, <a href="/wiki/Isamoltane" title="Isamoltane">isamoltane</a>, <a href="/wiki/Oxprenolol" title="Oxprenolol">oxprenolol</a>, <a href="/wiki/Penbutolol" title="Penbutolol">penbutolol</a>, <a href="/wiki/Pindobind" title="Pindobind">pindobind</a>, <a href="/wiki/Pindolol" title="Pindolol">pindolol</a>, <a href="/wiki/Propranolol" title="Propranolol">propranolol</a>, <a href="/wiki/Tertatolol" title="Tertatolol">tertatolol</a>)</li> <li><a href="/wiki/BMY-7,378" class="mw-redirect" title="BMY-7,378">BMY-7,378</a></li> <li><a href="/wiki/CSP-2503" title="CSP-2503">CSP-2503</a></li> <li><a href="/wiki/Dotarizine" title="Dotarizine">Dotarizine</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>)</li> <li><a href="/w/index.php?title=FCE-24379&amp;action=edit&amp;redlink=1" class="new" title="FCE-24379 (page does not exist)">FCE-24379</a></li> <li><a href="/wiki/Flopropione" title="Flopropione">Flopropione</a></li> <li><a href="/w/index.php?title=GR-46611&amp;action=edit&amp;redlink=1" class="new" title="GR-46611 (page does not exist)">GR-46611</a></li> <li><a href="/wiki/Isamoltane" title="Isamoltane">Isamoltane</a></li> <li><a href="/wiki/Lecozotan" title="Lecozotan">Lecozotan</a></li> <li><a href="/wiki/Mefway_(18F)" title="Mefway (18F)">Mefway</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/MIN-117" title="MIN-117">MIN-117 (WF-516)</a></li> <li><a href="/wiki/MPPF" title="MPPF">MPPF</a></li> <li><a href="/wiki/NAN-190" title="NAN-190">NAN-190</a></li> <li><a href="/wiki/Robalzotan" title="Robalzotan">Robalzotan</a></li> <li><a href="/wiki/S-15535" title="S-15535">S-15535</a></li> <li><a href="/wiki/SB-649,915" title="SB-649,915">SB-649,915</a></li> <li><a href="/w/index.php?title=SDZ_216-525&amp;action=edit&amp;redlink=1" class="new" title="SDZ 216-525 (page does not exist)">SDZ 216-525</a></li> <li><a href="/wiki/Spiperone" title="Spiperone">Spiperone</a></li> <li><a href="/wiki/Spiramide" title="Spiramide">Spiramide</a></li> <li><a href="/wiki/Spiroxatrine" title="Spiroxatrine">Spiroxatrine</a></li> <li><a href="/wiki/UH-301" title="UH-301">UH-301</a></li> <li><a href="/wiki/WAY-100135" title="WAY-100135">WAY-100135</a></li> <li><a href="/wiki/WAY-100635" title="WAY-100635">WAY-100635</a></li> <li><a href="/wiki/Xylamidine" title="Xylamidine">Xylamidine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Acetryptine" title="Acetryptine">Acetryptine</a></li> <li><a href="/wiki/Carvedilol" title="Carvedilol">Carvedilol</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1B_receptor" title="5-HT1B receptor">5-HT<sub>1B</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Anpirtoline" title="Anpirtoline">Anpirtoline</a></li> <li><a href="/wiki/CGS-12066A" title="CGS-12066A">CGS-12066A</a></li> <li><a href="/wiki/CP-93129" title="CP-93129">CP-93129</a></li> <li><a href="/wiki/CP-94253" title="CP-94253">CP-94253</a></li> <li><a href="/wiki/CP-122,288" title="CP-122,288">CP-122,288</a></li> <li><a href="/wiki/CP-135807" title="CP-135807">CP-135807</a></li> <li><a href="/wiki/Eltoprazine" title="Eltoprazine">Eltoprazine</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li> <li><a href="/wiki/RU-24,969" title="RU-24,969">RU-24,969</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Triptan" title="Triptan">Triptans</a> (e.g., <a href="/wiki/Avitriptan" title="Avitriptan">avitriptan</a>, <a href="/wiki/Donitriptan" title="Donitriptan">donitriptan</a>, <a href="/wiki/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="/wiki/Sumatriptan" title="Sumatriptan">sumatriptan</a>, <a href="/wiki/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a>)</li> <li><a href="/wiki/Trifluoromethylphenylpiperazine" title="Trifluoromethylphenylpiperazine">TFMPP</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>)</li> <li><a href="/wiki/Vortioxetine" title="Vortioxetine">Vortioxetine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/AR-A000002" title="AR-A000002">AR-A000002</a></li> <li><a href="/wiki/Beta_blocker" title="Beta blocker">Beta blockers</a> (e.g., <a href="/wiki/Alprenolol" title="Alprenolol">alprenolol</a>, <a href="/wiki/Carteolol" title="Carteolol">carteolol</a>, <a href="/wiki/Isamoltane" title="Isamoltane">isamoltane</a>, <a href="/wiki/Oxprenolol" title="Oxprenolol">oxprenolol</a>, <a href="/wiki/Penbutolol" title="Penbutolol">penbutolol</a>, <a href="/wiki/Propranolol" title="Propranolol">propranolol</a>, <a href="/wiki/Tertatolol" title="Tertatolol">tertatolol</a>)</li> <li><a href="/wiki/Elzasonan" title="Elzasonan">Elzasonan</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>)</li> <li><a href="/wiki/GR-127935" title="GR-127935">GR-127935</a></li> <li><a href="/wiki/Isamoltane" title="Isamoltane">Isamoltane</a></li> <li><a href="/wiki/LY-393558" title="LY-393558">LY-393558</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/SB-216641" title="SB-216641">SB-216641</a></li> <li><a href="/wiki/SB-224289" title="SB-224289">SB-224289</a></li> <li><a href="/wiki/SB-236057" title="SB-236057">SB-236057</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1D_receptor" title="5-HT1D receptor">5-HT<sub>1D</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/CP-122,288" title="CP-122,288">CP-122,288</a></li> <li><a href="/wiki/CP-135807" title="CP-135807">CP-135807</a></li> <li><a href="/w/index.php?title=CP-286601&amp;action=edit&amp;redlink=1" class="new" title="CP-286601 (page does not exist)">CP-286601</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/LSD" title="LSD">LSD</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>)</li> <li><a href="/w/index.php?title=GR-46611&amp;action=edit&amp;redlink=1" class="new" title="GR-46611 (page does not exist)">GR-46611</a></li> <li><a href="/wiki/L-694247" title="L-694247">L-694247</a></li> <li><a href="/w/index.php?title=L-772405&amp;action=edit&amp;redlink=1" class="new" title="L-772405 (page does not exist)">L-772405</a></li> <li><a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li> <li><a href="/w/index.php?title=PNU-109291&amp;action=edit&amp;redlink=1" class="new" title="PNU-109291 (page does not exist)">PNU-109291</a></li> <li><a href="/wiki/PNU-142633" title="PNU-142633">PNU-142633</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/TGBA01AD" title="TGBA01AD">TGBA01AD</a></li> <li><a href="/wiki/Triptan" title="Triptan">Triptans</a> (e.g., <a href="/wiki/Almotriptan" title="Almotriptan">almotriptan</a>, <a href="/wiki/Avitriptan" title="Avitriptan">avitriptan</a>, <a href="/wiki/Donitriptan" title="Donitriptan">donitriptan</a>, <a href="/wiki/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="/wiki/Frovatriptan" title="Frovatriptan">frovatriptan</a>, <a href="/wiki/Naratriptan" title="Naratriptan">naratriptan</a>, <a href="/wiki/Rizatriptan" title="Rizatriptan">rizatriptan</a>, <a href="/wiki/Sumatriptan" title="Sumatriptan">sumatriptan</a>, <a href="/wiki/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a>)</li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-Ethyl-DMT" title="5-Ethyl-DMT">5-Et-DMT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/5-(Nonyloxy)tryptamine" title="5-(Nonyloxy)tryptamine">5-(nonyloxy)tryptamine</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Alniditan" title="Alniditan">Alniditan</a></li> <li><a href="/wiki/BRL-15,572" title="BRL-15,572">BRL-15,572</a></li> <li><a href="/wiki/Elzasonan" title="Elzasonan">Elzasonan</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>)</li> <li><a href="/wiki/GR-127935" title="GR-127935">GR-127935</a></li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/wiki/LY-310762" title="LY-310762">LY-310762</a></li> <li><a href="/wiki/LY-367642" title="LY-367642">LY-367642</a></li> <li><a href="/wiki/LY-393558" title="LY-393558">LY-393558</a></li> <li><a href="/wiki/LY-456219" title="LY-456219">LY-456219</a></li> <li><a href="/wiki/LY-456220" title="LY-456220">LY-456220</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Mianserin" title="Mianserin">Mianserin</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li> <li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Acetryptine" title="Acetryptine">Acetryptine</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/Lysergol" title="Lysergol">lysergol</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1E_receptor" title="5-HT1E receptor">5-HT<sub>1E</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/BRL-54443" title="BRL-54443">BRL-54443</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>)</li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Triptan" title="Triptan">Triptans</a> (e.g., <a href="/wiki/Eletriptan" title="Eletriptan">eletriptan</a>)</li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/Tryptamine" title="Tryptamine">tryptamine</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="/wiki/Lysergol" title="Lysergol">lysergol</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT1F_receptor" title="5-HT1F receptor">5-HT<sub>1F</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/BRL-54443" title="BRL-54443">BRL-54443</a></li> <li><a href="/wiki/CP-122,288" title="CP-122,288">CP-122,288</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Lysergol" title="Lysergol">lysergol</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a> <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>)</li> <li><a href="/wiki/Lasmiditan" title="Lasmiditan">Lasmiditan</a></li> <li><a href="/wiki/LY-334370" title="LY-334370">LY-334370</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Triptan" title="Triptan">Triptans</a> (e.g., <a href="/wiki/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="/wiki/Naratriptan" title="Naratriptan">naratriptan</a>, <a href="/wiki/Sumatriptan" title="Sumatriptan">sumatriptan</a>)</li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Mianserin" title="Mianserin">Mianserin</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT2_receptor" title="5-HT2 receptor">5-HT<sub>2</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT<sub>2A</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> 25H/NB series (e.g., <a href="/wiki/25I-NBF" title="25I-NBF">25I-NBF</a>, <a href="/wiki/25I-NBMD" title="25I-NBMD">25I-NBMD</a>, <a href="/wiki/25I-NBOH" title="25I-NBOH">25I-NBOH</a>, <a href="/wiki/25I-NBOMe" title="25I-NBOMe">25I-NBOMe</a>, <a href="/wiki/25B-NBOMe" title="25B-NBOMe">25B-NBOMe</a>, <a href="/wiki/25C-NBOMe" title="25C-NBOMe">25C-NBOMe</a>, <a href="/wiki/25TFM-NBOMe" title="25TFM-NBOMe">25TFM-NBOMe</a>, <a href="/wiki/2CBCB-NBOMe" title="2CBCB-NBOMe">2CBCB-NBOMe</a>, <a href="/wiki/25CN-NBOH" title="25CN-NBOH">25CN-NBOH</a>, <a href="/wiki/2CBFly-NBOMe" title="2CBFly-NBOMe">2CBFly-NBOMe</a>)</li> <li><a href="/wiki/2C_(psychedelics)" title="2C (psychedelics)">2Cs</a> (e.g., <a href="/wiki/2C-B" title="2C-B">2C-B</a>, <a href="/wiki/2C-E" title="2C-E">2C-E</a>, <a href="/wiki/2C-I" title="2C-I">2C-I</a>, <a href="/wiki/2C-T-2" title="2C-T-2">2C-T-2</a>, <a href="/wiki/2C-T-7" title="2C-T-7">2C-T-7</a>, <a href="/wiki/2C-T-21" title="2C-T-21">2C-T-21</a>)</li> <li><a href="/wiki/2C-B-FLY" title="2C-B-FLY">2C-B-FLY</a></li> <li><a href="/wiki/2CB-Ind" title="2CB-Ind">2CB-Ind</a></li> <li><a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-Methoxytryptamines</a> (<a href="/wiki/5-MeO-DET" title="5-MeO-DET">5-MeO-DET</a>, <a href="/wiki/5-Methoxy-N,N-diisopropyltryptamine" class="mw-redirect" title="5-Methoxy-N,N-diisopropyltryptamine">5-MeO-DiPT</a>, <a href="/wiki/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, <a href="/wiki/5-MeO-DPT" title="5-MeO-DPT">5-MeO-DPT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li> <li><a href="/wiki/Substituted_alpha-alkyltryptamine" class="mw-redirect" title="Substituted alpha-alkyltryptamine">α-Alkyltryptamines</a> (e.g., <a href="/wiki/5-Chloro-%CE%B1MT" title="5-Chloro-αMT">5-Cl-αMT</a>, <a href="/wiki/5-Fluoro-AMT" title="5-Fluoro-AMT">5-Fl-αMT</a>, <a href="/wiki/5-MeO-AET" title="5-MeO-AET">5-MeO-αET</a>, <a href="/wiki/5-MeO-aMT" class="mw-redirect" title="5-MeO-aMT">5-MeO-αMT</a>, <a href="/wiki/Alpha-Methylserotonin" class="mw-redirect" title="Alpha-Methylserotonin">α-Me-5-HT</a>, <a href="/wiki/Alpha-Ethyltryptamine" class="mw-redirect" title="Alpha-Ethyltryptamine">αET</a>, <a href="/wiki/Alpha-Methyltryptamine" class="mw-redirect" title="Alpha-Methyltryptamine">αMT</a>)</li> <li><a href="/wiki/AL-34662" title="AL-34662">AL-34662</a></li> <li><a href="/wiki/AL-37350A" title="AL-37350A">AL-37350A</a></li> <li><a href="/wiki/Bromo-DragonFLY" title="Bromo-DragonFLY">Bromo-DragonFLY</a></li> <li><a href="/wiki/Dimemebfe" title="Dimemebfe">Dimemebfe</a></li> <li><a href="/wiki/DMBMPP" title="DMBMPP">DMBMPP</a></li> <li><a href="/wiki/DOx" title="DOx">DOx</a> (e.g., <a href="/wiki/2,5-Dimethoxy-4-bromoamphetamine" title="2,5-Dimethoxy-4-bromoamphetamine">DOB</a>, <a href="/wiki/2,5-Dimethoxy-4-chloroamphetamine" title="2,5-Dimethoxy-4-chloroamphetamine">DOC</a>, <a href="/wiki/2,5-Dimethoxy-4-iodoamphetamine" title="2,5-Dimethoxy-4-iodoamphetamine">DOI</a>, <a href="/wiki/2,5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li> <li><a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/1P-LSD" title="1P-LSD">1P-LSD</a>, <a href="/wiki/ALD-52" title="ALD-52">ALD-52</a>, <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Ergine" title="Ergine">ergine (LSA)</a>, <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/Lysergic_acid_2,4-dimethylazetidide" title="Lysergic acid 2,4-dimethylazetidide">LA-SS-Az</a>, <a href="/wiki/Lysergic_acid_2-butyl_amide" title="Lysergic acid 2-butyl amide">LSB</a>, <a href="/wiki/LSD" title="LSD">LSD</a>, <a href="/wiki/LSD-Pip" title="LSD-Pip">LSD-Pip</a>, <a href="/wiki/Lysergic_acid_hydroxyethylamide" title="Lysergic acid hydroxyethylamide">LSH</a>, <a href="/wiki/Lysergic_acid_3-pentyl_amide" title="Lysergic acid 3-pentyl amide">LSP</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Flumexadol" title="Flumexadol">Flumexadol</a></li> <li><a href="/wiki/IHCH-7113" title="IHCH-7113">IHCH-7113</a></li> <li><a href="/wiki/Jimscaline" title="Jimscaline">Jimscaline</a></li> <li><a href="/wiki/Lorcaserin" title="Lorcaserin">Lorcaserin</a></li> <li><a href="/wiki/Substituted_methylenedioxyphenethylamine" title="Substituted methylenedioxyphenethylamine">MDxx</a> (e.g., <a href="/wiki/3,4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="/wiki/MDMA" title="MDMA">MDMA (midomafetamine)</a>, <a href="/wiki/3,4-Methylenedioxy-N-hydroxyamphetamine" title="3,4-Methylenedioxy-N-hydroxyamphetamine">MDOH</a>, <a href="/wiki/MMDA_(drug)" title="MMDA (drug)">MMDA</a>)</li> <li><a href="/wiki/O-4310" title="O-4310">O-4310</a></li> <li><a href="/wiki/Oxaflozane" title="Oxaflozane">Oxaflozane</a></li> <li><a href="/wiki/PHA-57378" title="PHA-57378">PHA-57378</a></li> <li><a href="/wiki/PNU-22394" title="PNU-22394">PNU-22394</a></li> <li><a href="/wiki/PNU-181731" title="PNU-181731">PNU-181731</a></li> <li><a href="/wiki/RH-34" title="RH-34">RH-34</a></li> <li><a href="/wiki/SCHEMBL5334361" title="SCHEMBL5334361">SCHEMBL5334361</a></li> <li><a href="/wiki/Substituted_phenethylamine" title="Substituted phenethylamine">Phenethylamines</a> (e.g., <a href="/wiki/Lophophine" title="Lophophine">lophophine</a>, <a href="/wiki/Mescaline" title="Mescaline">mescaline</a>)</li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, <a href="/wiki/Quipazine" title="Quipazine">quipazine</a>, <a href="/wiki/Trifluoromethylphenylpiperazine" title="Trifluoromethylphenylpiperazine">TFMPP</a>)</li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/TCB-2" title="TCB-2">TCB-2</a></li> <li><a href="/wiki/TFMFly" title="TFMFly">TFMFly</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="/wiki/Diethyltryptamine" title="Diethyltryptamine">DET</a>, <a href="/wiki/Diisopropyltryptamine" class="mw-redirect" title="Diisopropyltryptamine">DiPT</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>, <a href="/wiki/Dipropyltryptamine" title="Dipropyltryptamine">DPT</a>, <a href="/wiki/Psilocin" title="Psilocin">psilocin</a>, <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a>, <a href="/wiki/Tryptamine" title="Tryptamine">tryptamine</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/5-I-R91150" title="5-I-R91150">5-I-R91150</a></li> <li><a href="/wiki/5-MeO-NBpBrT" title="5-MeO-NBpBrT">5-MeO-NBpBrT</a></li> <li><a href="/wiki/AC-90179" title="AC-90179">AC-90179</a></li> <li><a href="/wiki/Adatanserin" title="Adatanserin">Adatanserin</a></li> <li><a href="/wiki/Altanserin" title="Altanserin">Altanserin</a></li> <li><a href="/wiki/Antihistamine" title="Antihistamine">Antihistamines</a> (e.g., <a href="/wiki/Cyproheptadine" title="Cyproheptadine">cyproheptadine</a>, <a href="/wiki/Hydroxyzine" title="Hydroxyzine">hydroxyzine</a>, <a href="/wiki/Ketotifen" title="Ketotifen">ketotifen</a>, <a href="/wiki/Perlapine" title="Perlapine">perlapine</a>)</li> <li><a href="/wiki/9-Aminomethyl-9,10-dihydroanthracene" title="9-Aminomethyl-9,10-dihydroanthracene">AMDA</a></li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Amperozide" title="Amperozide">amperozide</a>, <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Blonanserin" title="Blonanserin">blonanserin</a>, <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>, <a href="/wiki/Carpipramine" title="Carpipramine">carpipramine</a>, <a href="/wiki/Clocapramine" title="Clocapramine">clocapramine</a>, <a href="/wiki/Clorotepine" title="Clorotepine">clorotepine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Fluperlapine" title="Fluperlapine">fluperlapine</a>, <a href="/wiki/Gevotroline" title="Gevotroline">gevotroline</a>, <a href="/wiki/Iloperidone" title="Iloperidone">iloperidone</a>, <a href="/wiki/Lurasidone" title="Lurasidone">lurasidone</a>, <a href="/wiki/Melperone" title="Melperone">melperone</a>, <a href="/wiki/Mosapramine" title="Mosapramine">mosapramine</a>, <a href="/wiki/Ocaperidone" title="Ocaperidone">ocaperidone</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Sertindole" title="Sertindole">sertindole</a>, <a href="/wiki/Zicronapine" title="Zicronapine">zicronapine</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>, <a href="/wiki/Zotepine" title="Zotepine">zotepine</a>)</li> <li><a href="/wiki/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li> <li><a href="/wiki/Cinanserin" title="Cinanserin">Cinanserin</a></li> <li><a href="/wiki/CSP-2503" title="CSP-2503">CSP-2503</a></li> <li><a href="/wiki/Deramciclane" title="Deramciclane">Deramciclane</a></li> <li><a href="/wiki/Dotarizine" title="Dotarizine">Dotarizine</a></li> <li><a href="/wiki/Eplivanserin" title="Eplivanserin">Eplivanserin</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Amesergide" title="Amesergide">amesergide</a>, <a href="/w/index.php?title=LY-53857&amp;action=edit&amp;redlink=1" class="new" title="LY-53857 (page does not exist)">LY-53857</a>, <a href="/wiki/LY-215,840" title="LY-215,840">LY-215,840</a>, <a href="/wiki/Mesulergine" title="Mesulergine">mesulergine</a>, <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Sergolexole" title="Sergolexole">sergolexole</a>)</li> <li><a href="/wiki/Fananserin" title="Fananserin">Fananserin</a></li> <li><a href="/wiki/Flibanserin" title="Flibanserin">Flibanserin</a></li> <li><a href="/wiki/Glemanserin" title="Glemanserin">Glemanserin</a></li> <li><a href="/w/index.php?title=Irindalone&amp;action=edit&amp;redlink=1" class="new" title="Irindalone (page does not exist)">Irindalone</a></li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/wiki/KML-010" title="KML-010">KML-010</a></li> <li><a href="/w/index.php?title=Landipirdine&amp;action=edit&amp;redlink=1" class="new" title="Landipirdine (page does not exist)">Landipirdine</a></li> <li><a href="/wiki/LY-393558" title="LY-393558">LY-393558</a></li> <li><a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li> <li><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/MIN-117" title="MIN-117">MIN-117 (WF-516)</a></li> <li><a href="/wiki/Naftidrofuryl" title="Naftidrofuryl">Naftidrofuryl</a></li> <li><a href="/wiki/Nantenine" title="Nantenine">Nantenine</a></li> <li><a href="/wiki/Nelotanserin" title="Nelotanserin">Nelotanserin</a></li> <li><a href="/wiki/Opiranserin" title="Opiranserin">Opiranserin (VVZ-149)</a></li> <li><a href="/wiki/Pelanserin" title="Pelanserin">Pelanserin</a></li> <li><a href="/wiki/Phenoxybenzamine" title="Phenoxybenzamine">Phenoxybenzamine</a></li> <li><a href="/wiki/Pimavanserin" title="Pimavanserin">Pimavanserin</a></li> <li><a href="/wiki/Pirenperone" title="Pirenperone">Pirenperone</a></li> <li><a href="/wiki/Pizotifen" title="Pizotifen">Pizotifen</a></li> <li><a href="/wiki/Pruvanserin" title="Pruvanserin">Pruvanserin</a></li> <li><a href="/wiki/Rauwolscine" title="Rauwolscine">Rauwolscine</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/Roluperidone" title="Roluperidone">Roluperidone</a></li> <li><a href="/wiki/S-14671" title="S-14671">S-14671</a></li> <li><a href="/wiki/Sarpogrelate" title="Sarpogrelate">Sarpogrelate</a></li> <li><a href="/wiki/Serotonin_antagonist_and_reuptake_inhibitor" title="Serotonin antagonist and reuptake inhibitor">Serotonin antagonists and reuptake inhibitors</a> (e.g., <a href="/wiki/Etoperidone" title="Etoperidone">etoperidone</a>, <a href="/wiki/Hydroxynefazodone" title="Hydroxynefazodone">hydroxynefazodone</a>, <a href="/wiki/Lubazodone" title="Lubazodone">lubazodone</a>, <a href="/wiki/Mepiprazole" title="Mepiprazole">mepiprazole</a>, <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a>, <a href="/wiki/Triazoledione" title="Triazoledione">triazoledione</a>, <a href="/wiki/Trazodone" title="Trazodone">trazodone</a>)</li> <li><a href="/w/index.php?title=SR-46349B&amp;action=edit&amp;redlink=1" class="new" title="SR-46349B (page does not exist)">SR-46349B</a></li> <li><a href="/wiki/TGBA01AD" title="TGBA01AD">TGBA01AD</a></li> <li><a href="/wiki/Teniloxazine" title="Teniloxazine">Teniloxazine</a></li> <li><a href="/w/index.php?title=Temanogrel&amp;action=edit&amp;redlink=1" class="new" title="Temanogrel (page does not exist)">Temanogrel</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Aptazapine" title="Aptazapine">aptazapine</a>, <a href="/wiki/Esmirtazapine" title="Esmirtazapine">esmirtazapine</a>, <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li> <li><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>)</li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="/wiki/Loxapine" title="Loxapine">loxapine</a>, <a href="/wiki/Perphenazine" title="Perphenazine">perphenazine</a>, <a href="/wiki/Pimozide" title="Pimozide">pimozide</a>, <a href="/wiki/Pipamperone" title="Pipamperone">pipamperone</a>, <a href="/wiki/Prochlorperazine" title="Prochlorperazine">prochlorperazine</a>, <a href="/wiki/Setoperone" title="Setoperone">setoperone</a>, <a href="/wiki/Spiperone" title="Spiperone">spiperone</a>, <a href="/wiki/Spiramide" title="Spiramide">spiramide</a>, <a href="/wiki/Thioridazine" title="Thioridazine">thioridazine</a>, <a href="/wiki/Tiotixene" title="Tiotixene">thiothixene</a>, <a href="/wiki/Trifluoperazine" title="Trifluoperazine">trifluoperazine</a>)</li> <li><a href="/wiki/Volinanserin" title="Volinanserin">Volinanserin</a></li> <li><a href="/wiki/Xylamidine" title="Xylamidine">Xylamidine</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Nicergoline" title="Nicergoline">nicergoline</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT2B_receptor" title="5-HT2B receptor">5-HT<sub>2B</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li> <li><a href="/wiki/Aminorex" title="Aminorex">Aminorex</a></li> <li><a href="/wiki/Substituted_amphetamine" title="Substituted amphetamine">Amphetamines</a> (e.g., <a href="/wiki/Chlorphentermine" title="Chlorphentermine">chlorphentermine</a>, <a href="/wiki/Cloforex" title="Cloforex">cloforex</a>, <a href="/wiki/Dexfenfluramine" title="Dexfenfluramine">dexfenfluramine</a>, <a href="/wiki/Fenfluramine" title="Fenfluramine">fenfluramine</a>, <a href="/wiki/Levofenfluramine" title="Levofenfluramine">levofenfluramine</a>, <a href="/wiki/Norfenfluramine" title="Norfenfluramine">norfenfluramine</a>)</li> <li><a href="/wiki/BW-723C86" title="BW-723C86">BW-723C86</a></li> <li><a href="/wiki/DOx" title="DOx">DOx</a> (e.g., <a href="/wiki/2,5-Dimethoxy-4-bromoamphetamine" title="2,5-Dimethoxy-4-bromoamphetamine">DOB</a>, <a href="/wiki/2,5-Dimethoxy-4-chloroamphetamine" title="2,5-Dimethoxy-4-chloroamphetamine">DOC</a>, <a href="/wiki/2,5-Dimethoxy-4-iodoamphetamine" title="2,5-Dimethoxy-4-iodoamphetamine">DOI</a>, <a href="/wiki/2,5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">dihydroergocryptine</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Lorcaserin" title="Lorcaserin">Lorcaserin</a></li> <li><a href="/wiki/Substituted_methylenedioxyphenethylamine" title="Substituted methylenedioxyphenethylamine">MDxx</a> (e.g., <a href="/wiki/3,4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="/wiki/MDMA" title="MDMA">MDMA (midomafetamine)</a>, <a href="/wiki/3,4-Methylenedioxy-N-hydroxyamphetamine" title="3,4-Methylenedioxy-N-hydroxyamphetamine">MDOH</a>, <a href="/wiki/MMDA_(drug)" title="MMDA (drug)">MMDA</a>)</li> <li><a href="/wiki/Substituted_piperazine" title="Substituted piperazine">Piperazines</a> (e.g., <a href="/wiki/Trifluoromethylphenylpiperazine" title="Trifluoromethylphenylpiperazine">TFMPP</a>)</li> <li><a href="/wiki/PNU-22394" title="PNU-22394">PNU-22394</a></li> <li><a href="/wiki/Ro60-0175" title="Ro60-0175">Ro60-0175</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/Alpha-Methylserotonin" class="mw-redirect" title="Alpha-Methylserotonin">α-Me-5-HT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="/wiki/Diethyltryptamine" title="Diethyltryptamine">DET</a>, <a href="/wiki/Diisopropyltryptamine" class="mw-redirect" title="Diisopropyltryptamine">DiPT</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>, <a href="/wiki/Dipropyltryptamine" title="Dipropyltryptamine">DPT</a>, <a href="/wiki/Psilocin" title="Psilocin">psilocin</a>, <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a>, <a href="/wiki/Tryptamine" title="Tryptamine">tryptamine</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a></li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Amisulpride" title="Amisulpride">amisulpride</a>, <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>, <a href="/wiki/Cariprazine" title="Cariprazine">cariprazine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/w/index.php?title=N-desalkylquetiapine&amp;action=edit&amp;redlink=1" class="new" title="N-desalkylquetiapine (page does not exist)">N-desalkylquetiapine (norquetiapine)</a>, <a href="/wiki/Desmethylclozapine" title="Desmethylclozapine">N-desmethylclozapine (norclozapine)</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Pipamperone" title="Pipamperone">pipamperone</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li> <li><a href="/wiki/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li> <li><a href="/wiki/EGIS-7625" title="EGIS-7625">EGIS-7625</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Amesergide" title="Amesergide">amesergide</a>, <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/w/index.php?title=LY-53857&amp;action=edit&amp;redlink=1" class="new" title="LY-53857 (page does not exist)">LY-53857</a>, <a href="/wiki/LY-272,015" title="LY-272,015">LY-272015</a>, <a href="/wiki/Mesulergine" title="Mesulergine">mesulergine</a>)</li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/wiki/LY-393558" title="LY-393558">LY-393558</a></li> <li><a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li> <li><a href="/wiki/Metadoxine" title="Metadoxine">Metadoxine</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Pirenperone" title="Pirenperone">Pirenperone</a></li> <li><a href="/wiki/Pizotifen" title="Pizotifen">Pizotifen</a></li> <li><a href="/wiki/Propranolol" title="Propranolol">Propranolol</a></li> <li><a href="/wiki/PRX-08066" title="PRX-08066">PRX-08066</a></li> <li><a href="/wiki/Rauwolscine" title="Rauwolscine">Rauwolscine</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/RS-127445" title="RS-127445">RS-127445</a></li> <li><a href="/wiki/Sarpogrelate" title="Sarpogrelate">Sarpogrelate</a></li> <li><a href="/wiki/SB-200646" title="SB-200646">SB-200646</a></li> <li><a href="/wiki/SB-204741" title="SB-204741">SB-204741</a></li> <li><a href="/wiki/SB-206553" title="SB-206553">SB-206553</a></li> <li><a href="/wiki/SB-215505" title="SB-215505">SB-215505</a></li> <li><a href="/wiki/SB-221284" title="SB-221284">SB-221284</a></li> <li><a href="/wiki/SB-228357" title="SB-228357">SB-228357</a></li> <li><a href="/wiki/SDZ_SER-082" title="SDZ SER-082">SDZ SER-082</a></li> <li><a href="/wiki/Tegaserod" title="Tegaserod">Tegaserod</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li> <li><a href="/wiki/Trazodone" title="Trazodone">Trazodone</a></li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>)</li> <li><a href="/wiki/TIK-301" title="TIK-301">TIK-301</a></li> <li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT2C_receptor" title="5-HT2C receptor">5-HT<sub>2C</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/2C_(psychedelics)" title="2C (psychedelics)">2Cs</a> (e.g., <a href="/wiki/2C-B" title="2C-B">2C-B</a>, <a href="/wiki/2C-E" title="2C-E">2C-E</a>, <a href="/wiki/2C-I" title="2C-I">2C-I</a>, <a href="/wiki/2C-T-2" title="2C-T-2">2C-T-2</a>, <a href="/wiki/2C-T-7" title="2C-T-7">2C-T-7</a>, <a href="/wiki/2C-T-21" title="2C-T-21">2C-T-21</a>)</li> <li><a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-Methoxytryptamines</a> (<a href="/wiki/5-MeO-DET" title="5-MeO-DET">5-MeO-DET</a>, <a href="/wiki/5-Methoxy-N,N-diisopropyltryptamine" class="mw-redirect" title="5-Methoxy-N,N-diisopropyltryptamine">5-MeO-DiPT</a>, <a href="/wiki/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, <a href="/wiki/5-MeO-DPT" title="5-MeO-DPT">5-MeO-DPT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li> <li><a href="/wiki/Substituted_alpha-alkyltryptamine" class="mw-redirect" title="Substituted alpha-alkyltryptamine">α-Alkyltryptamines</a> (e.g., <a href="/wiki/5-Chloro-%CE%B1MT" title="5-Chloro-αMT">5-Cl-αMT</a>, <a href="/wiki/5-Fluoro-AMT" title="5-Fluoro-AMT">5-Fl-αMT</a>, <a href="/wiki/5-MeO-AET" title="5-MeO-AET">5-MeO-αET</a>, <a href="/wiki/5-MeO-aMT" class="mw-redirect" title="5-MeO-aMT">5-MeO-αMT</a>, <a href="/wiki/Alpha-Methylserotonin" class="mw-redirect" title="Alpha-Methylserotonin">α-Me-5-HT</a>, <a href="/wiki/Alpha-Ethyltryptamine" class="mw-redirect" title="Alpha-Ethyltryptamine">αET</a>, <a href="/wiki/Alpha-Methyltryptamine" class="mw-redirect" title="Alpha-Methyltryptamine">αMT</a>)</li> <li><a href="/wiki/A-372159" title="A-372159">A-372159</a></li> <li><a href="/wiki/AL-38022A" title="AL-38022A">AL-38022A</a></li> <li><a href="/wiki/Alstonine" title="Alstonine">Alstonine</a></li> <li><a href="/wiki/CP-809101" title="CP-809101">CP-809101</a></li> <li><a href="/wiki/Dimemebfe" title="Dimemebfe">Dimemebfe</a></li> <li><a href="/wiki/DOx" title="DOx">DOx</a> (e.g., <a href="/wiki/2,5-Dimethoxy-4-bromoamphetamine" title="2,5-Dimethoxy-4-bromoamphetamine">DOB</a>, <a href="/wiki/2,5-Dimethoxy-4-chloroamphetamine" title="2,5-Dimethoxy-4-chloroamphetamine">DOC</a>, <a href="/wiki/2,5-Dimethoxy-4-iodoamphetamine" title="2,5-Dimethoxy-4-iodoamphetamine">DOI</a>, <a href="/wiki/2,5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/ALD-52" title="ALD-52">ALD-52</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergine" title="Ergine">ergine (LSA)</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/Lysergic_acid_2,4-dimethylazetidide" title="Lysergic acid 2,4-dimethylazetidide">LA-SS-Az</a>, <a href="/wiki/Lysergic_acid_2-butyl_amide" title="Lysergic acid 2-butyl amide">LSB</a>, <a href="/wiki/LSD" title="LSD">LSD</a>, <a href="/wiki/LSD-Pip" title="LSD-Pip">LSD-Pip</a>, <a href="/wiki/Lysergic_acid_hydroxyethylamide" title="Lysergic acid hydroxyethylamide">LSH</a>, <a href="/wiki/Lysergic_acid_3-pentyl_amide" title="Lysergic acid 3-pentyl amide">LSP</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Flumexadol" title="Flumexadol">Flumexadol</a></li> <li><a href="/wiki/Lorcaserin" title="Lorcaserin">Lorcaserin</a></li> <li><a href="/wiki/Substituted_methylenedioxyphenethylamine" title="Substituted methylenedioxyphenethylamine">MDxx</a> (e.g., <a href="/wiki/3,4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="/wiki/MDMA" title="MDMA">MDMA (midomafetamine)</a>, <a href="/wiki/3,4-Methylenedioxy-N-hydroxyamphetamine" title="3,4-Methylenedioxy-N-hydroxyamphetamine">MDOH</a>, <a href="/wiki/MMDA_(drug)" title="MMDA (drug)">MMDA</a>)</li> <li><a href="/wiki/MK-212" title="MK-212">MK-212</a></li> <li><a href="/wiki/ORG-12962" title="ORG-12962">ORG-12962</a></li> <li><a href="/wiki/ORG-37684" title="ORG-37684">ORG-37684</a></li> <li><a href="/wiki/Oxaflozane" title="Oxaflozane">Oxaflozane</a></li> <li><a href="/wiki/PHA-57378" title="PHA-57378">PHA-57378</a></li> <li><a href="/wiki/Substituted_phenethylamine" title="Substituted phenethylamine">Phenethylamines</a> (e.g., <a href="/wiki/Lophophine" title="Lophophine">lophophine</a>, <a href="/wiki/Mescaline" title="Mescaline">mescaline</a>)</li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, <a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a>, <a href="/wiki/Quipazine" title="Quipazine">quipazine</a>, <a href="/wiki/Trifluoromethylphenylpiperazine" title="Trifluoromethylphenylpiperazine">TFMPP</a>)</li> <li><a href="/wiki/PNU-22394" title="PNU-22394">PNU-22394</a></li> <li><a href="/wiki/PNU-181731" title="PNU-181731">PNU-181731</a></li> <li><a href="/wiki/Ro60-0175" title="Ro60-0175">Ro60-0175</a></li> <li><a href="/wiki/Ro60-0213" title="Ro60-0213">Ro60-0213</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="/wiki/Diethyltryptamine" title="Diethyltryptamine">DET</a>, <a href="/wiki/Diisopropyltryptamine" class="mw-redirect" title="Diisopropyltryptamine">DiPT</a>, <a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine">DMT</a>, <a href="/wiki/Dipropyltryptamine" title="Dipropyltryptamine">DPT</a>, <a href="/wiki/Psilocin" title="Psilocin">psilocin</a>, <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a>, <a href="/wiki/Tryptamine" title="Tryptamine">tryptamine</a>)</li> <li><a href="/wiki/Vabicaserin" title="Vabicaserin">Vabicaserin</a></li> <li><a href="/wiki/WAY-629" title="WAY-629">WAY-629</a></li> <li><a href="/wiki/WAY-161503" title="WAY-161503">WAY-161503</a></li> <li><a href="/wiki/YM-348" title="YM-348">YM-348</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Adatanserin" title="Adatanserin">Adatanserin</a></li> <li><a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a></li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Clorotepine" title="Clorotepine">clorotepine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Fluperlapine" title="Fluperlapine">fluperlapine</a>, <a href="/wiki/Iloperidone" title="Iloperidone">iloperidone</a>, <a href="/wiki/Melperone" title="Melperone">melperone</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Sertindole" title="Sertindole">sertindole</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>, <a href="/wiki/Zotepine" title="Zotepine">zotepine</a>)</li> <li><a href="/wiki/Captodiame" title="Captodiame">Captodiame</a></li> <li><a href="/wiki/6-Chloro-5-ethoxy-N-(pyridin-2-yl)indoline-1-carboxamide" title="6-Chloro-5-ethoxy-N-(pyridin-2-yl)indoline-1-carboxamide">CEPC</a></li> <li><a href="/wiki/Cinanserin" title="Cinanserin">Cinanserin</a></li> <li><a href="/wiki/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li> <li><a href="/wiki/Deramciclane" title="Deramciclane">Deramciclane</a></li> <li><a href="/wiki/Desmetramadol" title="Desmetramadol">Desmetramadol</a></li> <li><a href="/wiki/Dotarizine" title="Dotarizine">Dotarizine</a></li> <li><a href="/wiki/Eltoprazine" title="Eltoprazine">Eltoprazine</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Amesergide" title="Amesergide">amesergide</a>, <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/w/index.php?title=LY-53857&amp;action=edit&amp;redlink=1" class="new" title="LY-53857 (page does not exist)">LY-53857</a>, <a href="/wiki/LY-215,840" title="LY-215,840">LY-215,840</a>, <a href="/wiki/Mesulergine" title="Mesulergine">mesulergine</a>, <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Sergolexole" title="Sergolexole">sergolexole</a>)</li> <li><a href="/wiki/Etoperidone" title="Etoperidone">Etoperidone</a></li> <li><a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li> <li><a href="/w/index.php?title=FR-260010&amp;action=edit&amp;redlink=1" class="new" title="FR-260010 (page does not exist)">FR-260010</a></li> <li><a href="/w/index.php?title=Irindalone&amp;action=edit&amp;redlink=1" class="new" title="Irindalone (page does not exist)">Irindalone</a></li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/wiki/Ketotifen" title="Ketotifen">Ketotifen</a></li> <li><a href="/wiki/Latrepirdine" title="Latrepirdine">Latrepirdine (dimebolin)</a></li> <li><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a></li> <li><a href="/wiki/Pirenperone" title="Pirenperone">Pirenperone</a></li> <li><a href="/wiki/Pizotifen" title="Pizotifen">Pizotifen</a></li> <li><a href="/wiki/Propranolol" title="Propranolol">Propranolol</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/RS-102221" title="RS-102221">RS-102221</a></li> <li><a href="/wiki/S-14671" title="S-14671">S-14671</a></li> <li><a href="/wiki/SB-200646" title="SB-200646">SB-200646</a></li> <li><a href="/wiki/SB-206553" title="SB-206553">SB-206553</a></li> <li><a href="/wiki/SB-221284" title="SB-221284">SB-221284</a></li> <li><a href="/wiki/SB-228357" title="SB-228357">SB-228357</a></li> <li><a href="/wiki/SB-242084" title="SB-242084">SB-242084</a></li> <li><a href="/wiki/SB-243213" title="SB-243213">SB-243213</a></li> <li><a href="/wiki/SDZ_SER-082" title="SDZ SER-082">SDZ SER-082</a></li> <li><a href="/wiki/Tedatioxetine" title="Tedatioxetine">Tedatioxetine</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Aptazapine" title="Aptazapine">aptazapine</a>, <a href="/wiki/Esmirtazapine" title="Esmirtazapine">esmirtazapine</a>, <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li> <li><a href="/wiki/TIK-301" title="TIK-301">TIK-301</a></li> <li><a href="/wiki/Tramadol" title="Tramadol">Tramadol</a></li> <li><a href="/wiki/Trazodone" title="Trazodone">Trazodone</a></li> <li><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Loxapine" title="Loxapine">loxapine</a>, <a href="/wiki/Pimozide" title="Pimozide">pimozide</a>, <a href="/wiki/Pipamperone" title="Pipamperone">pipamperone</a>, <a href="/wiki/Thioridazine" title="Thioridazine">thioridazine</a>)</li> <li><a href="/wiki/Xylamidine" title="Xylamidine">Xylamidine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Ergometrine" class="mw-redirect" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="/wiki/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT3_receptor" title="5-HT3 receptor">5-HT<sub>3</sub></a><sub>–<a href="/wiki/5-HT7_receptor" title="5-HT7 receptor">7</a></sub></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT3_receptor" title="5-HT3 receptor">5-HT<sub>3</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Alcohol_(chemistry)" title="Alcohol (chemistry)">Alcohols</a> (e.g., <a href="/wiki/N-Butanol" class="mw-redirect" title="N-Butanol">butanol</a>, <a href="/wiki/Alcohol_(drug)" title="Alcohol (drug)">ethanol (alcohol)</a>, <a href="/wiki/2,2,2-Trichloroethanol" title="2,2,2-Trichloroethanol">trichloroethanol</a>)</li> <li><a href="/wiki/Chlorophenylbiguanide" title="Chlorophenylbiguanide">m-CPBG</a></li> <li><a href="/wiki/Phenylbiguanide" title="Phenylbiguanide">Phenylbiguanide</a></li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, <a href="/wiki/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a>, <a href="/wiki/Quipazine" title="Quipazine">quipazine</a>)</li> <li><a href="/wiki/RS-56812" title="RS-56812">RS-56812</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/SR-57227" title="SR-57227">SR-57227</a></li> <li><a href="/w/index.php?title=SR-57227A&amp;action=edit&amp;redlink=1" class="new" title="SR-57227A (page does not exist)">SR-57227A</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/2-Methyl-5-hydroxytryptamine" title="2-Methyl-5-hydroxytryptamine">2-Me-5-HT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/Bufotenidine" title="Bufotenidine">bufotenidine (5-HTQ)</a>)</li> <li><a href="/wiki/Inhalational_anaesthetic" class="mw-redirect" title="Inhalational anaesthetic">Volatiles/gases</a> (e.g., <a href="/wiki/Halothane" title="Halothane">halothane</a>, <a href="/wiki/Isoflurane" title="Isoflurane">isoflurane</a>, <a href="/wiki/Toluene" title="Toluene">toluene</a>, <a href="/wiki/1,1,1-Trichloroethane" title="1,1,1-Trichloroethane">trichloroethane</a>)</li> <li><a href="/wiki/YM-31636" title="YM-31636">YM-31636</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Alosetron" title="Alosetron">Alosetron</a></li> <li><a href="/wiki/Anpirtoline" title="Anpirtoline">Anpirtoline</a></li> <li><a href="/wiki/Arazasetron" class="mw-redirect" title="Arazasetron">Arazasetron</a></li> <li><a href="/wiki/AS-8112" title="AS-8112">AS-8112</a></li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a>)</li> <li><a href="/wiki/Azasetron" title="Azasetron">Azasetron</a></li> <li><a href="/wiki/Batanopride" title="Batanopride">Batanopride</a></li> <li><a href="/wiki/Bemesetron" title="Bemesetron">Bemesetron (MDL-72222)</a></li> <li><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a></li> <li><a href="/wiki/Cilansetron" title="Cilansetron">Cilansetron</a></li> <li><a href="/wiki/CSP-2503" title="CSP-2503">CSP-2503</a></li> <li><a href="/wiki/Dazopride" title="Dazopride">Dazopride</a></li> <li><a href="/wiki/Dolasetron" title="Dolasetron">Dolasetron</a></li> <li><a href="/wiki/Galanolactone" title="Galanolactone">Galanolactone</a></li> <li><a href="/wiki/Granisetron" title="Granisetron">Granisetron</a></li> <li><a href="/wiki/Hydroxybupropion" title="Hydroxybupropion">Hydroxybupropion</a></li> <li><a href="/wiki/Lerisetron" title="Lerisetron">Lerisetron</a></li> <li><a href="/wiki/Memantine" title="Memantine">Memantine</a></li> <li><a href="/wiki/Ondansetron" title="Ondansetron">Ondansetron</a></li> <li><a href="/wiki/Palonosetron" title="Palonosetron">Palonosetron</a></li> <li><a href="/wiki/Ramosetron" title="Ramosetron">Ramosetron</a></li> <li><a href="/wiki/Renzapride" title="Renzapride">Renzapride</a></li> <li><a href="/wiki/Ricasetron" title="Ricasetron">Ricasetron</a></li> <li><a href="/wiki/Tedatioxetine" title="Tedatioxetine">Tedatioxetine</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li> <li><a href="/wiki/Thujone" title="Thujone">Thujone</a></li> <li><a href="/wiki/Tropanserin" title="Tropanserin">Tropanserin</a></li> <li><a href="/wiki/Tropisetron" title="Tropisetron">Tropisetron</a></li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Loxapine" title="Loxapine">loxapine</a>)</li> <li><a href="/wiki/Inhalational_anaesthetic" class="mw-redirect" title="Inhalational anaesthetic">Volatiles/gases</a> (e.g., <a href="/wiki/Nitrous_oxide" title="Nitrous oxide">nitrous oxide</a>, <a href="/wiki/Sevoflurane" title="Sevoflurane">sevoflurane</a>, <a href="/wiki/Xenon" title="Xenon">xenon</a>)</li> <li><a href="/wiki/Vortioxetine" title="Vortioxetine">Vortioxetine</a></li> <li><a href="/wiki/Zacopride" title="Zacopride">Zacopride</a></li> <li><a href="/wiki/Zatosetron" title="Zatosetron">Zatosetron</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/w/index.php?title=LY-53857&amp;action=edit&amp;redlink=1" class="new" title="LY-53857 (page does not exist)">LY-53857</a></li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Naphthylpiperazine" title="Naphthylpiperazine">naphthylpiperazine</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT4_receptor" title="5-HT4 receptor">5-HT<sub>4</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a></li> <li><a href="/wiki/BIMU8" title="BIMU8">BIMU8</a></li> <li><a href="/wiki/Capeserod" title="Capeserod">Capeserod</a></li> <li><a href="/wiki/Cinitapride" title="Cinitapride">Cinitapride</a></li> <li><a href="/wiki/Cisapride" title="Cisapride">Cisapride</a></li> <li><a href="/wiki/CJ-033466" title="CJ-033466">CJ-033466</a></li> <li><a href="/wiki/Dazopride" title="Dazopride">Dazopride</a></li> <li><a href="/wiki/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li> <li><a href="/w/index.php?title=Minesapride&amp;action=edit&amp;redlink=1" class="new" title="Minesapride (page does not exist)">Minesapride</a></li> <li><a href="/wiki/Mosapride" title="Mosapride">Mosapride</a></li> <li><a href="/wiki/Prucalopride" title="Prucalopride">Prucalopride</a></li> <li><a href="/wiki/PRX-03140" title="PRX-03140">PRX-03140</a></li> <li><a href="/wiki/Renzapride" title="Renzapride">Renzapride</a></li> <li><a href="/wiki/RS-67,333" title="RS-67,333">RS-67,333</a></li> <li><a href="/w/index.php?title=RS-67,506&amp;action=edit&amp;redlink=1" class="new" title="RS-67,506 (page does not exist)">RS-67,506</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Tegaserod" title="Tegaserod">Tegaserod</a></li> <li><a href="/w/index.php?title=Usmarapride&amp;action=edit&amp;redlink=1" class="new" title="Usmarapride (page does not exist)">Usmarapride</a></li> <li><a href="/wiki/Velusetrag" title="Velusetrag">Velusetrag</a></li> <li><a href="/wiki/Zacopride" title="Zacopride">Zacopride</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/GR-113808" title="GR-113808">GR-113808</a></li> <li><a href="/w/index.php?title=GR-125487&amp;action=edit&amp;redlink=1" class="new" title="GR-125487 (page does not exist)">GR-125487</a></li> <li><a href="/wiki/Lysine" title="Lysine">L-Lysine</a></li> <li><a href="/wiki/Piboserod" title="Piboserod">Piboserod</a></li> <li><a href="/w/index.php?title=RS-39604&amp;action=edit&amp;redlink=1" class="new" title="RS-39604 (page does not exist)">RS-39604</a></li> <li><a href="/w/index.php?title=RS-67532&amp;action=edit&amp;redlink=1" class="new" title="RS-67532 (page does not exist)">RS-67532</a></li> <li><a href="/w/index.php?title=SB-203186&amp;action=edit&amp;redlink=1" class="new" title="SB-203186 (page does not exist)">SB-203186</a></li> <li><a href="/wiki/SB-204070" title="SB-204070">SB-204070</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT5A_receptor" title="5-HT5A receptor">5-HT<sub>5A</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/2-Bromo-LSD" title="2-Bromo-LSD">2-Br-LSD (BOL-148)</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/LSD" title="LSD">LSD</a>)</li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>)</li> <li><a href="/wiki/Valerenic_acid" title="Valerenic acid">Valerenic acid</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></li> <li><a href="/wiki/Latrepirdine" title="Latrepirdine">Latrepirdine (dimebolin)</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/SB-699551" title="SB-699551">SB-699551</a></li></ul> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>)</li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Naphthylpiperazine" title="Naphthylpiperazine">naphthylpiperazine</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT6_receptor" title="5-HT6 receptor">5-HT<sub>6</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">dihydroergocryptine</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/LSD" title="LSD">LSD</a>, <a href="/wiki/Mesulergine" title="Mesulergine">mesulergine</a>, <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>)</li> <li><a href="/wiki/Hypidone" title="Hypidone">Hypidone</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/2-Methyl-5-hydroxytryptamine" title="2-Methyl-5-hydroxytryptamine">2-Me-5-HT</a>, <a href="/wiki/5-Benzyloxytryptamine" title="5-Benzyloxytryptamine">5-BT</a>, <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">Bufotenin</a>, <a href="/wiki/E-6801" title="E-6801">E-6801</a>, <a href="/wiki/E-6837" title="E-6837">E-6837</a>, <a href="/wiki/EMD-386088" title="EMD-386088">EMD-386088</a>, <a href="/wiki/EMDT" title="EMDT">EMDT</a>, <a href="/w/index.php?title=LY-586713&amp;action=edit&amp;redlink=1" class="new" title="LY-586713 (page does not exist)">LY-586713</a>, <a href="/wiki/N-Methyl-5-HT" class="mw-redirect" title="N-Methyl-5-HT">N-Me-5-HT</a>, <a href="/wiki/ST-1936" title="ST-1936">ST-1936</a>, <a href="/wiki/Tryptamine" title="Tryptamine">tryptamine</a>)</li> <li><a href="/wiki/WAY-181187" title="WAY-181187">WAY-181187</a></li> <li><a href="/wiki/WAY-208466" title="WAY-208466">WAY-208466</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a href="/w/index.php?title=ABT-354&amp;action=edit&amp;redlink=1" class="new" title="ABT-354 (page does not exist)">ABT-354</a></li> <li><a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Clorotepine" title="Clorotepine">clorotepine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Fluperlapine" title="Fluperlapine">fluperlapine</a>, <a href="/wiki/Iloperidone" title="Iloperidone">iloperidone</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Tiospirone" title="Tiospirone">tiospirone</a>)</li> <li><a href="/wiki/AVN-101" class="mw-redirect" title="AVN-101">AVN-101</a></li> <li><a href="/wiki/AVN-211" title="AVN-211">AVN-211</a></li> <li><a href="/wiki/AVN-322" title="AVN-322">AVN-322</a></li> <li><a href="/wiki/AVN-397" title="AVN-397">AVN-397</a></li> <li><a href="/w/index.php?title=BGC20-760&amp;action=edit&amp;redlink=1" class="new" title="BGC20-760 (page does not exist)">BGC20-760</a></li> <li><a href="/w/index.php?title=BVT-5182&amp;action=edit&amp;redlink=1" class="new" title="BVT-5182 (page does not exist)">BVT-5182</a></li> <li><a href="/w/index.php?title=BVT-74316&amp;action=edit&amp;redlink=1" class="new" title="BVT-74316 (page does not exist)">BVT-74316</a></li> <li><a href="/wiki/Cerlapirdine" title="Cerlapirdine">Cerlapirdine</a></li> <li><a href="/wiki/EGIS-12,233" title="EGIS-12,233">EGIS-12,233</a></li> <li><a href="/w/index.php?title=GW-742457&amp;action=edit&amp;redlink=1" class="new" title="GW-742457 (page does not exist)">GW-742457</a></li> <li><a href="/wiki/Idalopirdine" title="Idalopirdine">Idalopirdine</a></li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/w/index.php?title=Landipirdine&amp;action=edit&amp;redlink=1" class="new" title="Landipirdine (page does not exist)">Landipirdine</a></li> <li><a href="/wiki/Latrepirdine" title="Latrepirdine">Latrepirdine (dimebolin)</a></li> <li><a href="/wiki/Masupirdine" title="Masupirdine">Masupirdine</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/MS-245" title="MS-245">MS-245</a></li> <li><a href="/wiki/PRX-07034" title="PRX-07034">PRX-07034</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/Ro_04-6790" title="Ro 04-6790">Ro 04-6790</a></li> <li><a href="/w/index.php?title=Ro_63-0563&amp;action=edit&amp;redlink=1" class="new" title="Ro 63-0563 (page does not exist)">Ro 63-0563</a></li> <li><a href="/wiki/SB-258585" title="SB-258585">SB-258585</a></li> <li><a href="/wiki/SB-271046" title="SB-271046">SB-271046</a></li> <li><a href="/wiki/SB-357134" title="SB-357134">SB-357134</a></li> <li><a href="/wiki/SB-399885" title="SB-399885">SB-399885</a></li> <li><a href="/wiki/Intepirdine" title="Intepirdine">SB-742457</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>)</li> <li><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a>, <a href="/wiki/Doxepin" title="Doxepin">doxepin</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Loxapine" title="Loxapine">loxapine</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/2-Bromo-LSD" title="2-Bromo-LSD">2-Br-LSD (BOL-148)</a>, <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Lergotrile" title="Lergotrile">lergotrile</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Naphthylpiperazine" title="Naphthylpiperazine">naphthylpiperazine</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5-HT7_receptor" title="5-HT7 receptor">5-HT<sub>7</sub></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/8-OH-DPAT" title="8-OH-DPAT">8-OH-DPAT</a></li> <li><a href="/wiki/AS-19_(drug)" title="AS-19 (drug)">AS-19</a></li> <li><a href="/wiki/Bifeprunox" title="Bifeprunox">Bifeprunox</a></li> <li><a href="/wiki/E-55888" title="E-55888">E-55888</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/LSD" title="LSD">LSD</a>)</li> <li><a href="/wiki/LP-12" title="LP-12">LP-12</a></li> <li><a href="/wiki/LP-44" title="LP-44">LP-44</a></li> <li><a href="/wiki/LP-211" title="LP-211">LP-211</a></li> <li><a href="/wiki/RU-24,969" title="RU-24,969">RU-24,969</a></li> <li><a href="/wiki/Sarizotan" title="Sarizotan">Sarizotan</a></li> <li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li> <li><a href="/wiki/Triptan" title="Triptan">Triptans</a> (e.g., <a href="/wiki/Frovatriptan" title="Frovatriptan">frovatriptan</a>)</li> <li><a href="/wiki/Substituted_tryptamine" title="Substituted tryptamine">Tryptamines</a> (e.g., <a href="/wiki/5-Carboxamidotryptamine" title="5-Carboxamidotryptamine">5-CT</a>, <a href="/wiki/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="/wiki/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="/wiki/N-Methylserotonin" title="N-Methylserotonin">N-Me-5-HT</a>)</li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Antagonists:</i> <a class="mw-selflink selflink">Atypical antipsychotics</a> (e.g., <a href="/wiki/Amisulpride" title="Amisulpride">amisulpride</a>, <a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="/wiki/Asenapine" title="Asenapine">asenapine</a>, <a href="/wiki/Brexpiprazole" title="Brexpiprazole">brexpiprazole</a>, <a href="/wiki/Clorotepine" title="Clorotepine">clorotepine</a>, <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Fluperlapine" title="Fluperlapine">fluperlapine</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Sertindole" title="Sertindole">sertindole</a>, <a href="/wiki/Tiospirone" title="Tiospirone">tiospirone</a>, <a href="/wiki/Ziprasidone" title="Ziprasidone">ziprasidone</a>, <a href="/wiki/Zotepine" title="Zotepine">zotepine</a>)</li> <li><a href="/wiki/Butaclamol" title="Butaclamol">Butaclamol</a></li> <li><a href="/wiki/DR-4485" title="DR-4485">DR-4485</a></li> <li><a href="/wiki/EGIS-12,233" title="EGIS-12,233">EGIS-12,233</a></li> <li><a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/2-Bromo-LSD" title="2-Bromo-LSD">2-Br-LSD (BOL-148)</a>, <a href="/wiki/Amesergide" title="Amesergide">amesergide</a>, <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="/wiki/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="/w/index.php?title=LY-53857&amp;action=edit&amp;redlink=1" class="new" title="LY-53857 (page does not exist)">LY-53857</a>, <a href="/wiki/LY-215,840" title="LY-215,840">LY-215,840</a>, <a href="/wiki/Mesulergine" title="Mesulergine">mesulergine</a>, <a href="/wiki/Metergoline" title="Metergoline">metergoline</a>, <a href="/wiki/Methysergide" title="Methysergide">methysergide</a>, <a href="/wiki/Sergolexole" title="Sergolexole">sergolexole</a>)</li> <li><a href="/wiki/JNJ-18038683" title="JNJ-18038683">JNJ-18038683</a></li> <li><a href="/wiki/Ketanserin" title="Ketanserin">Ketanserin</a></li> <li><a href="/wiki/LY-215,840" title="LY-215,840">LY-215,840</a></li> <li><a href="/wiki/Metitepine" title="Metitepine">Metitepine (methiothepin)</a></li> <li><a href="/wiki/Ritanserin" title="Ritanserin">Ritanserin</a></li> <li><a href="/wiki/SB-258719" title="SB-258719">SB-258719</a></li> <li><a href="/w/index.php?title=SB-258741&amp;action=edit&amp;redlink=1" class="new" title="SB-258741 (page does not exist)">SB-258741</a></li> <li><a href="/wiki/SB-269970" title="SB-269970">SB-269970</a></li> <li><a href="/w/index.php?title=SB-656104&amp;action=edit&amp;redlink=1" class="new" title="SB-656104 (page does not exist)">SB-656104</a></li> <li><a href="/w/index.php?title=SB-656104A&amp;action=edit&amp;redlink=1" class="new" title="SB-656104A (page does not exist)">SB-656104A</a></li> <li><a href="/w/index.php?title=SB-691673&amp;action=edit&amp;redlink=1" class="new" title="SB-691673 (page does not exist)">SB-691673</a></li> <li><a href="/w/index.php?title=SLV-313&amp;action=edit&amp;redlink=1" class="new" title="SLV-313 (page does not exist)">SLV-313</a></li> <li><a href="/w/index.php?title=SLV-314&amp;action=edit&amp;redlink=1" class="new" title="SLV-314 (page does not exist)">SLV-314</a></li> <li><a href="/wiki/Spiperone" title="Spiperone">Spiperone</a></li> <li><a href="/w/index.php?title=SSR-181507&amp;action=edit&amp;redlink=1" class="new" title="SSR-181507 (page does not exist)">SSR-181507</a></li> <li><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a> (e.g., <a href="/wiki/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="/wiki/Mianserin" title="Mianserin">mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li> <li><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a>, <a href="/wiki/Imipramine" title="Imipramine">imipramine</a>)</li> <li><a href="/wiki/Typical_antipsychotic" title="Typical antipsychotic">Typical antipsychotics</a> (e.g., <a href="/wiki/Acetophenazine" title="Acetophenazine">acetophenazine</a>, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Chlorprothixene" title="Chlorprothixene">chlorprothixene</a>, <a href="/wiki/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="/wiki/Loxapine" title="Loxapine">loxapine</a>, <a href="/wiki/Pimozide" title="Pimozide">pimozide</a>)</li> <li><a href="/wiki/Vortioxetine" title="Vortioxetine">Vortioxetine</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/Ergoline" title="Ergoline">Ergolines</a> (e.g., <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>)</li> <li><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="/wiki/Naphthylpiperazine" title="Naphthylpiperazine">naphthylpiperazine</a>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <ul><li><small><i><b>See also:</b> <a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></i></small></li> <li><small><i><a href="/wiki/Template:Adrenergic_receptor_modulators" title="Template:Adrenergic receptor modulators">Adrenergics</a></i></small></li> <li><small><i><a href="/wiki/Template:Dopamine_receptor_modulators" title="Template:Dopamine receptor modulators">Dopaminergics</a></i></small></li> <li><small><i><a href="/wiki/Template:Melatonin_receptor_modulators" title="Template:Melatonin receptor modulators">Melatonergics</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_reuptake_inhibitors" title="Template:Monoamine reuptake inhibitors">Monoamine reuptake inhibitors</a> and <a href="/wiki/Template:Monoamine_releasing_agents" title="Template:Monoamine releasing agents">releasing agents</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_metabolism_modulators" title="Template:Monoamine metabolism modulators">Monoamine metabolism modulators</a></i></small></li> <li><small><i><a href="/wiki/Template:Monoamine_neurotoxins" class="mw-redirect" title="Template:Monoamine neurotoxins">Monoamine neurotoxins</a></i></small></li></ul> </div></td></tr></tbody></table></div> <!-- NewPP limit report Parsed by mw‐web.codfw.main‐5c6f46dcf‐wphzp Cached time: 20250330222618 Cache expiry: 2592000 Reduced expiry: false Complications: [vary‐revision‐sha1, show‐toc] CPU time usage: 1.759 seconds Real time usage: 2.073 seconds Preprocessor visited node count: 14444/1000000 Post‐expand include size: 610508/2097152 bytes Template argument size: 16535/2097152 bytes Highest expansion depth: 25/100 Expensive parser function count: 8/500 Unstrip recursion depth: 1/20 Unstrip post‐expand size: 690853/5000000 bytes Lua time usage: 0.929/10.000 seconds Lua memory usage: 7123772/52428800 bytes Number of Wikibase entities loaded: 1/400 --> <!-- Transclusion expansion time report (%,ms,calls,template) 100.00% 1601.873 1 -total 54.22% 868.499 3 Template:Reflist 32.55% 521.363 90 Template:Cite_journal 13.29% 212.833 1 Template:Pharmacokinetics_of_long-acting_injectable_antipsychotics 9.28% 148.633 38 Template:No_selflink 8.41% 134.688 33 Template:Cite_web 5.55% 88.889 1 Template:Short_description 5.46% 87.469 18 Template:Cite_book 3.48% 55.706 6 Template:Fix 3.46% 55.345 2 Template:Pagetype --> <!-- Saved in parser cache with key enwiki:pcache:185272:|#|:idhash:canonical and timestamp 20250330222618 and revision id 1282674019. Rendering was triggered because: page-view --> </div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?useformat=desktop&amp;type=1x1&amp;usesul3=0" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Atypical_antipsychotic&amp;oldid=1282674019">https://en.wikipedia.org/w/index.php?title=Atypical_antipsychotic&amp;oldid=1282674019</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Atypical_antipsychotics" title="Category:Atypical antipsychotics">Atypical antipsychotics</a></li><li><a href="/wiki/Category:Hallucinogen_antidotes" title="Category:Hallucinogen antidotes">Hallucinogen antidotes</a></li><li><a href="/wiki/Category:Psychopharmacology" title="Category:Psychopharmacology">Psychopharmacology</a></li><li><a href="/wiki/Category:Treatment_of_psychosis" title="Category:Treatment of psychosis">Treatment of psychosis</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_numeric_names:_authors_list" title="Category:CS1 maint: numeric names: authors list">CS1 maint: numeric names: authors list</a></li><li><a href="/wiki/Category:All_articles_with_incomplete_citations" title="Category:All articles with incomplete citations">All articles with incomplete citations</a></li><li><a href="/wiki/Category:Articles_with_incomplete_citations_from_August_2013" title="Category:Articles with incomplete citations from August 2013">Articles with incomplete citations from August 2013</a></li><li><a href="/wiki/Category:Articles_with_incomplete_citations_from_August_2015" title="Category:Articles with incomplete citations from August 2015">Articles with incomplete citations from August 2015</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:Use_mdy_dates_from_January_2012" title="Category:Use mdy dates from January 2012">Use mdy dates from January 2012</a></li><li><a href="/wiki/Category:All_pages_needing_factual_verification" title="Category:All pages needing factual verification">All pages needing factual verification</a></li><li><a href="/wiki/Category:Wikipedia_articles_needing_factual_verification_from_February_2018" title="Category:Wikipedia articles needing factual verification from February 2018">Wikipedia articles needing factual verification from February 2018</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2023" title="Category:Articles with unsourced statements from March 2023">Articles with unsourced statements from March 2023</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_July_2013" title="Category:Articles containing potentially dated statements from July 2013">Articles containing potentially dated statements from July 2013</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Commons_category_link_from_Wikidata" title="Category:Commons category link from Wikidata">Commons category link from Wikidata</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 27 March 2025, at 22:39<span class="anonymous-show">&#160;(UTC)</span>.</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Atypical_antipsychotic&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://www.wikimedia.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/static/images/footer/wikimedia-button.svg" width="84" height="29"><img src="/static/images/footer/wikimedia.svg" width="25" height="25" alt="Wikimedia Foundation" lang="en" loading="lazy"></picture></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/w/resources/assets/poweredby_mediawiki.svg" width="88" height="31"><img src="/w/resources/assets/mediawiki_compact.svg" alt="Powered by MediaWiki" lang="en" width="25" height="25" loading="lazy"></picture></a></li> </ul> </footer> </div> </div> </div> <div class="vector-header-container vector-sticky-header-container"> <div id="vector-sticky-header" class="vector-sticky-header"> <div class="vector-sticky-header-start"> <div class="vector-sticky-header-icon-start vector-button-flush-left vector-button-flush-right" aria-hidden="true"> <button class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-sticky-header-search-toggle" tabindex="-1" data-event-name="ui.vector-sticky-search-form.icon"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </button> </div> <div role="search" class="vector-search-box-vue vector-search-box-show-thumbnail vector-search-box"> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail"> <form action="/w/index.php" id="vector-sticky-search-form" class="cdx-search-input cdx-search-input--has-end-button"> <div class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia"> <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <div class="vector-sticky-header-context-bar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-sticky-header-toc" class="vector-dropdown mw-portlet mw-portlet-sticky-header-toc vector-sticky-header-toc vector-button-flush-left" > <input type="checkbox" id="vector-sticky-header-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-sticky-header-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-sticky-header-toc-label" for="vector-sticky-header-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span> <span class="vector-dropdown-label-text">Toggle the table of contents</span> </label> <div class="vector-dropdown-content"> <div id="vector-sticky-header-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div class="vector-sticky-header-context-bar-primary" aria-hidden="true" ><span class="mw-page-title-main">Atypical antipsychotic</span></div> </div> </div> <div class="vector-sticky-header-end" aria-hidden="true"> <div class="vector-sticky-header-icons"> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-talk-sticky-header" tabindex="-1" data-event-name="talk-sticky-header"><span class="vector-icon mw-ui-icon-speechBubbles mw-ui-icon-wikimedia-speechBubbles"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-subject-sticky-header" tabindex="-1" data-event-name="subject-sticky-header"><span class="vector-icon mw-ui-icon-article mw-ui-icon-wikimedia-article"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-history-sticky-header" tabindex="-1" data-event-name="history-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-history mw-ui-icon-wikimedia-wikimedia-history"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only mw-watchlink" id="ca-watchstar-sticky-header" tabindex="-1" data-event-name="watch-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-star mw-ui-icon-wikimedia-wikimedia-star"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-edit-sticky-header" tabindex="-1" data-event-name="wikitext-edit-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-wikiText mw-ui-icon-wikimedia-wikimedia-wikiText"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-ve-edit-sticky-header" tabindex="-1" data-event-name="ve-edit-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-edit mw-ui-icon-wikimedia-wikimedia-edit"></span> <span></span> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-viewsource-sticky-header" tabindex="-1" data-event-name="ve-edit-protected-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-editLock mw-ui-icon-wikimedia-wikimedia-editLock"></span> <span></span> </a> </div> <div class="vector-sticky-header-buttons"> <button class="cdx-button cdx-button--weight-quiet mw-interlanguage-selector" id="p-lang-btn-sticky-header" tabindex="-1" data-event-name="ui.dropdown-p-lang-btn-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-language mw-ui-icon-wikimedia-wikimedia-language"></span> <span>22 languages</span> </button> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive" id="ca-addsection-sticky-header" tabindex="-1" data-event-name="addsection-sticky-header"><span class="vector-icon mw-ui-icon-speechBubbleAdd-progressive mw-ui-icon-wikimedia-speechBubbleAdd-progressive"></span> <span>Add topic</span> </a> </div> <div class="vector-sticky-header-icon-end"> <div class="vector-user-links"> </div> </div> </div> </div> </div> <div class="mw-portlet mw-portlet-dock-bottom emptyPortlet" id="p-dock-bottom"> <ul> </ul> </div> <script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-5c6f46dcf-n26vn","wgBackendResponseTime":388,"wgPageParseReport":{"limitreport":{"cputime":"1.759","walltime":"2.073","ppvisitednodes":{"value":14444,"limit":1000000},"postexpandincludesize":{"value":610508,"limit":2097152},"templateargumentsize":{"value":16535,"limit":2097152},"expansiondepth":{"value":25,"limit":100},"expensivefunctioncount":{"value":8,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":690853,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 1601.873 1 -total"," 54.22% 868.499 3 Template:Reflist"," 32.55% 521.363 90 Template:Cite_journal"," 13.29% 212.833 1 Template:Pharmacokinetics_of_long-acting_injectable_antipsychotics"," 9.28% 148.633 38 Template:No_selflink"," 8.41% 134.688 33 Template:Cite_web"," 5.55% 88.889 1 Template:Short_description"," 5.46% 87.469 18 Template:Cite_book"," 3.48% 55.706 6 Template:Fix"," 3.46% 55.345 2 Template:Pagetype"]},"scribunto":{"limitreport-timeusage":{"value":"0.929","limit":"10.000"},"limitreport-memusage":{"value":7123772,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-5c6f46dcf-wphzp","timestamp":"20250330222618","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Atypical antipsychotic","url":"https:\/\/en.wikipedia.org\/wiki\/Atypical_antipsychotic","sameAs":"http:\/\/www.wikidata.org\/entity\/Q758295","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q758295","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-02-19T18:32:33Z","dateModified":"2025-03-27T22:39:28Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/3\/32\/Clozapine.svg","headline":"class of pharmaceutical drugs"}</script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10